
























mitochondrial	 oxidative	 stress.	 Synaptic	 overgrowth	 is	 observed	 following	
treatment	with	DEM	 that	was	 shown	 to	 require	 the	 permissive	 action	 of	 Fos,	 Jun	
and	 the	 JNKKK,	ASK1.	Tandem	Affinity	Purification	 (TAP)-tagging	and	subsequent	
purification	 of	 neuronally	 expressed	 Fos	 and	 Jun	 led	 to	 the	 identification	 of	 the	
associated	protein	Punch.	Punch	is	the	Drosophila	orthologue	of	GTP	cyclohydrolase	
1	 (GTPCH1),	 haploinsufficient	 mutations	 of	 which	 are	 found	 in	 DOPA-responsive	
dystonia	and	Parkinson’s	disease	patients.	Punch	is	the	rate-limiting	enzyme	in	the	
biosynthesis	of	tetrahydrobiopterin	(BH4),	an	essential	cofactor	in	the	synthesis	of	
dopamine	and	 serotonin	as	well	 as	 a	potent	ROS	 scavenger.	Treatment	with	DEM	
appeared	to	cause	dissociation	of	Punch	from	AP-1	upon	increased	oxidative	stress.	
It	was	found	that	Punch,	Fos	and	Jun	are	localised	to	the	motor	neuron	cell	nuclei.	
Analysis	 of	 larval	 neuromuscular	 junctions	 revealed	 JNK/AP-1-mediated	 synaptic	
overgrowth	 in	 Punch	 heterozygote	 mutants.	 This	 is	 rescued	 when	 the	 oxidative	
stress	or	dopamine	deficit	 is	relieved.	Punch	overexpression	also	rescues	synaptic	
overgrowth	 associated	 with	 elevated	 JNK/AP-1	 signalling	 in	 the	 absence	 of	
oxidative	stress,	suggesting	Punch	constrains	AP-1	action.	Punch	expression	is	able	
to	reduce	oxidative	stress-synaptic	overgrowth	potentially	via	synthesis	of	BH4	and	
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As	 a	 cell	 enters	 senescence,	 it	 remains	 metabolically	 active	 while	 accumulating	
damaged	 or	 dysfunctional	 macromolecules	 toward	 the	 end	 of	 the	 lifespan.	
Organelles	 are	 degraded	 via	 the	 lysosome,	 which	with	 ageing	 becomes	 relatively	
inefficient	 and	 some	 dysfunctional	 molecules	 remain,	 often	 within	 the	
endolysosomal	system.	As	these	aggregate	they	are	able	to	form	a	non-degradable	
waste	material	named	lipofuscin,	also	known	as	the	age	pigment	(Katz	and	Robison,	











(short-lived,	 highly	 reactive	 molecules	 with	 unpaired	 valence	 electrons)	 derived	
from	molecular	 oxygen.	 In	 its	 ground	 state,	 molecular	 oxygen	 is	 a	 bi-radical	 and	
contains	 two	 unpaired	 electrons	 occupying	 two	 degenerate	 molecular	 orbitals,	
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which	 is	also	known	as	a	 triplet	state	(Turrens,	2003,	Apel	and	Hirt,	2004).	These	
two	 unpaired	 electrons	 make	 oxygen	 quite	 unreactive	 as	 oxidation	 of	 molecules	
require	partners	that	can	provide	a	pair	of	electrons	with	parallel	spins	that	fit	into	
its	 free	electron	orbitals.	However,	most	organic	molecules	 typically	have	pairs	of	
electrons	 with	 opposite	 spins,	 which	 prevent	 molecular	 oxygen	 directly	 reacting	
with	 them	 (Cadenas,	 1989).	 Ground	 state	 triplet	 oxygen	 can	 however	 undergo	
electron	transfer	reactions	in	which	superoxide	radical	anions	(O2!-)	are	generated	
through	 oxygen	 reduction.	 Superoxide	 anions	 can	 act	 as	 both	 an	 oxidant	 and	
reductant,	and	whilst	not	the	most	potent	ROS,	they	can	give	rise	to	other	extremely	
reactive	 free	 radicals	 and	 ROS,	most	 notably	 hydrogen	 peroxide	 (H2O2),	 hydroxyl	
radicals	 (!OH)	 and	hydroxyl	 anions	 (OH-).	Hydrogen	peroxide	 is	 formed	 after	 the	
rapid	dismutation	of	the	highly	unstable	superoxide	anion,	catalysed	by	superoxide	
dismutase	 (SOD),	which	allows	 the	 reaction	 to	occur	10,000	 times	 faster	 (McCord	
and	 Fridovich,	 1969a,	 McCord	 and	 Fridovich,	 1969b).	 SOD	 binds	 two	 superoxide	
anions	 and	 transfers	 the	 extra	 electron	 from	 one	 superoxide	 anion	 to	 the	 other,	
effectively	 generating	 one	 ground	 state	 triplet	 oxygen	 molecule	 and	 one	 oxygen	
molecule	 with	 two	 extra	 electrons,	 which	 rapidly	 react	 with	 two	 hydrogen	 ions	
forming	hydrogen	peroxide	(Fridovich,	1989).	The	reaction	follows:		
	O2!-	+	O2!-	+2H+	"	H2O2	+	O2	




usually	 within	 the	 lysosome	 which	 is	 a	 major	 site	 of	 iron	 storage	 and	 recycling	
(Radisky	and	Kaplan,	1998)	:	
Fe3+	+	O2!-	"	Fe2+	+	O2		




The	 hydroxyl	 radical	 generated	 here	 is	 the	 most	 biologically	 active	 free	 radical	
formed	under	hypoxic	conditions	(Michiels,	2004).	The	hydroxyl	radical	causes	the	
majority	 of	 oxidative	 damage	 via	 oxidising	 DNA	 bases,	 DNA	 strand	 breaks,	
generating	abasic	sites	and	DNA-DNA	intra-strand	adducts	(Randerath	et	al.,	1996,	
Lloyd	et	al.,	1997,	Cadet	et	al.,	1999).	Proteins	can	also	undergo	direct	oxidation	at	
the	 polypeptide	 backbone,	 leading	 to	 truncated	 peptides.	 Various	 oxidative	






1972),	 the	 cytosol	 (Kukreja	 et	 al.,	 1986),	 plasma	membrane	 (O'Donnell	 and	 Azzi,	
1996)	and	extracellular	space	(McNally	et	al.,	2003).		
1.2.2.1 	Mitochondrial	generation	of	ROS	
Mitochondria	 are	 the	 cellular	 energetic	 powerhouse,	 producing	 the	 majority	 of	
energy	 required	 in	 the	 lifetime	 of	 the	 cell.	 They	 are	 dynamic	 organelles,	 that	
undergo	fission	and	fusion	which	alters	their	length	and	shape	(van	der	Bliek	et	al.,	
2013).	 They	 have	 a	 double-membrane;	 consisting	 of	 an	 outer	 membrane	
surrounding	 an	 inner	membrane	 and	 including	 an	 intermembrane	 space	 (Palade,	
1953).	 The	 permeability	 of	 the	membranes	 differs.	 The	 outer	membrane	 features	
many	protein-based	pores	to	allow	the	passage	of	small	proteins	and	ions,	whereas	
the	 inner	 membrane	 is	 much	 less	 permeable.	 This	 is	 to	 accommodate	 the	
mitochondrial	matrix,	the	site	of	the	citric	acid	cycle,	which	ultimately	produces	the	
adenosine	 triphosphate	 (ATP)	 required	 by	 the	 cell.	 Mitochondrial	 respiration	
involves	 the	 movement	 of	 electrons	 through	 various	 electron	 donors,	 including	
nicotinamide	adenine	nucleotide	 (NADH)	and	reduced	 flavin	adenine	dinucleotide	
(FADH2),	 which	 transfer	 electrons	 down	 the	 electron	 transport	 chain	 (ETC)	
between	 complexes	 I	 –	 IV;	 electron	 carriers	 located	 in	 the	 inner	membrane.	 The	
electrons	are	finally	transferred	to	O2,	the	most	electronegative	electron	acceptor	in	
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the	 chain.	 As	 electrons	 pass	 along	 the	 ETC,	 free	 energy	 is	 released	 in	 small	
increments	 from	 NADH	 and	 FADH2;	 these	 exergenic	 processes	 are	 coupled	 to	
proton	 transport	 into	 the	 intermembrane	 space,	 which	 generates	 a	 proton	
concentration	 gradient.	 The	 outer	 membrane	 of	 the	 mitochondria	 is	 more	
permeable	 to	 protons,	 which	 makes	 the	 overall	 pH	 higher	 than	 that	 of	 the	
intermembrane	 space.	 Positively	 charged	 protons	 are	 also	 pumped	 out	 from	 the	
matrix	making	it	more	negative	compared	to	the	intermembrane	space,	resulting	in	
an	 electrical	 potential	 across	 the	 inner	membrane.	Both	 the	proton	 concentration	
gradient	 and	 the	 electrical	 potential	 store	 the	 free	 energy	 released	 during	 the	
oxidation	 of	 NADH	 and	 FADH2,	 this	 is	 known	 as	 the	 proton-motive	 force.	 The	
consequent	 flow	 of	 protons	 back	 into	 the	 matrix	 across	 the	 inner	 membrane	 is	
driven	 by	 the	 proton-motive	 force	 and	 by	 using	 the	 stored	 free	 energy,	 ATP	 is	
formed	 from	 adenosine	 diphosphate	 (ADP)	 and	 free	 phosphate	 (Pi)	 facilitated	 by	
ATP	synthase,	or	complex	V.	This	process	is	named	oxidative	phosphorylation	and	
is	 the	major	source	of	ATP	 in	aerobic	non-photosynthetic	cells.	Whilst	a	relatively	
efficient	 process,	 it	 is	 possible	 for	 electrons	 to	 leak	 from	 the	 electron	 transport	
chain	 where	 they	 can	 reduce	 molecular	 oxygen.	 It	 only	 requires	 a	 single	 leaked	
electron	 to	 reduce	 oxygen	 to	 a	 superoxide	 anion,	 the	 precursor	 of	 most	 ROS	
produced	 in	 the	 cell	 (Boveris	 and	 Chance,	 1973).	 The	 estimated	 steady	 state	
concentration	 of	 superoxide	 anions	 in	 the	mitochondrial	matrix	 is	 10−10	M,	 every	
anion	having	the	potential	to	induce	hydroxyl	formation	if	not	rapidly	dealt	with	by	
the	antioxidant	system	(Cadenas	and	Davies,	2000).		
Ordinarily,	 the	 first	 process	 in	 the	 series	 of	 electron	 transfers	 is	 the	 donation	 of	






This	 reaction	 releases	 energy,	 most	 of	 which	 is	 used	 to	 transport	 H+	 into	 the	
intermembrane	 space,	 however,	 a	 separate	 reaction	 exists	 wherein	 CoQ	 receives	
	 19	
electrons	from	complex	II	but	is	not	coupled	to	the	movement	of	H+	and	no	proton-
motive	 force	 is	 generated.	 Complex	 II,	 or	 succinate	 dehydrogenase,	 is	 an	 enzyme	
that	 oxidises	 succinate	 to	 fumarate	during	 the	 citric	 acid	 cycle.	The	 conversion	of	
succinate	to	fumarate	releases	two	electrons	that	are	initially	transferred	to	redox	
cofactor,	 oxidised	 flavin	 adenine	 dinucleotide	 (FAD)	 and	 then	 to	 an	 iron-sulphur	
carrier	 before	 finally	 reducing	 CoQ	 to	 CoQH2.	 CoQ	 can	 freely	 diffuse	 within	 the	
membrane	 and	 shuttles	 two	 electrons	 to	 complex	 III,	 or	 CoQH2–cytochrome	 c	
reductase,	regenerating	the	oxidised	CoQ	in	the	process.	
Cytochrome	 c	 reductase	 is	 a	 complex	made	up	 of	 an	 iron-sulphur	protein,	 two	b-
type	cytochromes	and	cytochrome	c1	of	which	the	electrons	transferred	from	CoQ	
are	 shuttled	 across	 and	 finally	 transferred	 to	 oxidised	 cytochrome	 c.	Each	 pair	 of	
electrons	 transferred	 here	 facilitates	 the	 translocation	 of	 four	 protons	 across	 the	
inner	membrane	from	the	matrix.		
Reduced	 cytochrome	 c	 now	 transports	 electrons	 to	 complex	 IV,	 or	 cytochrome	 c	
oxidase,	 the	 final	protein	 complex	 in	 the	ETC.	The	electrons	are	moved	 through	a	




inner	 membrane	 for	 every	 pair	 of	 electrons	 transferred	 from	 NADH	 to	 O2.	 The	
proton-motive	force	is	the	source	of	energy	required	for	ATP	synthesis,	utilised	by	
the	 FoF1	 complex,	 or	 ATP	 synthase.	 Fo	 is	 a	 membrane	 protein	 consisting	 of	 a	
transmembrane	 proton	 channel,	 through	 which	 protons	 move	 from	 the	
intermembrane	 space	 to	 the	 mitochondrial	 matrix	 downhill	 toward	 F1.	 This	
movement	 releases	 energy,	 which	 activates	 a	 conformational	 change	 in	 F1,	
catalysing	 the	 synthesis	 of	 ATP	 from	 ADP	 and	 Pi,	 and	 completing	 oxidative	
phosphorylation.	As	well	 as	powering	ATP	 synthase,	 the	proton-motive	 force	also	
provides	 the	 energy	 for	 the	 uptake	 of	 ADP	 and	 Pi	 from	 the	 cytosol	 into	 the	
mitochondria	in	exchange	for	the	release	of	ATP	and	OH-	into	the	cytosol.	
The	 formation	of	ROS	 from	the	mitochondria	 is	 thought	 to	 take	place	primarily	at	
complex	 I	 and	 complex	 III,	 the	 dominant	 source	 being	 organ	 dependent.	 At	 each	
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complex	where	electron	transfer	occurs	there	is	a	small	chance	of	a	single	electron	




from	 complex	 III,	 whereas	 in	 the	 mitochondria	 of	 the	 brain	 this	 occurs	 more	
commonly	from	complex	I	in	both	normal	and	ageing	brains	(Turrens	and	Boveris,	
1980,	 Turrens	 et	 al.,	 1982,	 Barja	 and	 Herrero,	 1998,	 Barja,	 1999).	 The	 rate	 of	
superoxide	 formation	 by	 the	 ETC	 is	 largely	 controlled	 by	mass	 action,	 increasing	
when	 the	 concentration	 of	 oxygen	 rises	 or	 when	 the	 flow	 of	 electrons	 slows	
(Turrens	 et	 al.,	 1982).	 As	 previously	 mentioned,	 the	 proton	 gradient	 powers	 the	
production	 of	 ATP,	 however	 this	 requires	 ADP,	 which	 when	 depleted,	 stops	 the	
proton	 flow	 through	 ATP	 synthase.	 Consequently,	 the	 proton	 gradient	




Whilst	 most	 consider	 the	 mitochondria	 the	 largest	 source	 of	 ROS	 many	 other	




Cytosolic	 sources	 of	 oxidative	 stress	 often	 involve	 cytosolic	 enzymes	 that	 act	 to	
generate	 ROS	 as	 a	 by-product	 of	 their	 main	 function.	 One	 such	 enzyme	 that	
produces	ROS	is	xanthine	oxidase	(XO),	which	generates	hydrogen	peroxide	when	it	








release,	 but	 upon	 neuronal	 injury	 its	 concentration	 rises	 at	 least	 10-fold,	 causing	
mass	damage.	NO	 can	 react	with	hydrogen	peroxide	 and	 form	 the	highly	 reactive	





and	 protein	 disulphide	 isomerase	 (PDI).	 ERO1	 is	 a	 thiol	 oxidase	 enzyme	 that	
catalyses	the	formation	of	disulphide	bonds	along	with	PDI	within	the	endoplasmic	
reticulum.	 Both	 proteins	 contribute	 to	 the	 production	 of	 ROS	 when	 incomplete	
reduction	 of	 oxygen	 occurs	 during	 the	 electron	 exchange	 process	 required	 for	
disulphide	 bond	 formation,	 producing	 hydrogen	 peroxide	 and	 superoxide	 anions	
(Bhandary	et	al.,	2013).		
Another	 important	 site	 of	 ROS	 production	 is	 the	 peroxisome;	 a	 single	membrane	
bound	 organelle	 filled	 with	 oxidative	 enzymes	 involved	 in	 metabolism	 and	 the	
breakdown	 of	 various	 fatty	 acids.	 They	 bud	 from	 the	 endoplasmic	 reticulum	 and	
through	 beta-oxidation	 they	 break	 down	 long	 chain	 fatty	 acids	 to	 medium	 chain	
fatty	acids,	which	are	 transported	 to	 the	mitochondria	 for	 further	breakdown	and	
synthesis	of	ATP.	The	oxidative	enzymes	use	oxygen	to	produce	hydrogen	peroxide	
when	 removing	 hydrogen	 atoms	 from	 organic	 substrates,	 RH2,	 in	 the	 following	
equation:	
RH2	+	O2"	R	+	H2O2	










synthesised	 by	 the	 Golgi	 apparatus	 instead	 of	 the	 ER.	 They	 contain	 hydrolytic	
enzymes	 such	 as	 proteases,	 lipases,	 peptidases	 and	 nucleases	 used	 to	 digest	
macromolecules	 of	 the	 cell	 (Bainton,	 1981).	 The	 lysosome	 is	 important	 for	
endocytosis	and	autophagy	but	is	also	a	potent	site	of	ROS	production.	Incomplete	
digestion	of	macromolecules	leads	to	the	formation	of	age-pigment,	lipofuscin.	This	
non-degradable	 pigment	 remains	 in	 the	 lysosome,	 sequestering	 the	 hydrolytic	
enzymes	and	reducing	the	efficiency	of	the	lysosomal	system	over	time	(Jolly	et	al.,	
1995).	As	this	builds	up	so	does	lysosomal	iron,	which	accumulates	in	the	lysosome	
after	 it	 is	 transported	 via	 autophagocytosed	 macromolecules	 during	 autophagy.	
This	 accumulation	 is	 particularly	 evident	 in	 long-lived	 post	 mitotic	 cells	 such	 as	
neurons,	 and	 through	 the	 Fenton	 reaction	 can	 generate	 ROS	 and	 the	 extremely	
reactive	 hydroxyl	 radical	 when	 reacting	 with	 hydrogen	 peroxide.	 Hydrogen	
peroxide	generated	in	the	mitochondria	that	escapes	degradation	via	catalase	(cat)	
and	glutathione	peroxidase	(GPx),	 is	able	to	diffuse	into	the	lysosome	where	these	
antioxidants	 do	 not	 occur	 (Figure	 1.1).	 It	 is	 then	 free	 to	 react	 with	 labile	 iron	





Lysosomal	 function	 is	 decreased	 upon	 the	 accumulation	 of	 lipofuscin,	 a	 non-degradable	 waste	





As	 previously	 described,	 ROS	 are	 produced	 as	 natural	 by-products	 of	 numerous	
cellular	 processes,	 mitochondrial	 respiration	 being	 the	 most	 prevalent	 (Turrens,	
2003).	A	battery	of	 antioxidants	 actively	 removes	ROS	ensuring	a	healthy	 cellular	
environment	where	low	levels	of	ROS	remain.	Maintaining	ROS	at	low	physiological	
levels	are	the	cellular	antioxidants,	which	act	to	scavenge	ROS	and	retain	the	tightly	
regulated	 redox	 balance	 within	 the	 cell.	 Oxidative	 stress	 occurs	 when	 the	 native	
antioxidant	system	is	overwhelmed	by	ROS,	either	 from	a	pathological	 increase	of	
ROS	 or	 inadequate	 detoxification.	 Oxidative	 stress	 causes	 random	 damage	 to	 the	
macromolecules	of	 the	cell	whilst	also	activating	cell-signalling	pathways	 involved	
in	 the	 cellular	 stress	 response.	 Such	oxidative	damage	 includes	DNA	 lesions,	 lipid	
peroxidation,	 and	 oxidisation/fragmentation	 of	 peptides	 often	 as	 a	 result	 of	mass	
chain	reactions	initiated	by	ROS.	Consequently,	oxidative	stress	has	been	implicated	
in	 a	 number	 of	 neurodegenerative	 disorders,	 including	 Parkinson’s	 Disease	 (PD)	
(Spina	and	Cohen,	1989)	and	Alzheimer’s	disease	 (AD)	 (Martins	et	al.,	1986).	The	
cellular	stress	response	involves	a	number	of	signalling	pathways	including	several	
mitogen-activated	 protein	 kinase	 (MAPK)	 pathways,	 namely	 the	 Jun	 N-terminal	
kinase	 (JNK)/extracellular	 signal-regulated	 kinase	 (ERK)/p38	 pathways	 or	 the	
stress-activated	 protein	 kinases	 (SAPK).	 Also	 activated	 are	 PI3-kinase/AKT,	 p53	
signalling,	 Nrf2/Keap1	 signalling	 and	 nuclear-factor	 κB	 (NF-κB)	 signalling	
pathways.	 These	 pathways	 culminate	 in	 the	 activation	 of	 proliferation,	 growth	
arrest,	autophagy	and	cellular	death	(Martindale	and	Holbrook,	2002).	In	summary,	
there	 are	 standing	 constitutive	 defences	 against	 oxidative	 stress,	 in	 the	 form	 of	
enzymatic	 antioxidants,	 non-enzymatic	 antioxidants	 as	 well	 as	 adaptive	






not	 properly	 neutralised.	 Cellular	 DNA	 can	 be	 damaged	 by	 the	 highly	 reactive	
hydroxyl	 radical	 through	 its	 addition	 to	 the	 double	 bonds	 of	 DNA	 bases	where	 a	
hydrogen	 atom	 is	 abstracted	 from	 the	 methyl	 group	 of	 thymine	 and	 from	 the	
carbon-hydrogen	 bonds	 of	 2’-deoxyribose	 (Sonntag,	 1987,	 Cooke	 et	 al.,	 2003).	
Damage	 to	 DNA	may	 also	 arise	 in	 the	 form	 of	 strand	 breaks	 when	 the	 hydroxyl	
radical	 reacts	 with	 the	 sugar	 moiety	 of	 DNA	 removing	 the	 hydrogen	 atom.	 ROS	
cause	 base	 and	 nucleotide	 modifications,	 microsatellite	 instability	 as	 well	 as	
changes	 in	 DNA	 conformation,	 which	 result	 in	 inaccurate	 or	 blocked	 replications	
(Cooke	et	al.,	2003).	The	methylation	status	of	cytosines	in	DNA	can	also	be	altered	
by	free	radicals,	changing	the	expression	level	of	the	affected	region	(Weitzman	et	
al.,	 1994).	 Similar	 to	 DNA,	 proteins	 can	 be	 damaged/oxidised	 by	 ROS	 though	 the	
hydroxyl-dependant	 abstraction	 of	 hydrogen	 from	 amino	 acids	 making	 up	 the	
polypeptide	 backbone	 (Berlett	 and	 Stadtman,	 1997).	 Oxidisation	 of	 the	 protein	
backbone	can	also	trigger	a	chain	reaction	by	which	alkyl,	alkoxyl	and	alkylperoxyl	
radicals	 form,	 inducing	 fragmentation	 of	 the	 protein.	 Peptide	 cleavage	 can	 also	
occur	when	 ROS	 attack	 protein	 side	 chains	 (glutamyl,	 aspartyl	 and	 prolyl),	 again	
through	hydroxyl-dependant	abstraction	of	hydrogen.	Protein	function	is	altered	by	
oxidation	 of	 amino	 acids,	 cysteine	 and	 methionine	 being	 especially	 susceptible	
where	 disulphide	 cross-links	 form	 upon	 oxidation	 (Berlett	 and	 Stadtman,	 1997).	
Fatty	 acids	 are	 also	 susceptible	 to	 damage	 by	 ROS.	 Phospholipid	membrane	 fatty	
acids,	or	polyunsaturated	fatty	acids	(PUFA)	are	oxidised	at	their	double	bonds	and	
degraded	 forming	 lipid	 peroxidation	 products	 (LPO)	 including	 lipid	 peroxyl	
radicals.	 Lipid	 peroxyl	 radicals	 are	 highly	 reactive,	 oxidising	 adjacent	 PUFA	 and	
attacking	membrane	proteins.	Lipid	peroxidation	is	a	self-propagating	autocatalytic	
process	 capable	 of	 exponentially	 producing	 more	 ROS	 until	 quenched	 by	
antioxidants.	When	 the	 LPO	 are	 broken	 down	 the	 resulting	 products	 are	 able	 to	
interact	 with	 DNA,	 causing	 adducts	 that	 are	 mutagenic,	 carcinogenic	 and	
debilitating	to	signal	transduction	pathways	(Marnett	and	Plastaras,	2001,	Hulbert	
et	al.,	2007).		
The	 exponential	 production	 of	 ROS	 can	 occur	 from	 chain	 reactions	 initiated	 by	
single	ROS	molecules.	This	makes	it	difficult	to	pinpoint	the	exact	cause	of	oxidative	
stress.	 ROS	 impact	 upon	 mitochondrial	 and	 lysosomal	 function	 increasing	 ROS	
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production	 further	 (see	Figure	1.1).	Oxidative	 stress	 and	ROS	 increase	 as	we	 age,	
overwhelming	 the	 native	 antioxidant	 defences,	 causing	 mass	 damage	 to	
macromolecules	 and	 incurring	 pathology.	 This	 is	 the	 hallmark	 of	 ageing	 and	 is	
implicated	in	the	onset	and	progression	of	a	number	of	neurodegenerative	diseases.	
Combatting	oxidative	stress	 is	a	battery	of	antioxidants	 that	act	 to	convert	ROS	to	




systems.	 An	 antioxidant	 is	 defined	 as	 “any	 substance	 that,	 when	 present	 at	 low	
concentrations	 compared	with	 that	of	 an	oxidisable	 substrate,	 significantly	delays	




• Tertiary	 antioxidants	 –	 repair	 oxidised	 molecules	 through	 dietary	 or	
consecutive	antioxidants.		
Antioxidants	 may	 be	 enzymatic	 or	 non-enzymatic.	 Enzymatic	 antioxidants	 can	
directly,	 or	 indirectly	 contribute	 to	 the	 defence	 against	 ROS.	 They	 include	
superoxide	 dismutase	 (SOD),	 catalase	 (Cat),	 glutathione	 peroxidase	 (GPx),	
glutathione	 reductase	 (GR)	 and	 thioredoxin	 reductase	 (Trx).	 Non-enzymatic	
antioxidants	 are	 ROS	 scavengers	 and	 include	 glutathione,	 vitamin	 E,	
tetrahydrobiopterin	 (BH4),	 uric	 acid,	 albumin,	 and	 bilirubin,	 amongst	 others	
(Halliwell,	1996,	Birben	et	al.,	2012,	Pathak	et	al.,	2015).	Primary	antioxidants	act	to	
break	 the	 ensuing	 chain	 reactions	 that	 lead	 to	 exponential	 ROS	 production	 and	
convert	 them	 to	 less	 reactive	 molecules.	 Secondary	 antioxidants	 act	 to	 scavenge	
ROS,	 becoming	 oxidised	 in	 the	 process	 and	 often	 through	 the	 action	 of	 primary	




stable	 hydrogen	 peroxide,	 which	 is	 longer	 lived	 and	 able	 to	 diffuse	 from	 the	





cofactor	 and	 functions	 as	 a	 homotetramer	 predominantly	 in	 the	 mitochondrial	
matrix	(Duttaroy	et	al.,	1997).	Extracellular	SOD3	(EcSOD)	also	exists	in	human	but	
is	tissue	specific	rather	than	ubiquitous	like	SOD1	and	SOD2	(Fattman	et	al.,	2003).		
Hydrogen	 peroxide	 is	 produced	 upon	 superoxide	 dismutation	 by	 SOD,	 and	 is	
converted	to	oxygen	and	water	by	the	enzymatic	function	of	catalase	(May,	1901).	
Catalase	is	a	tetrameric	enzyme	containing	a	heme	group	(Fe3+)	and	NADPH	in	the	
active	 centre	 of	 each	 of	 its	 four	 subunits.	 Catalase	 has	 two	 distinct	 biological	
functions	 depending	 on	 the	 concentration	 of	 hydrogen	 peroxide.	 At	 high	 levels	
catalase	acts	to	remove	hydrogen	peroxide	by	catalytically	converting	it	to	oxygen	
and	 water.	 The	 mechanism	 involves	 one	 molecule	 of	 hydrogen	 peroxide	 binding	
catalase,	splitting	to	release	water	while	oxygen	binds	the	Fe3+	group	facilitating	the	
binding	of	 a	 second	hydrogen	peroxide	molecule	 forming	water	 and	O2.	 (Alfonso-
Prieto	 et	 al.,	 2009).	 At	 low	 levels,	 catalase	 utilises	 hydrogen	 peroxide	 to	 detoxify	
phenols	and	alcohols	via	peroxidation.	Hydrogen	peroxide	can	also	be	removed	by	
the	 thiol-reducing	 systems	 of	 ROS	 scavengers,	 thioredoxin	 and	 glutathione.	 Thiol	
groups	 contain	 carbon-bonded	 sulphydryl	 groups,	 reducing	 agents	 that	 can	 be	
reversibly	oxidised	and	reduced	(Sies,	1997).	During	 the	degradation	of	hydrogen	
peroxide,	thioredoxin	is	oxidised	and	then	reduced	by	thioredoxin	reductase	using	
electrons	 donated	 from	 NADPH	 (Holmgren	 and	 Lu,	 2010).	 Glutathione	 also	
degrades	hydrogen	peroxide	through	the	catalytic	action	of	glutathione	peroxidase,	
generating	 water	 and	 oxidised	 glutathione	 disulphide.	 Oxidised	 glutathione	 is	
reduced	through	the	action	of	glutathione	reductase	using	electrons	donated	from	
NADPH,	regenerating	reduced	glutathione	(Bhabak	and	Mugesh,	2010).	During	the	
course	 of	 this	 investigation,	 we	 utilise	 diethyl	 maleate	 (DEM),	 which	 generates	
oxidative	stress	by	depleting	glutathione	from	the	cell	via	conjugation	(Weber	et	al.,	
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1990)	 (see	 Figure	 1.2).	 This	 increases	 the	 level	 of	 mitochondrially-produced	




soluble	 non-enzymatic	 analogue	 of	 vitamin	E,	which	 is	 thought	 to	 protect	 against	
ROS-induced	lipid	peroxidation	and	increase	 intracellular	ROS	scavenging	(Hamad	
et	 al.,	 2010).	 During	 several	 experiments,	 we	manipulate	 the	 levels	 of	 Punch,	 an	
enzyme	required	in	the	first	rate-limiting	step	of	BH4	biosynthesis	(Hatakeyama	et	
al.,	 1991).	 BH4	 also	 acts	 to	 scavenge	 ROS,	 being	 a	 powerful	 reducing	 agent	 and	
acting	as	a	preferable	oxidisable	target	in	the	cell.	It	is	recovered	from	its	oxidised	
state	 (BH2)	 via	 the	 actions	 of	 dihydrofolate	 reductase	 (DHFR),	 converting	back	 to	
the	reducing	form,	BH4	(Crabtree	and	Channon,	2011).	Following	oxidisation	and	a	
decrease	 in	 BH4,	 the	 levels	 of	 BH2	 rise,	 which	 block	 the	 coupling	 of	 BH4	 to	




healthy	 levels	 of	 ROS.	 The	 antioxidant	 defence	 system	 is	 highly	 complex,	 it	 is	 not	




































































































































































































































































































In	 response	 to	 increasing	 ROS,	 several	 important	 adaptive	 stress-response	
pathways	are	activated,	mainly	the	MAPK	signalling	pathways	JNK/ERK/P38,	with	
JNK	 signalling	 being	 the	major	 redox	 sensitive	 signalling	 pathway.	 Also	 playing	 a	
major	role	 in	 the	redox	response	 is	 the	nuclear	 factor	erythroid	2	 [NF-E2]-related	
factor	2(Nrf2)/	Kelch-like	erythroid	cell-derived	protein	with	CNC	homology	[ECH]-
associated	 protein	 1	 (Keap1)	 signalling	 pathway.	 These	 are	 the	 adaptive	 defence	
systems	in	combating	oxidative	stress.	
Second	 to	 the	 JNK	 signalling	 pathway,	 the	 Nrf2/Keap1	 signalling	 pathway	 is	
important	in	cell	defence	and	survival,	and	crucial	in	the	oxidative	stress	response.	




encodes	 a	 major	 detoxification	 enzyme	 (Chasseaud,	 1979),	 peroxiredoxin,	 which	
encodes	an	enzyme	that	reduces	hydrogen	peroxide	(Rhee	et	al.,	2001),	and	heme-
oxygenase-1,	 which	 encodes	 an	 essential	 enzyme	 in	 heme	 catabolism	 wherein	
neuroprotective	carbon	monoxide	(CO)	is	produced	(Ishii	et	al.,	2000,	Hettiarachchi	
et	al.,	2014).	Keap1,	a	cytoplasmic	actin	binding	protein	binds	Nrf2,	promoting	 its	
proteasomal	 degradation	 and	 regulating	 its	 activity.	 ROS	 bind	 to	 redox	 sensitive	
cysteine	residues	on	Keap1,	changing	its	conformation	to	dissociate	from	Nrf2.	Nrf2	
is	 then	 primed	 to	 translocate	 to	 the	 nucleus	 and	 bind	 the	 antioxidant	 response	
element	(ARE)	to	promote	transcription	of	cytoprotective	enzymes	(Taguchi	et	al.,	
2011).	 The	 ARE	 sequence	 exhibits	 high	 homology	 to	 the	 JNK/AP-1	 binding	
consensus	suggesting	a	level	of	cross-talk	between	the	two	pathways,	unsurprising	
as	 they	 are	 the	 two	 major	 redox	 sensitive	 signalling	 pathways	 and	 the	 cellular	
response	to	stress	is	vastly	complex.	It	has	recently	been	shown	that	Nrf2	signalling	
is	 epigenetically	 repressed	 in	 the	 developing	 neuron	 in	 order	 to	 allow	 functional	
maturation.	By	repressing	Nrf2	at	its	promoter	during	development	it	determines	a	
specific	 redox	 level	 within	 the	 neuron	 that	 allows	 for	 increased	 Wnt	 and	 JNK	
signalling,	important	for	correct	neuronal	development.	Ectopic	expression	of	Nrf2	




JNK,	 or	 Jun	 N-terminal	 Kinase	 signalling	 is	 activated	 in	 response	 to	 a	 number	 of	
intracellular	 and	 extracellular	 cues.	 It	 is	 a	 crucial	 node	 in	 the	 cellular	 stress	
response	and	will	be	 the	main	 focus	of	 this	 investigation.	 JNK	 is	a	stress-activated	
kinase	and	a	central	part	of	the	JNK	signalling	cascade	(Hibi	et	al.,	1993).	It	becomes	
activated	in	response	to	ROS	wherein	duel	phosphorylation	occurs	at	the	threonine	
and	 tyrosine	 of	 its	 Thr-Pro-Tyr	motif	 (Ip	 and	 Davis,	 1998).	 As	 JNK	 is	 the	 central	
kinase	 in	 the	 JNK	signalling	cascade	 its	activation	by	phosphorylation	 is	 regulated	
by	 upstream	 kinase	 activity	 from	 JNK	 kinases	 (JNKK)	 and	 JNK	 kinase	 kinases	
(JNKKK)	 (see	 Table	 1.1).	 MKK7	 is	 a	 JNKK	 shown	 to	 exhibit	 oxidative	 stress	
responses	in	mammals	and	Drosophila	(Hemipterous	(hep))	and	has	crucial	roles	in	
mediating	 TNF−α	 signalling	 and	 AP-1	 dependent	 transcription	 (Moriguchi	 et	 al.,	
1997).	 I	 focus	 on	 Drosophila	 here	 as	 it	 is	 the	 best-understood	 metazoan	 and	
members	 of	 the	 JNK	 signalling	 pathway	 are	 conserved	 and	 have	 limited	
redundancy.	 We	 also	 use	 Drosophila	 as	 our	 main	 experimental	 tool	 in	 this	




activation	of	apoptosis	 contributing	 to	 the	detrimental	effects	of	AD,	and	a	 loss	of	
function	confers	protective	effects	against	this	(Mazzitelli	et	al.,	2011).	However,	in	
non-diseased	 cells	mutations	 in	MKK7	have	been	 shown	 to	 increase	 sensitivity	 to	
oxidative	 insults,	 owing	 to	 the	 protective	 role	 of	 JNK	 signalling	 identified	 by	
overexpression	studies	(Wang	et	al.,	2003).	Upstream	of	JNKK	are	the	JNKK	kinases,	
or	 JNKKK.	 At	 least	 6	 JNKKKs	 exist	 in	 mammals	 and	 Drosophila,	 including	 ASK1	









Drosophila	is	 implicated	 in	neuronal	 cell	death	and	directly	phosphorylates	MKK4	
and	MKK7,	activating	JNK	as	well	as	P38	and	ERK	signalling	(Sathyanarayana	et	al.,	
2003).	 Drosophila	 Wallenda	 (Wnd)	 is	 homologous	 to	 vertebrate	 dual	 leucine-
zipper-bearing	 kinase	 (DLK)	 and	 human	 leucine-zipper-bearing	 kinase	 (LZK).	
Wallenda	was	originally	identified	as	being	required	for	Highwire	(hiw)-dependant	
synaptic	 overgrowth,	 and	 through	 overexpression	 was	 shown	 to	 play	 a	 role	 in	
synaptic	 growth	 via	 JNK	 activation	 (Collins	 et	 al.,	 2006).	 Axonal	 transport	 and	
regeneration	 following	 injury	 are	 also	 both	 regulated	 by	 Wallenda	 (Xiong	 et	 al.,	
2010).	 The	 JNKKK,	 TGF-β	 activated	 kinase	 1	 (TAK1)	 has	 also	 been	 shown	 to	
regulate	 synaptic	 growth	 and	 is	 essential	 for	Rab8-induced	 synaptic	 overgrowth.	
TAK1	 may	 also	 represent	 a	 bridge	 between	 TGF-β	 and	 JNK	 signalling	 in	 the	
regulation	 of	 synaptic	 growth	 (West	 et	 al.,	 2015).	 Upstream	 of	 these	 JNKKKs	 is	
JNKKK	 kinase	 misshapen,	 which	 is	 required	 for	 embryonic	 dorsal	 closure	 in	
Drosophila	 (Su	 et	 al.,	 1998).	 Importantly,	 JNK	 signalling	 is	 context	 dependant,	
implicated	 in	 innate	 immunity,	 wound	 healing,	 autophagy	 and	 even	 cancer.	
Depending	on	the	context	and	stimuli,	different	JNKKK	and	JNKKKK’s	are	activated	





























activation	 and	 activity	 of	 JNK	 in	 a	 phosphorylation-dependent	 manner.	 The	
extensive	number	of	targets	in	which	JNK	phosphorylates	and	exerts	its	effects	only	
exacerbates	 its	 complexity	 further.	 The	 main	 transcriptional	 target	 is	 activator	
protein-1	(AP-1),	a	dileucine	zipper	transcription	factor	consisting	of	dimers	of	Fos	
and	 Jun,	 known	 as	 kayak	 (kay)	 and	 Jun-related	 antigen	 (Jra)	 in	Drosophila.	 AP-1	
activity	is	upregulated	upon	phosphorylation,	wherein	it	translocates	to	the	nucleus	
and	 increases	 transcriptional	 output	 from	 the	 12-O-tetradecanoylphorbol-13-
acetate	 (TPA)	DNA	 responsive	 element	 (TRE).	A	 range	of	 stimuli,	 including	 stress	
signals,	 infection,	 growth	 factors	 and	 cytokines	 regulate	 AP-1	 activity,	 and	 the	
transcriptional	 output	 mediates	 such	 processes	 as	 proliferation,	 differentiation,	
apoptosis	 and	 autophagy	 (Hess	 et	 al.,	 2004).	 Fos	 and	 Jun	 are	 leucine	 zipper	
transcription	factors	with	a	basic	DNA-binding	domain.	These	transcription	factors	
are	 able	 to	 dimerise	 via	 their	 leucine	 zippers,	which	 also	 confers	 their	 specificity	
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and	 stability.	 In	mammals,	 c-jun	and	 c-fos	 are	known	 to	 form	heterodimers,	 c-jun	
can	homodimerise	but	c-fos	cannot	(Halazonetis	et	al.,	1988).	In	Drosophila	Fos	can	
homodimerise	 as	 well	 as	 form	 heterodimers	 with	 Jun,	 which	 increases	 its	 DNA	
binding	 efficiency	 25-fold	 (Perkins	 et	 al.,	 1990).	 AP-1	 activity	 via	 JNK	
phosphorylation	 is	essential	 for	 the	cellular	stress	response	 (Yang	et	al.,	1997),	 in	
particular	the	oxidative	stress	response	where	ROS	directly	activate	JNK	signalling,	
which	 has	 important	 implications	 in	 the	 onset	 and	 progression	 of	
neurodegenerative	 diseases	 (Chi	 et	 al.,	 2007).	 However,	 AP-1	 is	 readily	 oxidised	
when	 ROS	 levels	 increase,	 decreasing	 its	 DNA	 binding	 efficiency.	 Thus	 certain	
mechanisms	exist	to	keep	AP-1	in	its	reduced	state,	preserving	its	ability	to	bind	the	
TRE.	Multiprotein	 bridging	 factor-1	 (MBF1)	 prevents	 oxidation	 of	 redox	 sensitive	
cysteines	 upon	 Jun;	 and	 the	 redox	 protein	 apurinic/apyramidic	
endonuclease/redox	 factor	 1	 (APE-1/Ref-1)	 acts	 to	 reduce	 any	 oxidised	 AP-1	 as	
well	 as	 facilitate	 other	 reducing	 molecules	 like	 glutathione	 and	 thioredoxin	 to	
maintain	AP-1	activity	(Jindra	et	al.,	2004,	Ando	et	al.,	2008).	
Similar	 to	 ASK1,	 JNK	 is	 inhibited	when	 the	 cellular	 ROS	 level	 is	 low,	 through	 the	
binding	 of	 monomeric	 glutathione	 S-transferase	 pi	 (GSTp),	 blocking	 its	 activity.	
Upon	an	oxidative	stress	burden,	GSTp	is	displaced,	forming	dimers/oligomers	and	
uninhibiting	 JNK	 to	 become	 phosphorylated	 and	 activated	 (Adler	 et	 al.,	 1999a).	
Following	 activation,	 the	 initial	 output	 of	 JNK	 signalling	 is	 the	 transcription	 of	
negative	 feedback	 inhibitor,	 puckered	 (puc)	 via	AP-1	 (Martín-Blanco	et	 al.,	 1998).	
Puc	rapidly	inhibits	JNK	by	acting	as	a	JNK	phosphatase	and	reducing	JNK	signalling.	
Puckered	 expression	 is	 JNK-dependent,	 meaning	 that	 JNK	 signalling	 regulates	
expression	 of	 its	 own	 inhibitor.	 This	 is	 important	 with	 regards	 to	 its	 neuronal	










energy.	 The	mitochondria	 provide	ATP	 to	 fuel	 these	 processes;	 the	 by-product	 of	
this	 is	 the	generation	of	ROS	(Mattson	and	Liu,	2002).	An	established	neuron	also	
requires	 a	 huge	 amount	 of	 energy,	 not	 only	 to	 traffic	 proteins	 the	 length	 of	 the	
neuron	 but	 also	 in	 generating	 action	 potentials	 (Berndt	 and	 Holzhutter,	 2013).	






Aged	 neurons	 are	 at	 increasing	 risk	 of	 dysfunction	 and	 disease	 due	 to	 an	
accumulation	 of	 cellular	 damage	 and	 significant	 rise	 in	 oxidative	 stress.	 The	
mitochondria	 is	 often	 the	 focal	 point	 of	 disease	 onset	 in	 neurons	 and	 has	 been	
implicated	in	a	number	of	neurodegenerative	diseases	such	as	PD	(Mortiboys	et	al.,	
2010),	 AD	 (Ronnback	 et	 al.,	 2015)	 and	 amyotrophic	 lateral	 sclerosis	 (ALS)	 (Kong	
and	 Xu,	 1998).	 Damage	 to	 the	 mitochondrial	 DNA,	 unbalanced	 fission/fusion,	
reduced	membrane	 potential	 and	 aberrant	mitophagy	 can	 all	 lead	 to	 dysfunction	
and	increased	ROS	production,	owing	to	the	demise	of	neuronal	function	(Johri	and	
Beal,	2012).		
AD	 is	 the	 most	 common	 neurodegenerative	 disorder	 and	 is	 characterised	 by	
cognitive	 impairments	 following	 the	 accumulation	 of	 extracellular	 β-amyloid	
peptide	 (Aβ)	 plaques	 and	 intracellular	 neurofibrillary	 tangles	 consisting	 of	
hyperphosphorylated	 tau	 proteins	 (Swerdlow	 et	 al.,	 2010).	 In	 sporadic	 cases	 it	 is	
thought	 that	 the	 accumulation	 of	 Aβ	 plaques	 follows	 mitochondrial	 dysfunction.	
Several	 mitochondrial	 enzymes	 are	 thought	 to	 contribute	 to	 this	 dysfunction,	
including	 a	 reduction	 in	 pyruvate	 dehydrogenase	 complex	 activity	 (Sorbi	 et	 al.,	







phosphatase	 and	 tensin	homolog-induced	putative	 kinase	1	 (PINK1)	 are	 known	 PD	
risk	genes,	which	are	expressed	 in	 the	mitochondria	and	have	roles	 in	mitophagy.	
Mutations	 in	 PINK1-parkin	 perturb	 the	 autophagic	 removal	 of	 dysfunctional	
mitochondria,	 failing	 to	 remove	 those	producing	excessive	ROS	and	generating	an	
oxidative	stress	within	the	neuron	(Kim	et	al.,	2007a,	Deas	et	al.,	2011).	The	leucine-
rich	 repeat	 kinase	 2;	 LRRK2	 (G2019S)	 mutation	 has	 been	 identified	 as	 one	 of	 the	
most	 common	 causes	 of	 PD	 and	 impairs	 mitochondrial	 function	 by	 an	 as	 yet	
unknown	 mechanism.	 A	 decrease	 in	 mitochondrial	 membrane	 potential	 and	
intracellular	ATP	levels	are	observed	in	the	G2019S	mutation	of	LRRK2	(Mortiboys	
et	 al.,	 2010)	 as	 well	 as	 an	 imbalance	 in	 calcium	 homeostasis	 that	 manifests	 as	
excessive	mitophagy	and	dendrite	shortening	(Cherra	et	al.,	2013).		
ALS	 is	 a	 progressive	 neurodegenerative	 disorder	 characterised	 by	 the	 selective	
death	of	motor	neurons	and	the	onset	of	muscle	weakness,	atrophy	and	ultimately,	
respiratory	 failure	 and	death	 (Hayashi	 et	 al.,	 2015).	Though	not	 fully	understood,	
there	 appears	 to	 be	 a	 link	 between	 ALS	 and	 SOD1	 mutations	 resulting	 in	
mitochondrial	 damage	 and	 dysfunction.	 This	 appears	 in	 20%	 of	 familial	 cases	 of	
ALS,	 which	 account	 for	 10%	 of	 total	 cases	 (Andersen,	 2006).	 Mutations	 in	 SOD1	
largely	affect	the	dynamics	of	motor	neuron	mitochondria,	which	display	impaired	
fusion	 and	 axonal	 transport,	 a	 reduction	 in	 size	 and	 density	 and	 abnormal	
localisation	within	the	synapse	(Magrane	et	al.,	2012).		
Mutations	 in	 mitochondrial	 DNA	 are	 thought	 to	 contribute	 to	 the	 onset	 and	 /or	
progression	 of	 many	 neurodegenerative	 diseases.	 The	 mitochondrial	 genome	 is	
made	 up	 of	 a	 multi-copy	 circular	 double-stranded	 DNA	 molecule,	 approximately	
16.6kb	 long	 in	 humans.	 This	 encodes	 13	 of	 the	 92	 polypeptides	 required	 for	
oxidative	 phosphorylation	 as	 well	 as	 the	 necessary	 RNA	 machinery	 required	 for	
translation;	 the	 nuclear	DNA	 encodes	 the	 remaining	 (Taylor	 and	Turnbull,	 2005).	
Mutations	 present	 as	 either	 homoplasmic,	 where	 each	 copy	 of	 the	mitochondrial	
genome	 contains	 the	 mutation	 or	 heteroplasmic	 where	 only	 some	 copies	 are	
mutated.	Pathology	arises	when	the	number	of	heteroplasmic	mutations	crosses	a	
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threshold	 level.	 Common	 diseases	 involving	 variants	 of	 mitochondrial	 DNA	 or	
mutations	include	the	aforementioned	AD	and	PD	(Wallace,	1992),	but	also	diabetes	
(Lowell	 and	 Shulman,	 2005)	 and	 Leigh	 syndrome	 (de	 Vries	 et	 al.,	 1993).	 It	 is	
thought	 the	 pathological	 levels	 of	 ROS	 can	 cause	 somatic	 mutations	 in	 the	
mitochondrial	 DNA,	 and	 that	 accumulation	 of	 these	mutations	 contributes	 to	 the	
decline	of	mitochondrial	function	(Harman,	1992).	Certain	mutations	are	known	to	
directly	 increase	 the	 production	 of	 ROS	 from	 the	mitochondria,	 namely	 8993T>G	




systems.	 Common	 model	 organisms	 in	 the	 study	 of	 mitochondrial	 defects	 and	
ageing	are	mice,	however	they	have	their	limitations	in	the	study	of	PD,	as	they	do	
not	 present	 with	 the	 hallmark	 symptoms	 including	 tremors,	 unsteady	 gait	 and	
rigidity.	Mice	models	also	cannot	replicate	the	loss	of	dopaminergic	neurons	seen	in	












biology	 allowing	 discoveries	 of	 developmental	 processes	 and	 disease	 mechanics.	
Drosophila	are	easily	maintained	at	high	numbers	due	to	their	small	size	and	simple	
diet,	making	them	ideal	 for	raising	and	storing	 in	the	 laboratory.	A	short	 life	cycle	
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and	 high	 fecundity	 make	 Drosophila	 ideal	 for	 large-scale	 high-throughput	
experiments,	 with	 a	 generation	 time	 of	 10-12	 days	 at	 25°C.	 The	 lifespan	 of	
Drosophila	 can	 range	 between	 40-120	 days	 depending	 on	 their	 environment	 and	
the	presence	of	detrimental	 factors	such	as	stress	or	poor	diet,	meaning	 that	 they	
can	be	successfully	kept	as	live	stocks	as	long	as	ample	food	and	space	is	supplied.	
They	are	widely	kept	 in	small	vials	containing	yeast/cornmeal-based	 food	at	18°C	
and	 are	 transferred	 to	 a	 new	 vial	 every	 4-5	weeks.	 The	 strong	molecular-genetic	
toolset	 coupled	with	 a	 high	 fecundity	 and	 short	 life	 cycle	make	Drosophila	 a	 cost	
effective	 model	 without	 compromising	 the	 integrity	 and	 impact	 of	 the	 research.	
Humans	 and	 Drosophila	 share	 a	 large	 number	 of	 developmental	 processes	 and	
structurally/functionally	 similar	 proteins.	 Following	 the	 genomic	 sequencing	 of	
Drosophila	 in	2000,	 it	 is	 thought	that	77%	of	genes	causing	human	disease	have	a	
functional	 homolog	 in	 Drosophila,	 and	 that	 many	 disease	 pathways	 are	 highly	
conserved	(Adams	et	al.,	2000,	Reiter	et	al.,	2001).	The	Drosophila	genome	consists	
of	 approximately	 13,600	 genes	 across	 4	 chromosomes	 including	 the	 sex	
chromosomes	(X/Y)	i.e.	the	first	chromosome,	and	the	autosomes	or	chromosomes	
2,	3	and	4.	A	large	array	of	human	diseases	and	disorders	are	caused	by	mutations	
in	 genes	 orthologous	 to	 that	 of	 Drosophila,	 including	 neurological,	 metabolic,	
developmental	and	cardiovascular	disorders	as	well	as	cancer	(Bier,	2005).	It	is	well	
within	reason	to	say	that	the	use	of	Drosophila	in	the	study	of	genetics	and	human	
disease	 has	 contributed	 vastly	 to	 their	 understanding,	 proving	Drosophila	 to	 be	 a	





in	Drosophila	 also	 strengthens	 their	 role	 as	 important	model	 organisms.	Balancer	
chromosomes	bear	inversions	that	allow	the	stable	maintenance	of	lethal	mutations	
as	 heterozygotes	without	 the	 need	 for	 any	 selection	 process	 (Muller,	 1918).They	





Another	useful	property	of	Drosophila	 is	 the	availability	of	 the	UAS/GAL4	system,	
which	allows	 for	 targeted	gene	expression.	The	system	relies	on	 two	 independent	
components,	GAL4	and	an	upstream	activating	sequence	(UAS).	The	GAL4	protein	is	
encoded	 by	 881	 amino	 acids	 and	 was	 identified	 as	 a	 gene	 regulator	 in	
Saccharomyces	cerevisiae,	specific	to	the	UAS	(Laughon	and	Gesteland,	1984).	It	was	
established	 by	 Brand	 and	 Perrimon	 in	 1993	 and	 became	 a	 powerful	 asset	 in	
Drosophila	 research,	 revolutionising	how	we	address	 gene	 function	 in	vivo	 (Duffy,	




its	 expression	 is	 driven	 by	 the	 native	 genomic	 enhancers,	many	 GAL4	 lines	 have	
now	 been	 established,	 expressing	 GAL4	 in	 a	 nearly	 every	 cell	 and	 tissue	 type,	
including	 motor	 neurons,	 muscles	 and	 glia.	 A	 gene	 containing	 the	 GAL4	 binding	
sites	in	its	promoter	site	is	then	introduced	into	the	fly,	becoming	the	UAS	line;	this	
gene	 could	 be	 your	 protein	 of	 interest	 or	 non-coding	 interfering	 RNA	 (RNAi).	
Crossing	the	UAS	parent	line	to	the	GAL4	parent	line	completes	the	bipartite	system	
where	 GAL4	 will	 endogenously	 bind	 the	 UAS	 in	 the	 cell	 or	 tissue	 type	 allowing	
ectopic	expression	of	the	gene	product.	One	very	useful	advantage	of	using	the	UAS	
lines	 is	 that	 it	 is	 transcriptionally	 silent	until	GAL4	 is	present,	 allowing	controlled	
expression	 of	 gene	 products	 that	 may	 be	 toxic,	 lethal	 or	 cause	 reduced	 viability,	
obviating	the	maintaining	of	a	healthy	stock	containing	both	elements	together.	
As	 mentioned	 previously,	 non-coding	 RNAs	 can	 be	 expressed	 in	 Drosophila	 that	
knock	down	expression	of	individually	targeted	genes.	Since	the	discovery	of	double	






genes	 and	 collectively	 cover	 most	 of	 the	 genome,	 upwards	 of	 91%	 of	 the	 total	
protein-coding	genes.		
The	powerful	genetic	tool-set	in	Drosophila	sets	it	apart	from	other	animal	models	
in	genetic	 research.	With	many	human-disease	gene	orthologues	present	 in	 in	 the	
Drosophila	genome	and	the	ability	to	specifically	target	these	in	a	variety	of	ways	in	
vivo	 we	 can	 advance	 our	 understanding	 of	 disease	 genes.	 Drosophila	 are	 widely	




just	within	 the	 cuticle	 (see	 Figure	 1.3).	 The	muscles	 are	 arranged	 in	 overlapping,	
striated	 fibres	 attached	 to	 the	 body	 wall,	 in	 a	 pattern	 that	 is	 repeated	 for	 each	
hemisegment.	 The	 muscles	 have	 been	 fully	 annotated	 and	 mapped	 for	 ease	 of	
identification.	 Each	muscle	 is	 a	 single	multinucleated	 cell	 formed	by	 the	 fusion	of	
myoblasts	 and	 forms	 part	 of	 a	 set	 of	 30	 muscles	 that	 make	 up	 each	 abdominal	
hemisegment	from	A2	to	A7	(Keshishian	et	al.,	1996).	Differing	slightly	in	its	pattern	
is	 hemisegment	 A1,	 the	 most	 anterior	 hemisegment.	 Each	 hemisegment	 muscle	
receives	 innervation	 from	 2	 motor	 neurons,	 either	 the	 anterior	 intersegmental	
nerve	(ISN),	which	innervates	the	dorsal	muscle,	or	the	posterior	segmental	nerve	
(SN),	which	 innervates	 the	ventral	muscle	 (Johansen	et	al.,	1989a,	 Johansen	et	al.,	
1989b).		
We	 focus	 on	 muscle	 6/7	 of	 hemisegment	 A3,	 a	 very	 well	 characterised	 muscle	
widely	used	for	its	large	accessible	neuromuscular	junction	(NMJ)	synapse.	For	this	
synapse,	a	measure	of	its	growth	can	be	calculated	by	counting	the	total	number	of	
boutons.	Boutons	 are	 the	pre-synaptic	 swellings	 along	 the	 synaptic	 arbour	where	
neurotransmitter	release	is	facilitated.	This	NMJ	is	part	of	the	type	I	class	of	NMJs	as	
it	 features	 only	 type	 I	 boutons	 and	 functions	 to	 innervate	 the	 body	wall	muscles.	
Type	 I	 NMJs	 have	 large	 boutons	 and	 short	 terminal	 branches,	 they	 are	
predominantly	 glutamatergic	 and	 two	 types	 of	 boutons	 are	 present,	 type	 Ib	 (big)	
and	 type	 Is	 (small)	 (Menon	 et	 al.,	 2013).	 Type	 II	 NMJs	 are	 neuromodulatory,	
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determining	 the	 excitation	 state	 and	 transmit	 octopamine	 and	 glutamate	
(Monastirioti	 et	 al.,	 1995).	 Following	 glutamate	 release	 from	 the	 pre-synaptic	
terminal,	 it	binds	to	glutamate	receptors	(GluR)	 in	the	post-synaptic	membrane	of	
the	muscle,	 leading	 to	 innervation.	GluRs	are	receptor-gated	 ion	pores	and	during	
Drosophila	synaptogenesis	they	are	expressed	and	eventually	clustered	at	NMJ	sites	















information	 between	 the	 cells.	Drosophila	 larval	 NMJ’s	 have	 a	 degree	 of	 synaptic	
plasticity,	 allowing	 both	 structural	 and	 functional	 changes	 to	 occur	 during	
development	and	maturation.	Synaptic	plasticity	is	thought	to	be	the	foundation	of	
learning	and	memory	(Shen	and	Cowan,	2010,	Menon	et	al.,	2013).		
The	 NMJ	 begins	 to	 develop	 approximately	 9-10	 hours	 after	 egg	 laying;	 it	 begins	
when	 the	 axonal	 growth	 cone	 reaches	 its	 target	 muscle,	 which	 is	 determined	
genetically.	 At	 the	 site	 of	 contact	 between	 the	 growth	 cone	 and	 muscle,	 small	
clusters	 of	 postsynaptic	 GluRs	 and	 Disks	 large	 (Dlg)	 form.	 The	 growth	 cone	 then	
differentiates	into	a	presynaptic	terminal,	or	synaptic	bouton.	Dlg	is	the	Drosophila	
orthologue	 of	 the	 mammalian	 postsynaptic	 scaffolding	 protein	 PSD-95,	 and	 is	
critical	 for	 the	 postsynaptic	 assembly	 at	 glutamatergic	 synapses,	 specifically	
controlling	glutamate	receptor	subunit	composition	(Chen	and	Featherstone,	2005).	




forms	 around	 the	 larval	 presynaptic	 boutons,	 which	 become	 submerged	 deeper	
within	 the	 muscle.	 The	 SSR	 contains	 the	 neurotransmitter	 receptors	 and	
postsynaptic	 signalling	 complexes	 as	well	 as	 scaffolding	proteins	 required	 for	 the	
functionality	 of	 both	 (Rheuben	 et	 al.,	 1999,	Ataman	 et	 al.,	 2006).	 The	presynaptic	
bouton	 features	 small	 sections	 where	 synaptic	 vesicle	 exocytosis	 is	 restricted	 to	
which	is	termed	the	active	zone.	These	areas	house	electron-dense	projections	and	
in	Drosophila	are	referred	to	as	the	T	bar	(Zhai	and	Bellen,	2004,	Südhof,	2012).	In	
Drosophila,	 the	 active	 zones/T	 bars	 are	 home	 to	 the	 coiled-coil	 domain	 protein,	
Bruchpilot	(BRP)	which	is	required	for	the	formation	of	the	T-bar,	calcium	channel	
clustering,	 proper	 vesicle	 fusion	 and	 patterned	 synaptic	 plasticity	 (Kittel	 et	 al.,	
2006,	Wichmann	and	Sigrist,	2010).		
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The	 full	 development	 of	 the	 post-embryonic	 larval	 NMJ	 in	 Drosophila	 requires	
several	 signalling	 pathways;	 some	 morphogenic	 pathways	 direct	 the	 overall	
development	of	the	NMJ	like	transforming	growth	factor	beta	(TGF-β)	signalling	and	
Wingless	 (Wg)	 creating	 a	 basal	 synapse.	 Other	 pathways,	 MAPK	 signalling	 for	




The	 TGF-β	 family	 of	 ligands	 is	 a	 very	 large	 superfamily	 of	 proteins/ligands	 and	
plays	a	critical	role	in	NMJ	development	in	Drosophila,	as	well	as	having	roles	in	cell	
growth,	 differentiation	 and	 apoptosis.	 The	 TGF-β	 family	 includes	 TGF-β	 proteins,	
bone	 morphogenetic	 proteins	 (BMPs),	 growth	 and	 differentiation	 factors	 (GDFs),	
nodal	 and	 activins.	 These	 stimulate	 type	 I	 and	 type	 II	 serine/threonine-kinase	
receptors,	 which	 regulates	 Smad-dependant	 transcription	 (Derynck	 and	 Zhang,	
2003,	Wu	et	al.,	2010).	Genetic	studies	of	TGF-β	signalling,	specifically	mutations	in	
receptors	 and	 ligands	of	 the	 family,	 have	 revealed	 synaptic	 defects	 (Sweeney	 and	
Davis,	 2002,	McCabe	et	 al.,	 2003,	Rawson	et	 al.,	 2003,	Koh	et	 al.,	 2004).	The	BMP	
orthologue	glass	bottom	boat	(Gbb)	was	found	to	encode	a	protein	that	plays	a	role	
in	the	regulation	of	synapse	growth	in	Drosophila.	Gbb	mutants	exhibit	reduced	NMJ	
synapse	 size	 and	 neurotransmitter	 release	 as	 well	 as	 dysfunctional	 presynaptic	
ultrastructure	(McCabe	et	al.,	2003).	This	was	also	shown	to	be	a	retrograde	signal,	
as	 Gbb	 expression	 in	 the	 muscle	 rescued	 key	 aspects	 of	 the	 mutant	 phenotype,	
owing	 to	 the	 thought	 that	 the	 muscle	 has	 an	 important	 role	 in	 coordinating	
retrograde	 signalling	 for	 correct	 NMJ	 development.	 Presynaptic	 roles	 for	 TGF-β	
signalling	 in	 NMJ	 development	 have	 also	 been	 shown,	 the	 E3	 ubiquitin	 ligase	
Highwire	 (Hiw)	 was	 found	 to	 negatively	 regulate	 synaptic	 growth	 at	 the	 NMJ.	
Mutants	 of	 hiw	 have	 severely	 overgrown	 synapses,	 displaying	 a	 larger	 overall	
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synapse	as	well	as	increased	bouton	number	(Wan	et	al.,	2000,	McCabe	et	al.,	2004).	
Hiw	binds	 to	 the	 Smad	protein,	Medea	 (Med),	which	 binds	 to	 Smad	 transcription	
factor	 Mothers	 against	 dpp	 (Mad)	 and	 is	 part	 of	 a	 presynaptic	 BMP	 signalling	
cascade	consisting	of	3	receptor	subunits,	Wishful	thinking	(Wit),	Thickveins	(tkv)	
and	Saxophone	(Sax).	Transcription	factor	Mad	and	the	type	I	receptors,	Sax	and	tkv	
have	 been	 shown	 to	 have	 roles	 in	 structural	 and	 functional	 development	 of	 the	
Drosophila	NMJ,	and	mutations	in	wit,	which	encodes	the	type	II	receptor	displayed	





The	TGF-β	superfamily	as	a	whole	plays	a	major	 role	 in	NMJ	development;	 this	 is	
highlighted	by	the	presence	of	both	positive	(tkv,	Wit,	sax,	Mad,	med)	and	negative	
regulation	 (Daughters	 against	 dpp	 (Dad),	 Nervous	 wreck	 (Nwk))	 (Sweeney	 and	




and	 postsynaptic	 structure	 (Packard	 et	 al.,	 2002).	 This	 occurs	 through	 a	 heparin	
sulphate	 proteoglycan	 (HSPG)	 called	 perlecan/trol.	 Mutations	 in	 trol	 cause	
postsynaptic	 defects	 such	 as	 a	 reduction	 in	 the	 SSR	 as	well	 as	 increased	 synaptic	
boutons	at	the	Drosophila	NMJ.	Postsynaptic	expression	of	the	Frizzled	(receptor	for	









strength	 during	 development,	 as	well	 as	 long-term	 plasticity	 (Sanyal	 et	 al.,	 2002,	
Sanyal	et	al.,	2003).	As	outlined	above,	AP-1	 is	a	 transcription	 factor	consisting	of	
either	 homo	or	 heterodimers	 of	 basic	 leucine	 zipper	 proteins	 Fos	 and	 Jun,	 and	 is	
abundantly	 expressed	 in	 the	 larval	 motor	 neuron	 (Sanyal	 et	 al.,	 2003).	 AP-1	 is	
activated	by	JNK,	and	as	part	of	the	JNK	signalling	pathway	is	under	the	control	of	a	
negative	 feedback	 loop	 where	 puc	 is	 a	 direct	 transcriptional	 output	 of	 JNK	




and	 axonal	 guidance,	 and	 loss-of-function	 mutations	 in	 the	 pathway	 can	 impede	
axonal	regeneration	after	injury	(Collins	et	al.,	2006).	Though	I	previously	described	
a	 role	 for	Highwire	 in	 TGF-β	 signalling,	 it	 also	 plays	 a	major	 role	 in	 the	 negative	
regulation	 of	 this	 MAPK	 pathway.	 Hiw	 targets	 Wnd/DLK	 for	 degradation,	 which	
suppresses	 downstream	 MAPK/JNK	 signalling	 via	 binding	 to	 DFsn	 to	 restrain	
synaptic	 growth.	 However,	 hiw	 mutants	 display	 synaptic	 overgrowth,	 which	 was	
found	to	be	a	consequence	of	an	inability	to	degrade	Wnd.	(Collins	et	al.,	2006,	Wu	
et	 al.,	 2007).	 In	 complex	 with	 Hiw,	 SkpA	 has	 also	 been	 shown	 to	 cause	 synaptic	
overgrowth	when	mutated,	this	coincides	with	elevated	levels	of	Wnd,	a	MAPKKK,	
which	 in	 turn	 leads	 to	 an	 over	 activation	 of	 JNK	 signalling	 and	 consequently	 the	
synaptic	 overgrowth	 (Collins	 et	 al.,	 2006,	 Brace	 et	 al.,	 2014).	 Removing	








Autophagy	 is	 a	 lysosome-dependant	 degradation	 mechanism	 by	 which	
autophagosomes	 are	 formed.	 These	 encapsulate	 cytoplasmic	 waste	 material	 and	
transport	 it	 to	 the	 lysosome.	 The	waste	material	 is	 transferred	 into	 the	 lysosome	
through	fusion	of	the	loaded	autophagosome	and	the	lysosome.	Lysosomal	enzymes	
then	 digest	 the	 waste	 and	 recycle	 the	 resultant	 lipids,	 amino	 acids	 and	 sugars	
(Levine	 and	 Klionsky,	 2004).	 Several	 autophagy	 (ATG)	 genes	 exist	 which	 are	
conserved	 in	 Drosophila,	 many	 of	 which	 have	 been	 mutated	 or	 transgenically	
manipulated	 in	 Drosophila	 stocks.	 Increasing	 the	 levels	 of	 atg1,	 an	 initiator	 of	
autophagy	 induction,	has	been	shown	to	 increase	bouton	count	 twofold,	primarily	
though	elevated	levels	of	autophagy	(Scott	et	al.,	2007,	Levine	and	Kroemer,	2008,	
Shen	 and	 Ganetzky,	 2009).	 Mutations	 in	 atg18	 were	 shown	 to	 suppress	 the	 NMJ	
overgrowth	 in	atg1	overexpression	tests,	and	removing	both	copies	of	either	atg1	
or	 atg18	 reveals	 significant	 NMJ	 undergrowth,	 further	 suggesting	 that	 autophagy	
plays	a	large	role	in	NMJ	growth	(Shen	and	Ganetzky,	2009).	The	role	of	autophagy	
in	 NMJ	 overgrowth	 involves	 Hiw,	 specifically	 elevated	 levels	 of	 autophagy	 are	










As	 it	 emerges,	 JNK	 signalling	 and	 autophagy	 are	 closely	 regulated	 in	 their	 role	 in	





cellular	 resistance	 to	 oxidative	 damage	 (Wang	 et	 al.,	 2003).	 The	 activation	 of	
JNK/AP-1	 leads	 to	 an	 array	 of	 protective	 genes	 being	 expressed,	 increasing	 the	
tolerance	to	oxidative	stress.	Overexpression	of	 the	Drosophila	 JNK	protein	Basket	
(Bsk)	increased	resistance	to	the	ROS-generating	compound,	paraquat,	reducing	the	
number	 of	 flies	 that	 died	 during	 a	 survival	 test	 (Arking	 et	 al.,	 1991).	 Similarly,	
resistance	 to	 paraquat	 is	 observed	 in	 puc	 mutant	 heterozygotes,	 which	 exhibit	
increased	 JNK	 activity	 (Wang	 et	 al.,	 2003).	 However,	 flies	 heterozygous	 for	 the	
hypomorphic	bsk2	allele	that	exhibit	decreased	JNK	signalling	are	more	sensitive	to	
paraquat	treatment,	and	a	greater	number	died	during	the	survival	test	(Wang	et	al.,	
2003).	 The	 role	 of	 JNK	 signalling	 within	 neurons	 is	 critical,	 as	 activation	 offers	
increased	 tolerance	 to	 ROS.	 This	 is	 vital	 in	 neurons,	 which	 are	 rich	 with	
mitochondria	 and	 energetically	 demanding,	 generating	 relatively	 high	 amounts	 of	
ROS.	 This	 renders	 neurons	 particularly	 susceptible	 to	 oxidative	 stress	 due	 to	 a	
relatively	 low	 antioxidant	 defence	 system.	 However,	 ROS	 are	 also	 important	
signalling	 molecules	 in	 the	 development	 of	 neurons.	 A	 low	 antioxidant	 level	 is	
required	 for	 correct	 development	 of	 maturing	 neurons,	 and	 Nrf2	 signalling,	 the	
second	major	antioxidant	pathway	after	JNK	signalling,	is	actively	repressed	in	the	
developing	 forebrain	 neurons	 of	mice	 to	 ensure	 correct	 development	 (Bell	 et	 al.,	
2015).	 Ectopic	 expression	 of	Nrf2	 inhibits	 neurite	 outgrowth	 and	 synaptogenesis,	
lowering	the	activity	of	ROS-dependent	JNK	and	Wnt	signalling.	It	is	proposed	that	
the	epigenetic	repression	of	Nrf2	helps	to	create	an	environment	that	increases	the	
activation	of	 JNK	and	Wnt	 signalling	allowing	neurons	 to	develop	properly,	 at	 the	
cost	of	 low	antioxidant	defences	(Bell	et	al.,	2015).	Activation	of	 JNK	signalling	via	
ROS	 is	 therefore	 critical	 to	 the	 development	 of	 the	 synapse;	 not	 only	 is	 AP-1	
beneficial	for	synaptic	number	and	strength,	it	also	protects	the	cell	by	lowering	the	
ROS	level	after	the	synapse	has	developed	(Sanyal	et	al.,	2003).		
However,	ROS	are	highly	damaging	and	without	 the	 tight	 regulation	 from	various	





1.8 Drosophila	 as	 a	 model	 for	 oxidative	 stress	 and	 age-related	
neurodegenerative	diseases	
The	use	 of	Drosophila	 in	 the	 study	 of	 age-related	neurodegeneration	 is	 extensive.	
Due	 to	 their	 short	 lifespan,	 longevity	 and	 ageing	 are	 easily	 studied	 in	Drosophila	
and,	most	 human	 neurodegenerative	 disease	 genes	 have	 homologs	 in	 the	 fly	 and	
can	 often	 produce	 a	 disease	 phenotype.	 The	 large	 genetic	 toolbox	 allows	 these	
disease	genes	to	be	characterised	and	large-scale	genetic	screens	can	be	performed	
to	 identify	 enhancers	 or	 suppressors	 of	 genes	 that	 exacerbate	 or	 alleviate	 the	
disease	 symptoms.	 Screens	 of	 compounds	 can	 also	 be	 performed	 to	 identify	
potential	 drugs	 that	 could	 improve	 disease	 phenotypes,	 and	 this	 is	 easily	 tested	
using	Drosophila	as	the	drug	can	be	fed	to	both	the	larvae	and	adult	fly	by	mixing	it	
with	 specifically	 designed	 instant	 food	 (Hirth,	 2010).	 Neurodegenerative	 diseases	




transcription	 factors,	Fos	and	 Jun	have	also	been	extensively	 studied,	but	much	 is	











oxidative	 stress	 in	 the	nervous	 system	and	will	 try	 to	 elaborate	upon	 the	 already	























Pure	 powder;	 Acros	 Organics),	 39.12g/l	 maize	 flour	 (Gluten-free	 organic	 maize	
flour),	 37g/l	 Yeast	 (Pure	 Yeast,	 Lesaffre	 Human	 care;	 Lynside),	 93.75g/l	 Sucrose	
(Sucrose,	 analytical;	 Fischer	 Scientific)	 and	 6.75ml/l	 Propionic	 Acid	 (Acros	
Organics).		
Experimental	stocks	were	raised	on	instant	food	(Formula	4.24;	Carolina	Biological	
Supplies)	 containing	 10%	 Ethanol-Yeast	 paste	 (inactivated)	 plus	 pharmacological	
agents	 as	 required.	 Instant	 food	was	 prepared	 in	 plastic	 vials	 using	 3g	 of	 instant	
food	 and	 10ml	 of	 ddH2O	 and	 allowed	 to	 saturate	 fully.	 Inactivated	 yeast	 was	
prepared	 by	mixing	 20g	 of	 dried	 yeast	 (Dried	 active	 baking	 yeast;	 Allinson)	with	
100ml	ddH2O,	 forming	a	 thin	yeast	paste.	This	was	repeatedly	boiled	to	 inactivate	
the	 yeast	 and	 mixed	 to	 reduce	 the	 volume	 to	 50ml	 creating	 a	 thick	 yeast	 paste,	
which	is	stored	at	4°C.	Approximately	1ml	of	inactive	yeast	paste	is	heated	until	dry,	
allowed	to	cool	and	mixed	with	10%	ethanol	(Fischer	Scientific)	to	rehydrate	before	
adding	 to	 the	 instant	 food.	Pharmacological	agents	were	made	up	 in	10%	ethanol	
and	mixed	into	the	dried	yeast	paste	when	required.	Vials	were	plugged	with	cotton	




was	performed	using	 fly	 cages	 and	2%	agar	plates	which	keep	 the	 flies	hydrated.	











3-4	 days	 for	 as	 long	 as	 required.	 Fly	 selection	 and	 observation	 was	 performed	
whilst	 the	 flies	were	anaesthetised,	achieved	via	transferring	 flies	 to	a	porous	pad	
connected	 to	 a	 compressed	 CO2	 gas	 cylinder	 (Dutscher	 Scientific,	 UK).	 Dissection	
microscopes	(Stemi	2000	dissection	microscope;	Zeiss)	were	use	to	view	the	flies.	
Table	2.1	A	list	of	Drosophila	stocks	used	throughout	this	investigation	
Stock	 Chromosome	 Description	 Source	
WILD-TYPES	 	 	 	
Canton-S	(CS)	 n/a	 Wild-type,	red	eyes	 Sweeney	Lab	
Stock	
w1118	 n/a	 Wild-type,	white	eyes	 Sweeney	Lab	
Stock	
	 	 	 	




























































OK6GAL4/CyO-GFP	 Second	 Motor	neuronal	driver	 O'Kane	Lab	
(Cambridge,	
UK).	Lab	Stock	
actin5CGAL4	 Second	 Actin	driver	 (Ito	et	al.,	
1997).	Lab	
Stock	
























































	 	 	 	






















































































	 	 	 	
















Virgin	 females	were	 selected	 either	 by	 observation	 of	 the	meconium	 (first	 faecal	
matter	observed	as	black	spot	in	the	abdomen	of	freshly	emerged	flies),	if	the	wings	
were	unexpanded	or	if	the	fly	was	known	to	be	less	than	8	hours	old.	Virgin	females	
were	 kept	 separate	 from	 males	 for	 at	 least	 3	 days,	 laid	 eggs	 were	 checked	 for	
hatching	to	ensure	no	mating	has	occurred.		
2.1.3.2 	Balancer	chromosomes	
Balancer	 chromosomes	 were	 used	 in	 Drosophila	 to	 track	 mutant	 alleles	 or	
insertions/transgenes.	 These	 carry	 dominant	 phenotypic	 markers	 that	 are	 easily	
and	reliably	followed	in	the	stocks.	Recombination	is	prevented	by	the	presence	of	
large	 chromosomal	 inversions,	 permanently	 keeping	 the	 stock	 in	 a	 heterozygous	
state	 and	 preventing	 the	 loss	 of	 your	 genotype	 of	 interest	 (see	 Figure	 2.1).	 The	
balancers	used	to	maintain	stocks	on	the	2nd	chromosome	were	CyO	and	CyO-GFP,	
which	 display	 curly	wings	 as	 adults.	 The	 presence	 of	 GFP	 allows	 the	 selection	 of	
appropriate	 larvae,	 as	 GFP	 can	 be	 detected	 at	 this	 stage	 using	 a	 fluorescence	
microscope	(MZFL	III	fluorescence	scope;	Leica).	CyO	is	often	kept	in	stock	with	Sco	
on	 the	 opposing	 chromosome	 (CyO/Sco);	 Sco	 is	 a	 phenotypic	 marker	 on	 the	 2nd	
chromosome,	 which	 lacks	 bristles	 on	 the	 scutellum.	 The	 3rd	 chromosome	 is	
maintained	using	the	balancer	TM6b	that	carries	humoral	as	its	dominant	marker	in	
adults,	 showing	 increased	 ‘shoulder’	 bristles.	 TM6b	 also	 carries	 tubby,	 causing	











unfortunately	on	 the	same	chromosome	 in	 their	original	stocks.	Recombination	of	
the	 genetic	 features	 allows	 us	 to	 generate	 stocks	 carrying	 both	 upon	 a	 single	
chromosome,	 allowing	 the	 stock	 to	 be	 balanced	 also.	 In	Drosophila,	 only	 females	
undergo	 meiotic	 recombination.	 Recombination	 occurs	 by	 crossing	 the	 2	 stocks	
together	 and	 selecting	 the	 females	 that	 carry	 both	 genetic	 features.	 The	 females	
were	then	crossed	to	a	balancer	stock	and	recombinants	selected	based	on	whether	
they	carry	attributes	from	both	of	the	original	stocks	on	one	chromosome.	This	can	






Balancer	 chromosomes	 are	 used	 during	 crossing	 schemes	 to	 track	 mutations	 and	 select	 the	
desired	genotype	of	offspring.	They	also	maintain	mutations/transgenes	within	a	stock.	These	
‘balancers’	are	recessive	lethal	mutations,	which	prevent	the	loss	of	the	mutations	or	transgene	
and	 are	 phenotypically	 distinct	 due	 to	 the	 presence	 of	 a	 dominant	 visible	 mutation.	 One	
example	of	this	is	the	second	chromosome	balancer,	CyO	which	display	curly	wings.	Crossing	2	
stocks	 that	 are	 heterozygous	 for	 CyO	 and	 the	 desired	 mutation	 (A)	 results	 in	 3	 different	
outcomes;	a	heterozygous	offspring	of	either	mutation	1	(B)	or	2	(D)	over	CyO,	which	have	curly	
wings	and	a	stock	expressing	both	mutations	1	and	2,	which	display	straight	wings	as	CyO	is	not	





Wandering	 3rd	 instar	 larvae	 were	 selected	 and	 dissected	 in	 PBS	 (Phosphate	
Buffered	 Saline;	 Gibco®	 Invitrogen)	 and	 fixed	 in	 3.7%	 formaldehyde	 (37%	
formaldehyde	 solution;	 Sigma-Aldrich)	 in	 PBS	 for	 7	 minutes.	 Wandering	 larvae	
were	defined	by	their	exit	from	the	food	and	movement	up	the	side	of	the	vial;	the	
correct	genotype	was	selected	when	necessary.	The	dissection	took	place	in	a	drop	
of	 PBS	 upon	 a	 Sylgard	 dish	 (Silicone	 elastromer	 kit;	 Dow	 Corning).	 Larvae	 were	
dissected	by	pinning	down	the	anterior	and	posterior	ends	of	the	larvae	(Austerlitz	
Insect	Pins	0.1mm;	Fine	Science	Tools)	and	cutting	laterally	up	the	dorsal	side	using	
scissors	 (Vannas	 Spring	 Scissors	 -	 3mm	Blades;	 Fine	 Science	 Tools).	 The	 innards	
were	removed	using	forceps,	leaving	the	brain	intact	if	necessary.	The	muscle	wall	
was	 pinned	 out	 in	 four	 places	 forming	 a	 rectangle.	 The	 PBS	 was	 removed	 and	





5	 x	 3	 minutes	 of	 1ml	 PBS-T	 before	 secondary	 staining	 for	 2	 hours	 at	 room	
temperature	upon	a	nutator.	Dissections	were	washed	again,	5	x	3	minutes	of	1ml	
PBS-T	 before	 suspending	 in	 70%	 glycerol/30%	 PBS	 (Fischer	 Chemicals)	 at	 4°C	




Table	 2.2	 A	 list	 of	 primary	 antibodies	 used	 for	 larval	 stains	 throughout	 this	
investigation		
Primary	


























































1:1000	 Rabbit	 O’Donnell	Lab	 NA	
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Table	 2.3	 A	 list	 of	 secondary	 antibodies	 used	 for	 larval	 stains	 throughout	 this	
investigation	

























	 	 	 	
2.2.2 Imaging	and	analysis	of	Drosophila	neuromuscular	junctions	
The	quantification	and	analysis	of	the	Drosophila	NMJ	began	with	antibody	staining,	
using	 anti-horseradish-peroxidase-Cy3	 (HRP-Cy3)	 and	 anti-synaptotagmin	 (Anti-
SYT91)/goat-anti-rabbit-FITC	(see	Table	2.2	and	Table	2.3).	
2.2.2.1 	Synaptic	bouton	number	analysis	and	NMJ	imaging		
Using	 a	 fluorescence	 microscope	 (Axiovert	 200	 invert	 fluorescence	 microscope;	
Zeiss),	muscles	 6/7	 at	muscle	wall	 segment	 A3	were	 identified,	 and	 the	 NMJ	 lies	
between	muscles	 6/7.	 Each	NMJ	 had	 its	 boutons	 counted	 using	 the	 40x	 objective	
and	an	image	of	the	muscle	was	taken	using	the	10x	objective	in	order	to	normalise	
the	bouton	number	according	to	muscle	size.	The	mean	muscle	surface	area	(MSA)	
of	 wild-type	 larvae,	 which	 are	 a	 cross	 of	 w1118	and	 Canton-S	 (w1118/CS)	 and	 will	
hereby	be	referred	to	as	WT,	in	control	food	was	calculated	using	ImageJ	to	measure	
the	 length	and	width	of	 the	muscle	 in	pixels,	which	 is	converted	 to	µm	by	 ImageJ.	
The	MSA	was	 used	 to	 normalise	 the	 bouton	 count	 from	 each	NMJ	 (divided	 by	 its	
MSA	and	multiplied	by	the	mean	MSA)	in	order	to	adjust	for	muscle	size	changes	in	
the	 larvae.	 Normalised	 bouton	 counts	 from	 each	 test	 were	 averaged	 and	 the	
standard	error	of	the	mean	(SEM)	calculated.		
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One	NMJ	 from	 each	 test	was	 imaged	 using	 a	 confocal	microscope	 (LSM	880	 on	 a	
motorised	invert	microscope;	Zeiss)	using	a	63x	objective	(oil	immersion).	A	Z-stack	





Using	a	 confocal	microscope	 (LSM	880)	on	a	20x	objective,	1	NMJ	per	 larvae	was	
imaged	by	taking	a	Z-stack	on	the	Cy3	channel	only.	This	generated	an	image	of	the	
whole	NMJ	when	compiled	in	ImageJ;	it	was	saved	as	a	.tif	file.	This	file	was	loaded	
using	 NeuronJ,	 an	 extension	 for	 ImageJ	 that	 allows	 the	 quantification	 of	 branch	
number	and	NMJ	 length.	The	NMJ	was	manually	 traced	over	 its	entirety.	A	branch	
was	defined	here	as	any	protrusions	from	the	main	stem	of	the	motor	neuron	that	




also	raised	 in	 food	containing	10%	ethanol	 in	yeast	paste.	Pharmacological	agents	
were	 made	 up	 in	 10%	 ethanol	 and	 mixed	 into	 yeast	 paste	 before	 applying	 to	
saturated	instant	food	(see	section	2.1.2).	
Various	 pharmacological	 agents	 were	 used	 (see	 Table	 2.4).	 Oxidative	 stress	 was	
induced	 in	 Drosophila	 by	 feeding	 them	 diethyl	 maleate	 (DEM)	 (Diethyl	 Maleate	
97%;	 Sigma-Aldrich).	 Various	 concentrations	 of	 DEM	were	 used.	 Oxidative	 stress	
was	relieved	using	the	antioxidant,	Trolox	(Trolox®,	97%;	Acros	Organics).	We	also	
treated	 Drosophila	 with	 Levodopa	 (L-DOPA)	 (3,	 4-dihydroxy-L-phenylalanine	 ≤	
98%;	Sigma-Aldrich).	 	
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Table	 2.4	 Pharmacological	 agents	 and	 their	 concentrations	 used	 throughout	 this	
investigation	
Chemical	 Concn	 MW	 Vehicle	and	volume	 Amount	used	
DEM	 30mM	 172.18	 10%	Ethanol/	100ml	 517µl	
DEM	 10mM	 172.18	 10%	Ethanol/	100ml	 172µl	
DEM	 3mM	 172.18	 10%	Ethanol/	100ml	 51.7µl	
DEM	 1mM	 172.18	 10%	Ethanol/	100ml	 17.2µl	
Trolox	 10mM	 250.29	 10%	Ethanol/	10ml	 25.029mg	
L-DOPA	 1mg/ml-1	 197.19	 10%	Ethanol/	10ml	 10mg	





(PCR	Master	Mix,	 2x;	 Promega),	 1µM	 of	 each	 primer	 and	 approximately	 1-2ng	 of	
plasmid	DNA,	all	of	which	were	combined	into	PCR	reaction	tubes	(0.2ml	PCR	tube,	
Flat	cap;	STARLAB)	kept	on	ice.	Nuclease-free	water	was	used	to	top	up	the	reaction	
volume	 to	20µl.	Reactions	were	 run	 for	 30	 cycles	 in	 a	PCR	machine	 (TC-512	PCR	






cycles	 Temperature	(°C)	 Time	(Mins)	 Stage	











1	 72	 10	 Final	extension	

















Agarose	 gel	 electrophoresis	 was	 performed	 to	 analyse	 PCR	 products	 and	 DNA	
recovered	from	restriction	digests.	Agarose	gels	(100ml)	are	made	at	0.7%	in	TAE	
buffer,	 which	 consists	 of	 40mM	 Tris	 acetate	 and	 1mM	 EDTA	 at	 pH	 8.3.	 10µl	 of	
SYBR®	 safe	 (SYBR®	 Safe	 DNA	 gel	 stain;	 Invitrogen)	 was	 added	 to	 allow	
visualisation	 of	 DNA	when	 exposed	 to	 blue	 light.	 The	 gel	was	 submerged	 in	 TAE	
buffer	 in	 the	 electrophoresis	 tank.	 DNA	was	 prepared	 for	 loading	 into	 the	 gel	 by	
mixing	 with	 loading	 dye,	 consisting	 of	 0.25%	 w/v	 bromophenol	 blue	 and	 30%	
glycerol	v/v	in	dH2O.	The	volume	of	loaded	DNA	depends	on	the	purpose	of	the	gel,	




DNA	 fragments	 were	 cut	 from	 the	 agarose	 gel	 using	 a	 blade	 and	 placed	 into	





DNA	 fragments	 were	 prepared	 for	 plasmid	 insertion	 by	 generating	 sticky	 ends	
through	 restriction	 endonuclease	 digestion.	 This	 allows	 for	 the	 insertion	 of	 DNA	
into	 plasmids,	which	 are	 digested	 using	 complimentary	 restriction	 enzymes.	 This	
technique	can	also	be	used	to	cut	DNA	from	plasmids;	either	for	transferring	into	a	
different	 plasmid	 or	 to	 check	 the	 cloning	 has	 worked	 correctly.	 Appropriate	
restriction	 enzymes	 and	 buffers	 were	 incubated	 with	 the	 DNA	 sample	 requiring	
digestion,	usually	at	a	concentration	that	will	provide	at	 least	20ng	of	the	smallest	
possible	 fragment,	 in	 order	 to	 visualise	 post	 gel	 electrophoresis.	 The	 incubation	
period	was	at	 least	2	hours	at	37°C.	The	restriction	enzymes	were	deactivated	by	
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incubation	 at	 80°C	 for	 15	 minutes.	 Cleaved	 fragments	 were	 analysed	 by	 gel	
electrophoresis.		
2.4.5 DNA	ligation	
Cleaved	DNA	 fragments	were	 ligated	 into	 cleaved	plasmids	 via	 a	 ligation	 reaction	











was	 achieved	 by	 transforming	 into	 E.coli	 cells	 (XL-1	 Blue	 supercompetent	 E.coli	




yeast	 extract.	 Plasmid	 transformation	 required	 1µl	 of	 the	 ligation	 reaction.	
Transformed	cells	were	plated	on	LB	agar	plates,	which	was	standard	LB	plus	20g/l	
agar	 as	well	 as	200µg/ml	 ampicillin	 (AMP)	 for	 antibiotic	 selection,	 and	 incubated	
overnight	at	37°C.		
Individual	 colonies	 were	 picked	 and	 transferred	 into	 culture	 tubes	 (14ml	
polypropylene	round-bottom	tubes;	Falcon)	containing	5ml	LB	plus	AMP.	Cultures	







by	 purifying	 a	 sample	 of	 the	 culture	 via	miniprep.	 1.5ml	 of	 the	 overnight	 culture	
derived	 from	the	plated	transformants	was	pelleted	at	13000g	 for	2	minutes	on	a	
bench	 top	 centrifuge	 (Eppendorf	 Centrifuge	 5417C;	 Eppendorf).	 The	 supernatant	
was	 removed	 and	 the	 pellet	 frozen	 at	 -20°C	 to	 improve	 miniprep	 efficiency.	
Minipreps	were	generated	using	the	Qiaprep®	Spin	MiniPrep	Kit	(Qiagen,	UK)	and	
by	 following	 the	 instructions	provided.	A	NanoDrop	(ND-1000;	Thermo	Scientific)	
was	used	to	determine	the	concentration	before	performing	a	restriction	digest	(see	







Cultures	 were	 transferred	 to	 2x50ml	 conical	 bottom	 tubes	 (CELLSTAR®	 tubes;	
Greiner	 bio-one)	 and	 centrifuged	 at	 6000rpm	 for	 15	 minutes	 at	 4°C.	 The	
supernatant	 was	 discarded	 and	 the	 pellet	 frozen	 at	 -20°C	 to	 improve	 midiprep	
efficiency.	 Midipreps	 were	 generated	 using	 a	 kit	 (HiSpeed®	 Plasmid	 midi	 kit;	
Qiagen,	UK)	following	the	instructions	provided.	
2.5 Generating	transgenic	Drosophila	lines	and	antibodies	










2.4.6).	 Restriction	 digests	 upon	 the	 purified	 plasmids	 excised	 the	 required	 cDNA	






NTAP	(GS)	vector	 (see	Figure	2.2)	generating	complimentary	 sticky	ends	 to	allow	
the	 insertion	 of	 Fos	 and	 Jun	 into	 the	 NTAP-vector	 (Veraksa	 et	 al.,	 2005).	 Gel	
extraction	was	performed	(see	section	2.4.3)	to	purify	the	correct	sized	Fos	and	Jun	
cDNA	sequences	as	well	as	purify	the	NTAP-vector	away	from	its	cleaved	sequence.	





The	NTAP	 vector	 used	 during	 this	 investigation.	 The	 cDNA	 for	 Fos	 and	 Jun	was	 inserted	 into	 the	
multiple	 cloning	 site	 (MCS)	 in	 the	 correct	 frame	 for	expression	with	 the	addition	of	 an	N-terminal	
TAP-tag.	 The	 vector	 image	 was	 generated	 using	 the	 Addgene	 sequence	 analysis	 tool.	 The	 linear	
sequence	is	adapted	with	permission	from	Veraksa	et	al.	(2005).	
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The	UAS-NTAP-Fos,	 and	UAS-NTAP-Jun	 vectors	were	 separately	 transformed	 into	
super-competent	 E.coli	 cells	 (see	 section	 2.4.6)	 Successful	 transformations	 were	
miniprepped	 (see	 section	 2.4.7.1)	 checked	 and	 sequenced	 (University	 of	 York,	
Technology	 Facility,	 Genomics	 Lab)	 to	 ensure	 the	 sequence	 was	 correct.	 100ml	
overnight	cultures	were	set	up	using	 the	successfully	 transformed	cultures	before	




sodium	 acetate	 and	 120µl	 of	 100%	 ethanol	 then	 incubated	 overnight	 at	 -20˚C.	
Samples	were	centrifuged	for	30	minutes	at	13000	rpm,	washed	with	70%	ethanol,	
air	 dried	 then	 resuspended	 in	 20µl	 of	 Spradling	 Buffer	 (5mM	 KCl,	 0.1mM	 PO4,	
pH7.8).	
Following	 the	 Sweeney	 lab	 protocol	 for	 microinjection,	 large	 numbers	 of	 w1118	
embryos	less	than	1	hour	old	were	collected	and	dechorinated	using	adhesive	tape.	
Dechorinated	 embryos	 were	 lined	 up	 on	 adhesive	 tape	 upon	 a	 cover	 slip	 and	
allowed	 to	 dry	 for	 10	 minutes	 before	 covering	 in	 voltaleff	 oil.	 The	 coverslip	 is	
mounted	 on	 a	 microscope	 slide	 and	 microinjected	 with	 either	 NTAP-Fos	 or	 Jun.	
Surviving	 larvae	are	raised	 to	adulthood	and	crossed	 to	w1118	 flies	of	 the	opposite	
sex.	Those	that	successfully	incorporated	the	NTAP-Fos	or	Jun	vector	expressed	w+,	
present	 because	 of	 the	 insertion,	 and	 displayed	 red/yellow	 eyes	 as	 adults.	 Stocks	
were	generated	from	the	successful	survivors	and	balanced	accordingly.	The	NTAP	
tag	itself	consisted	of	two	IgG	binding	domains	of	Protein	A	(Staphylococcus	aureus)	
and	 a	 streptavidin	 binding	 peptide	 separated	 by	 a	 Tobacco	 Etch	 Virus	 (TEV)	
protease	 cleavage	 site.	 This	 allows	 us	 to	 purify	 out	 our	 tagged	 proteins	 by	
incubating	with	 IgG	covered	beads,	 the	 tag	binds	 the	beads	and	was	 then	cleaved	
using	 TEV	 protease.	 Adding	 the	 cleaved	 proteins	 to	 streptavidin	 beads	 gives	 a	
second	 purification	 step.	 The	 still	 intact	 streptavidin	 binding	 peptide	 binds	 the	
beads,	 which	 were	 then	 purified	 and	 washed	 to	 remove	 any	 remaining	
contaminants.	Our	bound	 tagged-Fos	 and	 Jun	were	 eluted	along	with	 any	binding	
partners	 by	 boiling	 in	 Sodium	 Dodecyl	 Sulphate	 (SDS).	 The	 proteins	 were	 then	
identified	 via	 mass	 spectrometry	 (see	 section	 2.6.4).	 Following	 successful	
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generation	of	 the	NTAP-fly	 stocks,	we	 tested	whether	 the	 tagged	protein	was	 still	
functional	and	able	to	compensate	for	loss	of	their	respective	endogenous	protein.	
We	 expressed	 NTAP-	 tagged-Fos	 in	 a	 Fos	 null	 background	 (kay1/kay2)	 using	
actin5CGAL4	(referred	to	as	actinGAL4	onwards)	and	searched	the	progeny	for	those	





A:	 UAS-NTAP-Fos	 and	 kay1	 are	 doubled	 balanced	 into	 the	 same	 fly	 stock	 are	 crossed	 to	 double	
balanced	 Actin5CGAL4	 and	 kay2	 flies.	 B:	 Progeny	 from	 the	 aforementioned	 cross	 displaying	 curly	
wings	(CyO)	only	carry	either	Actin5CGAL4	or	UAS-NTAP-Fos	so	tagged	Fos	is	not	expressed	and	the	
combination	 of	 both	 kay	 mutant	 alleles	 is	 lethal.	 C:	 This	 progeny	 display	 neither	 balancer	
(CyO/TM6b)	 and	 are	 expressing	 tagged	 Fos	 in	 the	 kay	 null	 background,	 allowing	 rescue	 of	 this	






double	 balanced	 SpinGAL4	 and	 jraIA109	flies.	B:	 Progeny	 from	 the	 aforementioned	 cross	 displaying	
curly	wings	(CyO)	are	only	expressing	either	jra76-19	or	jraIA109	therefore	not	a	Jun	null	mutant	and	are	
discarded.	C:	This	progeny	display	neither	balancer	(CyO/TM6b)	and	are	expressing	tagged	Jun	in	the	
jra	 null	 background,	 allowing	 rescue	 of	 this	 otherwise	 lethal	 combination.	D:	 These	 flies	 display	
increased	 humeral	 bristles	 (TM6b)	 and	 are	 only	 expressing	 either	 SpinGAL4	 or	 UAS-NTAP-Jun,	





Punch	 cDNA	was	obtained	by	 streaking	a	 chloramphenicol	plate	using	E.coli	 from	
the	 Sweeney	 lab	 cDNA	 library	 (pOT2-LD37787).	 Streaked	 plates	 were	 incubated	
overnight	 at	 37°C	 and	 single	 colonies	 containing	 pOT2-Punch	 were	 picked	 and	
grown	 in	 5ml	 overnight	 cultures	 containing	 5µl/ml	 chloramphenicol	 (see	 section	
2.4.6).	 Each	overnight	 culture	had	 a	 sample	miniprepped	 (see	 section	2.4.7.1).	 To	
remove	 the	 Punch	 cDNA	 from	 the	 pOT2	 vector,	 restriction	 digest	was	 performed	
(see	 section	 2.4.4)	 using	 restriction	 enzymes	 XbaI	 and	 BGLII	 and	 Buffer	 D	










for	 UAS-Punch,	 plus	 the	 HA	 tag	 in	 UAS-Punch-HA.	 This	 PCR	was	modified	 and	 is	
different	to	the	previously	outlined	method.	We	altered	the	reaction	volume	to	50µl	
and	adjusted	the	other	volumes	accordingly.	We	also	ran	this	PCR	for	45	cycles.	Gel	
extraction	 (see	 section	 2.4.3)	 of	 the	 correct	 fragments	 purified	 them	 ready	 for	 a	
restriction	 digest,	 which	 was	 performed	 upon	 both	 newly	 PCR-generated	 cDNA	
fragments	 as	 well	 as	 the	 pUAST-attB	 vector	 to	 generate	 sticky	 ends	 ready	 for	
ligation	(see	section	2.4.4).	The	fragments	were	gel	extracted	again	before	ligation	
was	 performed	 (see	 section	 2.4.5).	 Ligated	 products	were	 transformed	 into	E.coli	
and	purified	following	the	same	protocol	as	outlined	previously	(see	section	2.5.1).	
Upon	acquiring	midiprepped	 samples	of	UAS-Punch	and	UAS-Punch-HA,	both	had	
their	 concentrations	 calculated	 using	 a	 NanoDrop	 (ND-1000,	 Thermo	 Scientific).	
Neither	were	concentrated	enough	for	microinjection	so	ethanol	precipitation	was	
performed.	 100µl	 of	 both	 constructs	 were	 incubated	 with	 10µl	 of	 3M	 sodium	
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acetate	 and	 330µl	 of	 100%	 ice	 cold	 ethanol,	 overnight	 at	 -20°C.	 The	 DNA	 was	
pelleted	 via	 centrifugation	 at	 13000g	 for	 30	 minutes	 at	 4°C.	 The	 supernatant	 is	
removed	 and	 the	 pellet	 washed	 with	 1ml	 70%	 ethanol	 and	 centrifuged	 again	 at	
13000g	 for	10	minutes.	The	supernatant	 is	removed	and	the	pellet	 is	air	dried	for	
10	minutes.	The	pellet	is	resuspended	in	25µl	resulting	in	concentrations	for	UAS-
Punch	 of	 1327.9ng/µl	 and	 UAS-Punch-HA	 of	 1078ng/µl	 as	 calculated	 by	 the	
NanoDrop.	 Each	 of	 the	 constructs	 were	 sequenced	 and	 confirmed	 to	 be	 correct	
using	the	GATC	light	run	service.	We	outsourced	the	microinjection	of	these	stocks	
to	 The	University	 of	 Cambridge,	 Department	 of	 Genetics,	 Fly	 Facility.	 The	 phiC31	
integrase	system	can	be	used	as	we	have	inserted	the	Punch	cDNA	into	the	pUAST-
attB	vector.	This	system	utilises	site-directed	recombination	to	insert	our	sequence	
into	 the	 genome.	 The	 phiC31	 integrase	 is	 a	 sequence	 specific	 recombinase	 that	
mediates	 the	 recombination	between	attachment	 sites,	 one	of	which	 is	present	 in	
our	 vector	 (attB),	 the	 other	 in	 the	 target	 Drosophila	 line	 (attP).	 The	 integrase	
facilitates	 the	 recombination	 of	 these	 sites,	 inserting	 the	 gene	 of	 interest	 into	 the	
Drosophila	line	following	microinjection.	We	wanted	stocks	of	UAS-Punch	and	UAS-





The	 integrase	 is	 removed	 and	 successful	 lines	were	 balanced	 before	we	 received	
them	back	from	Cambridge.		
2.5.3 Generating	antibodies	
Four	 antibodies	 were	 generated	 as	 part	 of	 this	 study.	 The	 cDNA	 encoding	
Drosophila	 Jun,	 isoform	A	and	Drosophila	Punch,	 isoform	A	were	used	 to	generate	
soluble	 Jun	and	Punch	proteins	by	the	Technology	Facility	Protein	Production	Lab	
(Biology,	University	of	York).	These	were	used	to	inoculate	2	guinea	pigs	(Jun)	and	2	
rats	 (Punch)	 over	 a	 three-month	 immunisation	 scheme	 (Eurogentec,	 Belgium)	





This	 investigation	 aims	 to	 identify	 the	 binding	 partners	 of	 Fos	 and	 Jun	 during	
conditions	of	oxidative	stress	compared	to	controls.	We	generated	Drosophila	lines,	
UAS-NTAP-Fos	and	UAS-NTAP-Jun	 in	order	 to	express	 these	 in	 fly	neuronal	 tissue	
and	 extract	 Fos	 and	 Jun	 utilising	 the	 tag	 that	 we	 added.	 This	 was	 achieved	 by	
performing	 tandem	 affinity	 purification	 (TAP)	 on	 a	 homogenised	 sample	 of	 4500	
heads	per	sample.	The	details	are	outlined	below.	
2.6.1 Generating	UAS-NTAP-Fos	and	UAS-NTAP-Jun	fly	samples		
Large	 numbers	 of	 homozygous	 UAS-NTAP-Fos	 and	 UAS-NTAP-Jun	 males	 were	
crossed	 to	 homozygous	 elavGAL4	 virgin	 females,	 generating	 approximately	 9000	
flies	per	genotype.	We	crossed	to	elavGAL4	to	achieve	pan-neuronal	expression	of	
NTAP-tagged	Fos	and	Jun,	as	we	aimed	to	determine	the	role	of	Fos	and	Jun	in	the	
neurons	 only.	 Half	 of	 these	 were	 immediately	 stored	 at	 -80°C	 and	 formed	 the	
control,	 non-oxidatively	 stressed	 sample.	 The	 remaining	 4500	 were	 starved	
overnight	in	a	cage	containing	a	2%	agar	plate	(see	section	2.1.2).	The	following	day,	
a	 mix	 of	 20mM	 DEM,	 5%	 sucrose	 (Sucrose;	 Fisher	 Scientific)	 and	 blue	 food	 dye	
(Blue	 Food	 Colouring;	Nestle)	was	 used	 to	 saturate	 thick	 filter	 paper	 (Qualitative	
filter	 paper,	 Grade	 6,	 circles;	Whatman®)	 and	 this	was	 added	 to	 the	 cage	 of	 flies	
which	is	kept	at	25°C	for	5	hours.	After	1	hour	the	cage	was	checked	to	ensure	the	





















Once	all	 samples	had	been	collected	and	stored	at	 -80°C	we	began	processing	 the	
samples.	We	are	only	interested	in	the	heads	and	see	needed	to	separate	the	head	
from	 the	 remainder	 of	 the	 body.	 To	 do	 so	 we	 used	 a	 series	 of	 molecular	 sieves	
(3310/BS:	410-1:2000/	710	and	425	Micron	mesh;	ISO).	Two	separate	sieves	were	
used,	one	with	a	mesh	size	of	710	microns	which	allowed	 the	heads	and	 limbs	 to	
pass	through	but	retains	the	abdomen	and	wings.	The	next	sieve	had	a	mesh	size	of	
425	microns,	which	allowed	the	limbs	to	pass	through,	retaining	the	heads	only.	We	
first	 froze	 these	 sieves	 at	 -80°C	 in	 order	 to	 keep	 the	 samples	 chilled	 during	 the	
separation	 process.	 The	 samples	 were	 vortexed	 quickly,	 which	 breaks	 the	 heads	
from	 the	 rest	 of	 the	 carcass.	 The	 samples	were	 added	 to	 the	 chilled	 sieves	which	
were	 kept	 on	 dry	 ice	 in	 a	 4°C	 cold	 room	 and	 rapidly	 and	 vigorously	 shaken	 to	
ensure	all	heads	had	passed	through	to	the	second	sieve	and	that	no	limbs	remained	
in	the	second	sieve.	We	collected	the	heads	from	the	second	sieve	into	a	falcon	tube	
which	was	 quickly	 transferred	 back	 into	 the	 -80°C	 freezer	 to	 ensure	 they	 do	 not	
defrost.	The	frozen	heads	were	then	transferred	to	a	highly	polished	agate	mortar	




3ml	 Bouwmeester’s	 buffer	 (50mM	 Tris-HCl	 (Sigma),	 125mM	 NaCl	 (Fischer	
Scientific),	 5%	glycerol	 (Sigma),	 0.2%	NP40	 (Igepal;	 Fluka),	 1.5mM	MgCl2(Sigma),	
1mM	 DTT	 (Melfords),	 25mM	 NaF	 (Sigma),	 1mM	 Na3VO4(Sigma),	 1mM	 EDTA	
(Sigma),	2mM	EGTA	(Amresco)	and	1	tablet/10ml	protease	inhibitor	cocktail	(PIC)	
(cOmplete	 EDTA-free,	 mini	 tablets;	 Roche))	 (Pepper	 et	 al.,	 2012).	 The	 fly	
homogenate	 was	 transferred	 into	 1.5ml	 Eppendorf	 tubes	 and	 centrifuged	 at	 4°C,	
13,200g	 for	15	minutes	 to	 clarify	 the	homogenate.	The	 supernatant	was	 removed	
and	 centrifuged	 again	 to	 clarify	 further;	 TAP	was	 performed	 on	 this	 lysate.	 Small	
amounts	were	retained	to	perform	a	western	blot	(running	5µl	of	each	sample)	 in	
order	 to	 check	 that	 the	 tagged	 Fos	 and	 Jun	 are	 present	 and	uncontaminated	 (see	
Figure	4.1).	
2.6.3 Tandem	affinity	purification	(TAP)	
The	 first	 step	 requires	 incubating	 the	 lysates	 overnight	 at	 4°C	 with	 pre-washed	
agarose	 beads	 (Rabbit-IgG	 Agarose	 beads;	 Sigma).	Washing	 of	 the	 agarose	 beads	
consisted	 of	 200µl	 of	 the	 beads	 in	 a	 15ml	 conical	 bottom	 tube	 (Corning)	 being	
nutated	for	15	minutes	with	500µl	of	Buffer	B	(20mM	hepes	(Sigma),	20%	glycerol	
(Sigma),	 0.5%	NP40	 (Igepal;	 Fluka),	 200mM	KCl	 (Sigma),	 0.5mM	DTT	 (Melfords),	
1mM	 EDTA	 (Sigma),	 20mM	 EGTA	 (Amresco)	 and	 1	 tablet/10ml	 PIC	 (cOmplete	
EDTA-free,	mini	 tablets;	Roche))	after	each	wash	 the	 tube	was	centrifuged	at	4°C,	












buffer	 (10mM	 Tris-HCl	 (Sigma),	 150mM	 NaCl	 (Fischer	 Scientific),	 0.1%	 NP-40	
(Igepal;	 Fluka),	 1mM	 DTT	 (Melfords),	 0.5mM	 EDTA	 (Sigma))	 then	 centrifuged	 at	
4°C,	100g	for	2	minutes	after	each	wash.	A	10µl	sample	of	the	beads	were	retained	
for	western	blot	analysis,	this	is	the	fraction	of	proteins	bound	to	IgG	beads.	40	units	
of	 TEV	 protease	 (ProTEVplus	 protease;	 Promega)	 were	 added	 to	 400µl	 of	 TEV	
cleavage	buffer	and	1mM	DTT	(Melfords).	This	was	used	to	resuspend	the	IgG	beads	




times	 its	 volume	 of	 Bouwmeester’s	 buffer.	 Streptavidin	 beads	 were	 prepared	 by	
adding	 100µl	 into	 a	 1.5ml	 Eppendorf	 tube	 and	 washed	 twice	 with	 500µl	 of	
Bouwmeester’s	buffer,	 then	 centrifuged	at	4°C,	 1500rpm	 for	2	minutes	 after	 each	
wash.	The	supernatant/buffer	mix	was	added	to	the	washed	Streptavidin	beads	and	
incubated	 overnight	 at	 4°C	 with	 nutation.	 Following	 incubation	 the	 beads	 were	
centrifuged	 at	 4°C,	 1500rpm	 for	 2	 minutes.	 The	 supernatant	 was	 removed	 and	
retained;	a	sample	is	taken	for	analysis,	which	is	the	fraction	that	did	not	bind	the	
streptavidin	 beads.	 The	 remaining	 beads	 were	 washed	 3	 times	 with	 500µl	
Bouwmeester’s	 buffer	 and	 centrifuged	 at	 4°C,	 1500rpm	 for	 2	 minutes	 after	 each	
wash.		
The	 purified	 Fos	 and	 Jun	 proteins,	 along	with	 their	 binding	 partners	were	 eluted	
from	 the	 streptavidin	 beads	 by	 heating	 in	 25µl	 of	 SDS	 sample	 buffer,	 95°C	 for	 5	
minutes.	A	small	amount	of	this	elution	(1µl,	diluted	1	in	6)	is	kept	for	western	blot	
analysis.	This	protocol	was	adapted	from	several	other	studies	(Veraksa	et	al.,	2005,	
Tian	 et	 al.,	 2011,	 Pepper	 et	 al.,	 2012).	 The	 remaining	 elution	 was	 used	 in	 mass	
spectrometry.		
Prior	to	this	larger	scale	experiment,	a	pilot	run	was	performed	using	500	heads	per	





MG-115,	 1mM	 PMSF,	 25mM	 beta-glycerophosphate,	 Complete	 mini	 protease	
inhibitor	tablets	1	per	10ml	extraction	solution,	EDTA-free,	Roche	Applied	Science.	





2.6.4 In-Gel	 tryptic	 digest	 and	 liquid	 chromatography–mass	
spectrometry/mass	spectrometry	(LC-MS/MS)	
Materials	 and	 apparatus	were	 supplied	 by	 the	 Proteomics	 Lab	 in	 the	 Technology	
Facility	who	also	performed	the	following	protocol	(Biology,	University	of	York).	
Each	elution	was	 loaded	(24µl)	 into	a	10%	Bis-tris	gel	 (NuPAGE	10%	Bis-Tris	Gel	
1mm	 x	 10	 well;	 Novex)	 and	 sodium	 dodecyl	 sulphate	 polyacrylamide	 gel	
electrophoresis	(SDS-PAGE)	(see	section	2.7.3)	was	performed	at	200v.	We	did	not	
want	 to	 separate	 out	 the	 proteins	 as	 would	 normally	 occur	 in	 SDS-PAGE,	 so	 the	









100µl	 of	 10mM	 dithioerythrietol	 (DTE)	 in	 100mM	 ammonium	 bicarbonate	 for	 1	
hour	at	56°C.	The	gel	pieces	were	allowed	to	return	to	room	temperature	and	the	
supernatant	 removed.	 They	 were	 then	 incubated	 with	 100µl	 of	 50mM	
iodoacetamide	 in	 100mM	 ammonium	 bicarbonate	 for	 30	 minutes	 in	 the	 dark	 at	
room	 temperature.	 The	 supernatant	 was	 removed	 and	 the	 gel	 pieces	 washed	 in	
100µl	 of	 100mM	 ammonium	 bicarbonate	 for	 15	 minutes.	 The	 supernatant	 was	
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removed	 and	 the	 gel	 pieces	washed	 again	with	 25mM	ammonium	bicarbonate	 in	





up	 the	 solution	 for	 10	 minutes.	 The	 gel	 pieces	 were	 then	 covered	 in	 25mM	
ammonium	 bicarbonate	 using	 as	 small	 a	 volume	 possible.	 These	 were	 incubated	
overnight	at	37°C.	
The	sample	was	acidified	by	adding	1/10th	volume	of	1%	Trifluoroacetic	acid	(TFA).	




repeated	 at	 least	 10	 times.	 As	 much	 of	 the	 liquid	 was	 expelled	 from	 the	 tip	 as	







at	 high	 pressure,	 which	 is	 the	 mobile	 phase.	 The	 column	 is	 packed	 with	 silica	
particles	with	attached	chains	of	octadecylsilyl	(C18),	which	is	the	modified	organic	
particle	that	makes	up	the	stationary	phase.	This	system	separates	the	peptides	in	
the	 sample	based	on	 their	hydrophobic	 character	by	 running	 the	 sample	across	 a	
linear	gradient	of	organic	solvent,	acetonitrile.	The	peptides	are	forced	through	the	
stationary	phase	consisting	of	C18	chains	bound	to	silica	particles	which	captures	the	
peptides	 based	 on	 their	 hydrophobicity	 followed	 by	 their	 sequential	 elution.	 The	
UPLC	system	was	equipped	with	a	nanoAcquity	Symmetry	C18,	5µm	trap	(180µm	x	
20mm;	Waters)	 and	 a	 nanoAcquity	 HSS	 T3	 1.8µm	 C18	 capillary	 column	 (75µm	 x	
250mm;	Waters).	The	wash	solvent	for	the	trap	was	0.1%	(v/v)	aqueous	formic	acid	
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and	was	washed	 for	5	minutes	before	switching	 flow	to	 the	capillary	column.	The	
trapping	flow	rate	was	10µl/min.	Separation	of	the	sample	used	a	gradient	elution	








and	 CaptiveSpray	 ionisation	 source	 (Bruker	 Daltonics).	 Positive	 electrospray	
ionisation	(ESI)-MS	and	MS/MS	spectra	were	acquired	using	AutoMSMS	mode.	ESI	
produces	ions	from	your	sample	using	an	electrospray,	which	applies	high	voltage	




electric	 filed.	 The	 instrument	 settings	 for	 the	mass	 analyser	were	 as	 follows:	 ion	
acquisition	range:	m/z	150-2,000,	MS	spectra	rate:	5Hz,	MS/MS	spectra	rate:	5Hz	at	
2,500cts	 to	 20Hz	 at	 250,000cts,	 cycle	 time:	 1	 second,	 quadrupole	 low	mass:	 300	
m/z,	 collision	 RF:	 1,400	 Vpp,	 transfer	 time	 120ms.	 The	 collision	 energy	 and	
isolation	 width	 settings	 were	 automatically	 calculated	 using	 the	 AutoMSMS	
fragmentation	 table,	 absolute	 threshold	 200	 counts,	 preferred	 charge	 states:	 2–4,	
singly	charged	ions	were	excluded.	
The	mass	 analyser	 separates	 the	 ions	 based	 on	 their	mass	 to	 charge	 ratio	 (m/z),	
which	 is	 determined	 by	 time-of-flight	 (TOF).	 TOF	 measures	 the	 time	 that	 the	
peptide	 ions	 take	 to	 travel	over	 the	 flight	 tube	within	 the	mass	analyser.	Peptides	
with	 a	 high	 m/z	 travel	 slower	 than	 peptides	 with	 a	 low	 m/z.	 A	 set	 of	 known	
calibrated	m/z	standards	is	used	to	determine	the	m/z	value	of	the	sample	peptide	
ions	 based	 on	 their	 flight	 time.	 A	 single	MS/MS	 spectrum	was	 acquired	 for	 each	
precursor	 and	 former	 target	 ions	were	excluded	 for	0.8	min	unless	 the	precursor	
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MASCOT	 processing	 matches	 peptide	 spectra	 to	 sequences	 within	 a	 database	 in	
order	 to	 identify	 proteins	 based	 on	 the	 number	 of	 matches	 a	 specific	 peptide	
sequence	accumulates	(Mallick	and	Kuster,	2010).	As	a	result,	a	list	of	proteins	with	
their	matching	peptides	is	produced.	The	following	criteria	were	used	to	refine	the	
MASCOT	 search.	 Our	 peptide	 sequences	 were	 searched	 against	 the	



















excluding	 less	 significant	 identifications	 and	 less	 well-matched	 peptides	
respectively.	 It	 is	 important	 to	 note	 here	 that	 while	 we	 have	 set	 a	 stringency	 to	
exclude	 false	 positive	 results,	 there	 was	 still	 a	 chance	 that	 we	 included	 false	
positives	in	our	results.	Following	the	MASCOT	search,	a	list	of	proteins,	 identified	




Abundance	 Index	 (emPAI)	 score.	 The	 number	 of	 significant	 sequences	 is	
determined	by	the	number	of	peptide	sequences	identified	that	match	the	identified	
protein.	The	number	of	significant	matches	 is	determined	by	 the	number	of	 times	




removed	 from	 our	 experimental	 data	 before	 further	 analytical	 processing	 was	
performed	using	WebGestalt	and	STRING.		
2.6.5.2 	WebGestalt	
The	 protein	 accession	 numbers	 were	 entered	 into	WebGestalt	 (WEB-based	 GEne	
SeT	 AnaLysis	 Toolkit),	 specifically	 searching	 against	 the	Drosophila	melanogaster	
database	 and	 identified	 as	 dmelanogaster_uniprot_swissprot_accession	 (Zhang	 et	
al.,	 2005).	 Some	 proteins	 from	 the	 original	 list	 required	 their	 accession	 number	
converting	to	fit	this	classification,	this	was	performed	manually	using	the	Uniprot	










levels	 in	 a	 variety	 of	 experiments,	 specifically	 in	 following	 bait	 proteins	 through	
TAP,	in	the	characterisation	of	antibodies	and	to	assess	mutants.	
2.7.1 Protein	extraction	from	fly	heads	
The	head	of	 the	 fly	was	used	to	assess	protein	 levels,	as	we	are	mainly	concerned	
with	neuronal	 cells.	 Flies	were	 collected	 in	15ml	 falcon	 tubes	and	 frozen	at	 -80°C	
before	 transferring	 to	 dry	 ice.	 The	 tubes	 were	 placed	 into	 50ml	 falcon	 tubes	
containing	dry	 ice	and	vortexed	vigorously	 for	10	seconds	before	placing	back	on	
dry	ice	to	ensure	they	did	not	thaw.	A	mortar	was	placed	on	dry	ice	and	allowed	to	
cool	 before	 the	 vortexed	 flies	 were	 added,	 at	 this	 point	 the	 flies	 are	 broken	 into	
pieces	 and	 the	 heads	 have	 separated	 off.	 30	 heads	 were	 collected	 from	 each	
genotype	 and	 placed	 into	 tubes	 containing	 30µl	 of	 ice	 cold	
Radioimmunoprecipitation	assay	(RIPA)	buffer	(150mM	NaCl,	1.0	%	IGEPAL®	CA-
630,	0.5	%	sodium	deoxycholate,	0.1	%	SDS,	50mM	Tris,	pH	8.0;	Sigma)	which	we	
also	 added	 1	 tablet/10ml	 Protease	 inhibitor	 cocktail	 (PIC)	 (cOmplete	 EDTA-free,	
mini	 tablets;	 Roche).	 The	 heads	 were	 homogenised	 using	 sterile	 pellet	 pestles	
(Sigma).	The	homogenate	was	centrifuged	at	13000g	for	15	minutes	at	4°C	to	clarify	
the	 sample,	 the	 supernatant	 was	 removed	 and	 rapidly	 frozen	 on	 dry	 ice	 before	
transferring	to	-80°C	for	storage.	
2.7.2 Quantification	 of	 protein	 concentration:	 Bicinchoninic	 acid	
assay	(BCA)	
The	BCA	assay	was	used	to	determine	protein	concentrations	within	our	samples,	






also	 used,	 performed	 using	 dilutions	 ranging	 from	 2mg/ml	 BSA	 down	 to	
0.03125mg/ml	 BSA	 and	 finally	 0mg/ml	 BSA/RIPA	 buffer.	 Each	 dilution	 was	
achieved	 through	 the	 addition	 of	RIPA	buffer,	 as	 this	was	 the	 vehicle	 our	 protein	
sample	 was	 in.	 200µl	 of	 the	 reaction	 assay	 was	 added	 to	 every	 used	 well	 and	
incubated	at	37°C	for	around	an	hour,	or	until	a	range	of	colour	change	is	observed	
in	 the	 BSA	 standards.	 The	 plate	 was	 inserted	 in	 a	 plate	 reader	 (Multiskan	 GO;	
Thermo	 Scientific)	 and	 the	 absorbance	 of	 each	well	 was	measured	 using	 the	 on-
board	program,	the	measurements	were	repeated	several	times	to	ensure	accurate	






Using	 samples	 of	 known	 protein	 concentration,	 SDS-PAGE	 was	 performed	 to	
separate	 the	 proteins.	 The	 sample	 was	 mixed	 in	 a	 3:1	 ratio	 with	 sample	 buffer,	
made	 up	 as	 100µl	 of	 β–mercaptoethanol	 in	 900µl	 of	 4x	 laemmli	 buffer	 (Bio-rad).	
















PVDF	 (Amersham	 Hybond	 0.45	 µm	 PVDF;	 GE	 Healthcare)	 was	 cut	 to	 size	 and	
activated	 in	methanol	 for	60	seconds	before	rinsing	 in	 transfer	buffer	and	placing	
on	the	gel	blot	paper	on	the	white	(+ve)	side	of	the	cassette.	The	cassette	was	folded	
together	and	compressed	to	expel	air	bubbles	that	may	have	been	trapped	between	
the	 layers.	 The	 cassette	 was	 sealed	 and	 placed	 into	 the	 transfer	 cell	 in	 the	 tank,	
which	 was	 filled	 with	 transfer	 buffer.	 The	 whole	 unit	 was	 placed	 at	 4°C	 and	 the	
transfer	 proceeds	 at	 100v	 for	 1	 hour,	 or	 30v	 overnight	 followed	 by	 60v	 for	 30	
minutes.	
2.7.5 PVDF	membrane	blocking	and	antibody	probing	
The	 membrane	 containing	 the	 transferred	 proteins	 was	 blocked	 at	 room	
temperature	 in	 3%(w/v)	 Marvel	 milk	 or	 5%(w/v)	 BSA	 in	 Tris	 buffered	 Saline-
Tween	 (TBS-T)	 (10mM	Tris,	 pH	 7.6,	 150mM	NaCl	 and	 0.1	%	 (v/v)	 TweenTM-20),	
depending	on	the	incubation	requirements	of	the	desired	antibody.	The	membrane	
was	 blocked	 for	 at	 least	 1	 hour.	 The	 primary	 antibody	 was	 incubated	 with	 the	
membrane	overnight	 in	 the	 relevant	blocking	agent	at	4°C	on	a	 shaker.	Following	
incubation	 the	membrane	 is	washed	 in	TBS-T	5	 times	 for	 at	 least	 3	minutes.	 The	
secondary	 antibody,	 HRP-conjugated	 and	 appropriate	 species,	 was	 added	 to	 the	
relevant	blocking	agent	and	the	membrane	is	incubated	with	this	for	1	hour	at	room	
temperature	 with	 shaking	 before	 5	 washes	 for	 at	 least	 3	 minutes	 in	 TBS-T.	 The	
membrane	 was	 incubated	 in	 enhanced	 chemiluminescence	 (ECL)	 reagent	 (GE	
Healthcare)	for	1	minute	and	the	excess	was	blotted	off	using	Whatman®	gel	blot	
paper.	 The	 membrane	 was	 visualised	 by	 placing	 chemiluminescence	 film	
(Amersham	Hyperfilm™	ECL;	GE	Healthcare)	on	top	for	varying	times	depending	on	
the	 level	 of	 light	 emitted.	The	 film	was	 then	developed	 for	1	minute	 in	developer	
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(Carestream®	 autoradiography	 GBX	 Developer;	 Sigma)	 before	 rinsing	 for	 30	





Antibody	 Stage	 Species	 Source	 Dilution	 Comments	
Anti-Fos88	 Primary	 Rabbit	 Sweeney	Lab	 1:10000	 Polyclonal	
serum	







































































resulting	 in	 a	 continuous	 or	 sustained	 over-activation	 of	 JNK	 signalling.	 This	 has	
been	shown	to	cause	synaptic	overgrowth	 in	 the	Drosophila	 larval	neuromuscular	
junction	 (NMJ)	 as	 a	 result	 of	 increased	 activation	 of	 AP-1,	 a	 transcription	 factor	
consisting	 of	 leucine	 zipper	 proteins	 Fos	 and	 Jun,	 the	 transcriptional	 effectors	 of	
JNK	signalling	(Milton	et	al.,	2011).	Depending	on	the	source	of	oxidative	stress,	 it	
has	 been	 suggested	 that	 AP-1	 will	 form	 differentially	 composed	 dimers.	 During	





oxidative	 stress	 response	 is	 clearly	 incomplete,	 particularly	 in	 neurons.	 This	
differential	role	for	Fos	and	Jun	could	be	critical	to	the	understanding	of	age-related	
neurodegenerative	diseases	where	oxidative	stress	has	been	implicated.	The	aim	of	
this	 chapter	 is	 to	 define	 the	 role	 of	 Fos	 and	 Jun	 in	 motor	 neurons	 during	
mitochondrial	 oxidative	 stress,	 where	 we	 will	 utilise	 Drosophila	 and	 establish	 a	
model	of	oxidative	stress	where	we	can	study	this	question.		
The	 compound	 diethyl	 maleate,	 (DEM)	 is	 used	 here	 to	 generate	 mitochondrial	
oxidative	stress.	When	oxidative	stress	occurs,	reduced	glutathione	is	preferentially	
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oxidised	 to	 protect	 the	 macromolecules	 of	 the	 cell	 from	 redox	 damage.	 DEM	
alkylates	 the	 sulfhydryl	 group	 of	 reduced	 glutathione	 and	 blocks	 its	 defensive	
mechanism	 via	 conjugation.	 This	 induces	 oxidative	 stress	 in	 the	 cell	 as	 ROS	
generated	from	mitochondria	accumulate	and	can	attack	the	macromolecules	of	the	
cell	 with	 increased	 frequency	 (Hidaka	 et	 al.,	 1990).	 The	 effects	 of	 DEM	 upon	
Drosophila	 larvae	 are	 to	 be	 characterised	 and	 the	 role	 of	 Fos	 and	 Jun	 in	 this	
response	will	be	identified.		
3.2 Results	
3.2.1 Diethyl	 maleate	 causes	 synaptic	 overgrowth	 in	 Drosophila	
larvae	
Oxidative	 stress	 in	Drosophila	 causes	 the	 larval	 NMJ	 to	 become	 overgrown	when	
compared	to	larvae	under	non-stressed	conditions	(Milton	et	al.,	2011).	The	growth	
of	the	NMJ	is	primarily	measured	by	quantifying	the	synaptic	boutons,	in	relation	to	
muscle	size,	but	 it	can	also	be	measured	 in	 terms	of	number	of	synaptic	branches	
and	 the	 cumulative	 overall	 length	 of	 the	 synapse	 and	 branches	 (Schuster	 et	 al.,	
1996).	Treating	Drosophila	larvae	with	DEM	can	generate	oxidative	stress,	through	
a	depletion	of	 reduced	 glutathione,	 the	 primary	defence	 to	 redox	damage.	A	dose	
response	of	DEM	was	performed	to	determine	the	concentration	required	to	cause	
significant	 growth	 of	 the	 NMJ	 at	muscle	 6/7,	 hemisegment	 A3.	 Dehydrated	 yeast	
paste	was	rehydrated	with	solutions	of	1mM,	3mM,	10mM	or	30mM	DEM	(see	Table	
2.4	 and	 section	 2.1.2)	 that	were	made	 up	 in	 10%	 ethanol	 and	 this	was	 added	 to	
hydrated	 instant	 food	 in	 vials.	 Canton-S	 (CS)	 virgin	 females	 and	w1118	 males	 are	
crossed	to	generate	wild-type	(WT)	progeny	that	were	raised	in	each	experimental	
DEM	condition.	This	cross	was	 the	standard	wild-type	used	 throughout	 this	study	
and	herein	will	be	referred	to	as	WT.	Furthermore,	unless	stated	otherwise;	flies	are	
outcrossed	 to	CS	 to	 generate	heterozygotes.	These	were	 compared	 to	a	 control	of	
instant	food	and	a	10%	ethanol	yeast	paste.	Third	instar	larvae	from	each	condition	
were	 dissected,	 stained	 with	 antibodies	 and	 the	 NMJ	 analysed	 (see	 section	 2.2).	
Quantification	of	the	mean	synaptic	bouton	number	per	NMJ	normalised	to	muscle	
size	 revealed	 that	 10mM	 and	 30mM	 DEM	 are	 both	 significantly	 overgrown	
compared	 to	 1mM	DEM	 and	 3mM	DEM	 as	well	 as	 the	 10%	 ethanol	 only	 control	
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(Figure	 3.1A;	 p<0.001,	 ANOVA).	 Normalisation	 of	 synaptic	 bouton	 number	 to	
muscle	size	is	required	as	synaptic	growth	and	bouton	number	are	proportional	to	





to	 controls	 (Figure	 3.1C;	 p>0.05,	 ANOVA).	 However,	 treatment	 with	 3mM	 DEM	
caused	 a	 significant,	 albeit	modest,	 increase	 in	MSA	 compared	 to	 treatment	with	
10mM	DEM	(p<0.05;	ANOVA).	The	reason	for	this	is	unclear.	
Mean	 normalised	 branch	 number	 and	 NMJ	 length	 were	 also	 plotted	 against	 the	
concentration	 of	 DEM.	 Mean	 normalised	 branch	 number	 per	 NMJ	 is	 significantly	
increased	upon	 treatment	with	10mM	and	30mM	DEM	compared	 to	10%	ethanol	






increases	 of	 each	 the	mean	 normalised	 bouton	 number,	 branch	 number	 and	 size	
under	 each	 treatment	 was	 also	 calculated.	 The	 dose	 at	 which	 significant	 NMJ	
overgrowth	occurs	is	10mM	DEM;	causing	bouton	number,	branch	number	and	NMJ	
length	 to	 increase	 by	 58.1%,	 85.2%	 and	 33%	 respectively	 (Figure	 3.2C).	 Both	
percentage	 change	 in	 bouton	 and	 branch	 number	 significantly	 increase	 at	 10mM	
and	30mM	DEM	compared	to	0mM	DEM	(Figure	3.2C;	p<0.001,	ANOVA).	NMJ	length	
at	 10mM	and	30mM	DEM	does	 not	 show	any	 significant	 difference	 in	 percentage	
change	 compared	 to	 0mM	 DEM,	 suggesting	 overall	 length	 is	 less	 amenable	 to	
change	 due	 to	 oxidative	 stress	 than	 bouton	 and	 branch	 number	 (Figure	 3.2C;	
p>0.05,	ANOVA).	
Treatment	with	10mM	DEM	does	not	 alter	muscle	 size	but	 significantly	 increases	
synapse	growth	in	terms	of	bouton	and	branch	number,	and	to	a	lesser	extent	NMJ	
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length.	 10mM	 DEM	 is	 used	 to	 model	 oxidative	 stress	 and	 induce	 synaptic	
overgrowth	in	all	subsequent	experiments.	
3.2.2 DEM	 causes	 synaptic	 overgrowth	 that	 can	 be	 rescued	 by	
treating	with	Trolox	
In	 order	 to	 confirm	 treatment	 with	 DEM	 causes	 increased	 ROS	 levels,	 we	
determined	whether	the	effects	of	DEM	could	be	rescued	by	also	feeding	flies	with	
an	 antioxidant.	 We	 use	 the	 vitamin	 E	 analogue,	 Trolox,	 which	 acts	 to	 non-
enzymatically	scavenge	ROS	and	has	previously	been	shown	to	alleviate	the	effects	
of	DEM	via	a	reduction	in	hydrogen	peroxide	(Hamad	et	al.,	2010,	Vergauwen	et	al.,	
2015).	We	 found	 that	 Trolox-treatment	 of	WT	 larvae	 did	 not	 significantly	 change	
bouton	 number	 compared	 to	WT	 controls	 (Figure	 3.3;	 p>0.05,	 ANOVA).	 Treating	
WT	larvae	with	both	10mM	DEM	and	Trolox	resulted	in	a	bouton	count	significantly	
lower	 than	 WT	 treated	 with	 DEM	 alone	 (p<0.001,	 ANOVA).	 Larvae	 treated	 with	
DEM	 and	 Trolox	 also	 show	 no	 significant	 difference	 to	 WT	 controls	 (NS	 p>0.05,	
ANOVA).	Branch	number	and	 length	(µm)	are	also	significantly	 increased	 in	DEM-
treated	WT	 compared	 to	WT	 controls	 (Figure	 3.4;	 p<0.05,	 ANOVA).	 Both	 branch	
number	 and	 length	 are	 significantly	 reduced	 in	 WT	 treated	 with	 both	 DEM	 and	








containing	 10mM	 and	 30mM	 DEM	 during	 development	 show	 significantly	 increased	 mean	
normalised	synaptic	bouton	numbers	(124±6.9,	n=18	and	123±7.6,	n=16	respectively)	compared	to	
controls	 (78±2.8,	 n=18)	 (WT	 +	 10%	 ethanol	 in	 yeast	 paste)	 (***p<0.001;	 ANOVA	 with	 post	 hoc	
Bonferroni	correction).	Treatments	of	1mM	(79±4.8,	n=16)	and	3mM	DEM	(80±2.6,	n=15)	show	no	
significant	 difference	 compared	 to	 controls	 (NS	 p>0.05;	 ANOVA	 with	 post	 hoc	 Bonferroni	
correction).	Error	bars	display	±SEM.	B:	Representative	image	of	the	NMJ	at	muscle	6/7	segment	A3	
imaged	 from	 each	 dose	 of	 DEM;	 increased	 numbers	 of	 boutons	 (green)	 and	 branching	 of	 the	
synapse	 (magenta)	 are	 observed	when	 treating	with	 10mM	 and	 30mM	DEM.	 Scale	 bar	 30µm.	C:	
Analysis	of	larval	muscle	surface	area	(MSA)	of	muscle	6/7	segment	A3	across	each	dose	reveals	no	
significant	 difference	 between	 controls	 (74892±1956.42µm2,	 n=18)	 and	 DEM	 treatments,	 1mM	
(81307±3085.42,	 n=16),	 3mM	 (84376±3014.2,	 n=15),	 10mM	 (70958±2744.5,	 n=18)	 and	 30mM	






Figure	 3.2	 DEM	 increases	 NMJ	 branch	 number	 and	 length,	 causing	 synaptic	
overgrowth	
A:	Analysis	of	 the	NMJ	at	muscle	6/7	segment	A3	of	3rd	 instar	WT	 larvae	 treated	with	a	yeast	
paste	 containing	 10mM	 and	 30mM	 DEM	 show	 significantly	 increased	 mean	 normalised	 NMJ	
branch	number	(17.1±1.3,	n=10	and	16.9±1.4,	n=10	respectively)	compared	to	controls	(9.3±1.1,	
n=8)	 (WT	 +	 10%	 ethanol	 in	 yeast	 paste)	 (***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	
correction).	 Treatments	 of	 1mM	 (11±0.78,	 n=9)	 and	 3mM	 DEM	 (11.4±1.1,	 n=10)	 do	 not	
significantly	 increase	 branch	number	 compared	 to	 controls	 (NS	 p>0.05;	ANOVA	with	 post	 hoc	
Bonferroni	 correction).	 Error	 bars	 display	 ±SEM.	 B:	 Treatments	 of	 10mM	 and	 30mM	 DEM	
display	 significantly	 increased	 mean	 normalised	 NMJ	 length	 (µm)	 (496µm±33µm,	 n=10	 and	
511µm±26µm,	 n=10	 respectively)	 compared	 to	 controls	 (373µm±38µm,	 n=8)	 (WT	 +	 10%	
ethanol	 in	 yeast	 paste)	 (*p<0.05;	 ANOVA	with	 post	 hoc	 Bonferroni	 correction).	 Treatments	 of	
1mM	(403µm±21.2µm,	n=9)	and	3mM	DEM	(403µm±21.5µm,	n=10)	do	not	significantly	increase	
NMJ	length	compared	to	controls	(NS	p>0.05;	ANOVA	with	post	hoc	Bonferroni	correction).	Error	
bars	 display	 ±SEM.	C:	Dose	 response	 data	 converted	 to	 a	 percentage	 change	 from	0mM	DEM.	
Bouton	 and	 branch	 number	 both	 significantly	 increase	 at	 10mM	 and	 30mM	 DEM	 treatment	
(***p<0.001;	ANOVA	with	post	hoc	Bonferroni	correction).	However,	NMJ	length	(µm)	at	10mM	







containing	 10mM	 DEM	 during	 development	 show	 significantly	 increased	 mean	 normalised	
synaptic	 bouton	 numbers	 (126±9.5,	 n=16)	 compared	 to	 controls	 (80±2.4,	 n=16)	 (WT	 +	 10%	
ethanol	 in	yeast	paste)	 (***p<0.001;	ANOVA	with	post	hoc	Bonferroni	 correction).	Treating	with	
10mM	 Trolox	 shows	 no	 significant	 differences	 in	 mean	 normalised	 synaptic	 bouton	 numbers	
(74±3.6,	 n=16)	 compared	 to	 controls	 (NS	 p>0.05;	 ANOVA	with	 post	 hoc	 Bonferroni	 correction).	
Treating	 with	 10mM	 DEM	 and	 10mM	 Trolox	 significantly	 reduced	 mean	 normalised	 synaptic	
bouton	 number	 (89±5,	 n=16)	 compared	 to	 larvae	 treated	 with	 10mM	 DEM	 alone.	 (***p<0.001;	
ANOVA	with	post	hoc	Bonferroni	correction).	Error	bars	display	±SEM.	B:	Representative	image	of	





































































































































































































































































































































































































































































































































































































































































































































3.2.3 Mutations	 in	SOD1	 cause	 synaptic	overgrowth	 in	Drosophila	
larvae	
Synaptic	 overgrowth	 can	 also	 be	modelled	 by	 removing	 both	 copies	 of	 the	 SOD1	
gene.	SOD1	encodes	the	enzyme	Superoxide	Dismutase	1,	which	acts	to	metabolise	
superoxide	 free	 radicals	within	 the	 cytosol	 and	 the	mitochondrial	 intermembrane	
space,	 acting	 as	 a	 primary	 defence	 against	 ROS	 generated	 by	 the	 mitochondria	
(Field	 et	 al.,	 2003,	 Bernard	 et	 al.,	 2011).	 Hypomorphic	 SOD1	 mutants	 were	
generated	 by	 crossing	 SOD1n1	 and	 SOD1n64	 flies	 together.	 Quantification	 revealed	
significantly	 increased	 mean	 normalised	 bouton	 number	 per	 NMJ	 in	
SOD1n1/SOD1n64	larvae	compared	to	WT	controls	(Figure	3.5;	p<0.001,ANOVA).	The	
overgrowth	 observed	was	 not	 significantly	 different	 to	 that	 achieved	 via	 a	 10mM	
DEM	 treatment	 (p>0.05,	 ANOVA),	 which	 showed	 significant	 synaptic	 overgrowth	
compared	 to	WT	 controls	 (p<0.001,	 ANOVA).	 Treating	SOD1	mutants	with	 10mM	
DEM	 did	 not	 increase	 the	 synaptic	 overgrowth	 (p>0.05,	 ANOVA),	 suggesting	
manipulation	of	 the	cellular	antioxidant	capacity	alone	has	a	 finite	ability	 to	affect	
the	 synaptic	 growth	 response	 within	 the	 NMJ.	 We	 showed	 that	 SOD1	 mutant	
synaptic	overgrowth	was	significantly	reduced	when	treating	with	Trolox	compared	
to	SOD1	mutant	controls	(Figure	3.8;	p<0.01,	ANOVA).	No	significant	difference	was	
found	 between	 WT	 controls	 and	 SOD1	 mutants	 treated	 with	 Trolox	 (p>0.05,	











yeast	 paste)	 (***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 Hypomorphic	 SOD1	
mutants	 show	 significant	 increases	 in	 mean	 normalised	 synaptic	 bouton	 numbers	 per	 NMJ	
(120±7.2,	n=16)	(SOD1n1/SOD1n64	+	10%	ethanol	in	yeast	paste)	compared	to	controls	(***p<0.001;	
ANOVA	with	 post	 hoc	Bonferroni	 correction).	 Treating	SOD1	mutants	with	 10mM	DEM	does	 not	
significantly	 increase	mean	normalised	synaptic	bouton	number	further	(125±6,	n=16)	compared	








Two	major	 pathways	 that	 regulate	 synaptic	 plasticity	 in	Drosophila	 are	 JNK/AP-1	
and	TGF-β	signalling.	Activation	of	these	pathways	leads	to	synaptic	growth,	which	
can	 be	manipulated	 by	 removing	 one	 copy	 of	 their	 feedback	 inhibitors,	 puckered	
(puc),	a	JNK-phosphatase	and	daughters	against	Dpp	(Dad),	a	non-phosphorylatable	
MAD-like	 protein,	 respectively	 (Martín-Blanco	 et	 al.,	 1998,	 Aberle	 et	 al.,	 2002,	
Marques	et	al.,	2002,	Sanyal	et	al.,	2002,	Sweeney	and	Davis,	2002).	
Using	 heterozygous	 pucE69	 flies,	 a	 single	 copy	 of	 the	 puckered	 gene	 is	 removed,	
reducing	puc	 levels	 and	 relieving	 the	negative	 feedback	 inhibition	 that	puc	exerts	
upon	JNK	signalling.	We	showed	that	puc	mutants	displayed	significantly	increased	
mean	 normalised	 bouton	 number	 per	NMJ	 compared	 to	WT	 controls	 (Figure	 3.6;	
p<0.001,	ANOVA).	No	significant	difference	was	observed	between	WT	treated	with	
10mM	DEM,	heterozygous	pucE69	mutants,	and	heterozygous	pucE69	mutants	treated	
with	 10mM	 DEM	 (p>0.05,	 ANOVA).	 This	 suggests	 that	 JNK/AP-1	 signalling	
facilitates	the	oxidative	stress-induced	synaptic	overgrowth;	no	further	overgrowth	
occurs	when	larvae	exhibiting	reduced	JNK	inhibition	are	subject	to	DEM	treatment.	
It	 is	 postulated	 that	 DEM-induced	 oxidative	 stress	 activates	 JNK	 signalling,	
increasing	 its	 activity	 causing	 synaptic	 overgrowth.	We	 confirmed	 that	 increased	
JNK	 signalling	 causes	 overgrowth	 and	 not	 oxidative	 stress	 in	 the	 heterozygous	
pucE69	mutants	by	treating	them	with	10mM	Trolox	that	did	not	significantly	reduce	
the	 bouton	 number	 when	 compared	 to	 pucE69/+	 controls	 (Figure	 3.8;	 p>0.05,	
ANOVA).		
The	 puc	 equivalent	 within	 TGF-β	 signalling	 is	 Dad,	 an	 inhibitory	 Smad	 that	 is	
induced	 by	 activation	 of	 the	 pathway	 and	 acts	 as	 a	 negative	 feedback	 regulator.	
Heterozygous	 Dadlacz	 larvae	 showed	 significantly	 increased	 mean	 normalised	
bouton	number	per	NMJ	 compared	 to	WT	controls	 (Figure	3.7;	p<0.001,	ANOVA).	
Both	Dadlacz	control	and	DEM	treated	show	significantly	increased	mean	normalised	
bouton	number	per	NMJ	compared	to	WT	treated	with	DEM	(p<0.001	and	p<0.05	
respectively,	 ANOVA).	 No	 significant	 differences	 in	 synaptic	 bouton	 number	 are	
found	between	Dadlacz	control	and	DEM	treated	(p>0.05,	ANOVA).	These	data	show	
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similar	 results	 to	 a	 previous	 publication,	 which	 shows	 that	 TGF-β	 signalling	 can	
mediate	 synaptic	 growth	 and	 mutations	 in	 Dad	 cause	 synaptic	 overgrowth	
(Sweeney	 and	 Davis,	 2002).	 It	 has	 also	 been	 shown	 that	 TGF-β	 promotes	 the	
development	and	maintenance	of	the	nervous	system,	offering	neuroprotection	and	
deficiencies	 in	 TGF-β	 cause	 neurodegeneration,	 implying	 that	 this	 signalling	
pathway	has	an	extremely	important	role	in	the	neuron	(König	et	al.,	2005,	Tesseur	












mean	 normalised	 synaptic	 bouton	 number	 further	 (134±7.3,	 n=16)	 compared	 to	 puc	 mutant	
controls	 and	 wild-types	 treated	 with	 10mM	 DEM	 (NS	 p>0.05;	 ANOVA	 with	 post	 hoc	 Bonferroni	
correction).	Error	bars	display	±SEM.	B:	Representative	image	of	the	NMJ	at	muscle	6/7	segment	A3	







with	 a	 yeast	paste	 containing	10mM	DEM	during	development	 show	significantly	 increased	mean	
normalised	 synaptic	 bouton	 numbers	 (121±6.8,	 n=15)	 compared	 to	 WT	 controls	 (77±2.5,	 n=16)	
(WT,	 10%	 ethanol	 in	 yeast	 paste)	 (***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	
Heterozygous	Dad	mutants	show	significant	increases	in	mean	normalised	synaptic	bouton	numbers	




controls	 and	DEM	 treated	 show	significantly	 increased	mean	normalised	bouton	number	per	NMJ	
compared	 to	WT	 treated	with	 DEM	 (***p<0.001	 and	 *p<0.05	 respectively;	 ANOVA	with	 post	 hoc	
Bonferroni	correction).	Error	bars	display	±SEM.	B:	Representative	image	of	the	NMJ	at	muscle	6/7	
segment	A3	imaged	from	each	condition	of	the	experiment;	 increased	numbers	of	boutons	(green)	




































































































































































































































































































































































































































































































































































































































From	 my	 analysis,	 increased	 activation	 of	 JNK/AP-1	 signalling	 contributes	 to	
synaptic	overgrowth	(Figure	3.6).	Given	the	known	prominent	role	for	the	JNK/AP-
1	 signalling	 pathway	 in	 oxidative	 stress	 defence	 in	 other	 tissues,	 mechanism	
becomes	the	main	focus	of	our	investigation	and	we	aim	to	elucidate	this	pathway	
further	by	examining	 the	 role	of	Fos	and	 Jun	 in	 the	DEM-induced	oxidative	 stress	
response	 in	 neurons.	 The	 JNK-kinase	 kinase	 (JNKKK),	 ASK1,	 or	 apoptosis	 signal-
regulating	 kinase	 1,	 is	 activated	 by	 oxidative	 stress,	 and	 initiates	 the	
phosphorylation	 cascade	 that	 initiates	 JNK	 signalling.	 To	 investigate	 their	 role	 in	
synaptic	 overgrowth	 we	 expressed	 dominant	 negative	 (DN)	 versions	 of	 ask1,	 fos	
and	 jun	 in	 a	pre-	 and	post-synaptic	manner	via	SpinGAL4	and	analysed	 the	 larval	
NMJ.	 Expressing	 UAS-ask1DN,	 fosDN	 and	 junDN	 via	 SpinGAL4	 in	 control	 conditions	
showed	 no	 significant	 differences	 in	 mean	 normalised	 bouton	 number	 per	 NMJ	
compared	 to	 WT	 controls	 (Figure	 3.9;	 p>0.05,	 ANOVA).	 Treating	 WT	 with	 DEM	
showed	 significantly	 increased	 mean	 normalised	 bouton	 number	 per	 NMJ	
compared	 to	 WT	 controls	 (p<0.001,	 ANOVA).	 However,	 treating	 the	 animals	
expressing	 dominant	 negative	 transgenes	 with	 DEM	 showed	 no	 significant	
increases	 compared	 to	 WT,	 or	 their	 respective	 non-treated	 controls	 (p>0.05,	
ANOVA).	Significant	reductions	in	mean	normalised	bouton	number	per	NMJ	were	
found	 in	 fosDN	 larvae	 compared	 to	 junDN	 and	 ask1DN	 when	 treated	 with	 DEM	
(p<0.001	 and	 p<0.05	 respectively,	 ANOVA).	 This	may	 indicate	 a	more	 prominent	
role	 for	 Fos	 in	 the	 synaptic	 growth	 response	 than	 ASK1	 and	 Jun,	 though	 it	 is	
possible	 that	due	 to	 the	potential	 for	Fos	 to	 form	a	homodimer	during	activation,	
expressing	fosDN	may	affect	both	Fos:Fos	homodimer	and	Fos:Jun	heterodimer,	thus	


























































































































































































































































































































































































































































































































































































































































































































































A	 powerful	 tool	 in	 our	 investigation	 into	 the	 role	 of	 Fos	 and	 Jun	 in	 the	 oxidative	
stress	 response	 is	 the	 generation	 of	 antibodies	 to	 detect	 them.	 The	 Sweeney	 lab	
previously	 raised	 an	 antibody	 in	 rabbits	 to	 detect	 Fos	 (Rabbit	 anti-Fos88	 and	
Fos89).	To	coincide	with	our	investigation	we	raised	an	antibody	in	guinea	pigs	to	
detect	Jun	(Guinea	pig	anti-Jun59	and	Jun60).	
3.2.6.1 	Investigating	 the	 working	 concentration	 of	 Fos	 and	 Jun	
antibodies		
Initially,	the	working	concentration	for	each	antiserum	was	investigated	by	staining	
larvae	with	varying	 concentrations.	We	used	1:500	 (data	not	 shown),	1:1000	and	
1:5000	(data	not	shown)	and	both	antisera	against	Fos	and	Jun	were	determined	to	






The	 specificity	 of	 each	 antibody	 was	 determined	 initially	 by	 using	 them	 to	 stain	




so	 Jra	 protein	 isoforms	 A,	 B	 and	 C	 were	 tagged	 with	 GFP	 and	 expressed	 in	 flies	
under	 near-normal	 endogenous	promoter	 conditions	whilst	 co-staining	with	 anti-
Jun59	 and	 Jun60.	 This	 allowed	us	 to	 determine	 how	 specific	 our	 antibodies	were	
based	 on	 expression	 patterns.	 We	 observed	 colocalisation	 of	 both	 anti-Jun59	
(Figure	 3.12A(IV))	 and	 Jun60	 (Figure	 3.12B(IV))	 with	 Jra-GFP.FLAG,	 which	 was	
identified	by	 the	presence	of	white	 labelled	nuclei,	 resulting	 from	colocalised	GFP	
expression	 with	 Cy3	 (magenta)	 fluorescence.	 Fos	 and	 Jun	 are	 known	 to	 form	
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heterodimers,	which	 should	be	detectable	as	 colocalisation	when	co-staining	with	
both	 anti-Jun59/Jun60	 and	 anti-Fos88/Fos89.	 Colocalisation	 was	 found,	
determined	by	the	presence	of	white-labelled	nuclei,	when	staining	with	anti-Jun59-




(Spokony	 and	 White,	 2013).	 Staining	 larvae	 expressing	 kay-GFP.FLAG	 with	 both	
anti-Fos88	 (Figure	 3.12C(III))	 and	 anti-Fos89	 (Figure	 3.12D(III))	 showed	
colocalisation	of	our	antibodies	to	GFP	tagged	Fos.	
This	 data	 suggests	 that	 our	 antibodies	 show	 some	 specificity	 to	 their	 target	
proteins,	 as	 they	are	 likely	 to	be	 staining	either	 the	endogenous	Fos	or	 Jun	 in	 the	
same	 nuclei	 or	 the	 tagged	 versions	 of	 Fos	 and	 Jun	 themselves.	 We	 have	 not,	
however,	 fully	 characterised	 these	 antibodies,	 therefore	 caution	 is	 advised	 when	










Figure	 3.11	 Guinea	 pig	 anti-Jun59	 and	 Jun60	 stain	 in	 the	 ventral	 nerve	 cord	 and	
muscle	





































































































































































































































































































































































































To	 determine	 the	 role	 of	 Fos	 and	 Jun	 in	 the	 oxidative	 stress	 response	within	 the	
motor	 neuron,	 we	 confirmed	 their	 expression	 there.	 The	 OK6-GFP	 reporter	











Larvae	 expressing	 the	motor	neuron	denoting	OK6-GFP	 reporter	 construct	which	highlights	 the	
cell	 membrane	 of	 the	 motor	 neuron	 (A)	 were	 co-stained	 with	 anti-Fos88	 (Alexa-Fluor®	 405	






Cellular	 ageing	 is	 characterised	 by	 an	 increase	 in	 ROS	 and	 the	 onset	 of	 oxidative	
stress.	The	high	metabolic	demand	of	neurons,	their	aversion	to	undergo	apoptosis	
and	 the	 inability	 to	 replace	 these	 post-mitotic	 cells	 means	 these	 cells	 are	 longer	
lived	 and	 particularly	 susceptible	 to	 oxidative	 stress	 (Benn	 and	 Woolf,	 2004).	 A	
number	 of	 neurodegenerative	 diseases	 implicate	 oxidative	 stress	 and	 damage	 to	
their	 onset	 and	 progression.	 In	 our	Drosophila	 model	 of	 mitochondrial	 oxidative	
stress	 we	 find	 that	 above	 a	 certain	 threshold,	 oxidative	 stress	 leads	 to	 synaptic	
overgrowth,	 which	 is	mediated	 by	members	 of	 the	 JNK/AP-1	 signalling	 pathway.	
Synaptic	 overgrowth	 can	 occur	 regardless	 of	 redox	 status	 due	 to	 over-
activation/decreased	 inhibition	 of	 JNK	 signalling,	 as	 long	 as	 Fos	 and	 Jun	 are	 still	
functionally	 active.	 Fos	 and	 Jun	 dimerise	 forming	 AP-1,	 and	 are	 enriched	 in	 the	
motor	neuron	nuclei	of	Drosophila	larval	brains.		
3.3.1 Oxidative	stress	causes	synaptic	overgrowth	
In	 this	 investigation,	 we	 devised	 a	 model	 for	 mitochondrial	 oxidative	 stress	 in	
Drosophila.	Feeding	 larvae	DEM,	we	were	 able	 to	 cause	 significant	 overgrowth	 of	
the	 NMJ,	 which	 we	 know	 is	 caused	 by	 increases	 in	 ROS.	 In	 the	 mitochondria,	
glutathione	 is	 the	main	 line	 of	 defence	 against	 ROS,	 maintaining	 the	 appropriate	
redox	 environment	 and	 preventing	 oxidative	 damage	 and	 mitochondrial	
dysfunction.	Glutathione	mainly	acts	to	efficiently	remove	hydrogen	peroxide	from	
the	mitochondria,	 before	 it	 reacts	with	 lipid	membranes	 and	 generates	 the	more	





DEM	 caused	 significant	 synaptic	 overgrowth,	 which	 cannot	 be	 exacerbated	 by	
increasing	 the	 concentration	 of	 DEM.	 This	 suggests	 that	 10mM	DEM	 is	 depleting	
enough	glutathione	within	the	mitochondria	so	that	standing	defences	are	no	longer	
adequate.	Increasing	the	concentration	of	DEM	has	no	further	effect,	as	presumably	
the	majority	 of	 glutathione	 is	 conjugated	 to	 DEM.	 Treating	 larvae	with	 1mM	 and	
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3mM	DEM	did	 not	 cause	 significant	 overgrowth;	 the	 abundance	 of	 glutathione	 in	
these	larvae	must	be	high	enough	to	combat	the	ROS	produced	by	the	mitochondria.	





levels	 of	 superoxide	 anions	 generating	 oxidative	 stress.	 Normally,	 SOD1	 converts	
superoxide	 anions	 into	 hydrogen	 peroxide,	 which	 is	 then	 neutralised	 by	 several	





further	 effect	 when	 hydrogen	 peroxide	 is	 not	 generated	 due	 to	mutations	 in	 the	
SOD1	gene.	




A	 recent	 publication,	 described	 that	 ROS	 are	 major	 regulators	 of	 synaptic	
overgrowth	via	activation	of	 the	 JNK	signalling	pathway	 (Milton	et	 al.,	 2011).	The	
Drosophila	spin	mutants	were	studied	as	a	starting	point.	When	analysed,	 the	spin	
mutants	 displayed	 cytosolic	 oxidative	 stress-induced	 synaptic	 overgrowth.	 This	
study	went	on	 to	demonstrate	 that	 the	activation	of	 JNK	and	Fos	are	 required	 for	
spin	 mutant	 synaptic	 overgrowth,	 but	 not	 Jun	 and	 ASK1,	 suggesting	 a	 context-
dependent	 activation	 of	 Jun	 in	 the	 regulation	 of	 synapse	 growth	 (Milton	 et	 al.,	
2011).	It	is	well	documented	that	Fos	can	homodimerise	during	cytoskeletal	stress,	
and	along	with	the	spin	mutant	data	suggests	that	ASK1	and	Jun	are	not	required	in	
all	 responses	 to	 oxidative	 stress	 (Massaro	 et	 al.,	 2009).	 It	was	 conceived	 that	 Jun	
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and	ASK1	may	only	have	a	role	in	mediating	synaptic	overgrowth	when	the	source	
of	 oxidative	 stress	 is	 the	 mitochondria.	 Using	 our	 model	 we	 showed	 that	
mitochondrial	oxidative	stress-induced	overgrowth	of	the	NMJ	requires	the	activity	





to	 relieve	 the	 problem,	 or	 is	 it	 pathological	 and	 contributing	 to	 the	 problem?”	
Currently	 the	 answer	 remains	 unclear.	 It	 is	 thought	 that	 JNK	 signalling	 acts	 to	
protect	 against	 oxidative	 stress	 through	 autophagy	 activation.	 Several	 autophagy	
(ATG)	genes	are	transcriptionally	activated	upon	JNK	activation	and	the	protective	
effects	 of	 JNK	 signalling	 are	 reduced	 upon	 a	 loss	 of	 these	 ATG	 genes	 (Wu	 et	 al.,	
2009).	Suppression	of	neuronal	autophagy	in	mice	causes	protein	aggregation	and	
neurodegeneration,	 and	with	age,	 the	 levels	of	ATG	 gene	expression	 in	Drosophila	
neural	 tissues	 are	 reduced.	 It	 has	 been	 shown	 that	 atg8a	 mutations	 lead	 to	
increased	 sensitivity	 to	 oxidative	 stress,	 and	 that	 overexpression	 of	 the	 same	
protein,	presumably	increasing	autophagy,	leads	to	increased	resistance	(Simonsen	
et	 al.,	 2008).	 Autophagy,	 which	 is	 important	 for	 synaptic	 development	 has	 been	
shown	 to	 positively	 regulate	 the	 Drosophila	 NMJ;	 promoting	 NMJ	 growth	 by	
reducing	Highwire	(Hiw)	levels	(Shen	and	Ganetzky,	2009).	Hiw	is	an	E3	ubiquitin	
ligase	 that	 normally	 acts	 to	 restrain	 growth	 of	 the	 synapse	 by	 down-regulating	
Wallenda	(Wnd),	a	mitogen	activated	protein	kinase	kinase	kinase	(MAPKKK).	Wnd	
also	 triggers	 JNK	 activation	 (Ma	 et	 al.,	 2015).	 Hiw	 also	 negatively	 regulates	 TGF-
β/BMP	signalling,	which	is	proposed	to	occur	by	targeting	Medea	for	degradation;	
the	 associated	NMJ	 overgrowth	 can	 also	 be	 partially	 rescued	by	 introducing	 BMP	
family	mutations	(McCabe	et	al.,	2004,	Liebl,	2006).	
This	 may	 help	 to	 explain	 why	 we	 observe	 synaptic	 overgrowth.	 DEM-treatment	
continually	activates	 JNK	signalling	causing	an	overexpression	of	autophagy	genes	
and	maintaining	low	levels	of	Hiw.	Unrestrained	Wnd	would	then	increase	synaptic	
growth	 via	 further	 activation	 of	 JNK	 signalling,	 leading	 to	 a	 vicious	 cycle	 of	
sustained	 JNK	 activity.	 We	 have	 shown	 that	 ASK1	 is	 required	 for	 DEM-induced	
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overgrowth;	 therefore	 Wnd	 and	 ASK1	 may	 have	 similar	 functions.	 Synaptic	
overgrowth	 results	 from	dysfunctional	 regulation	of	 the	 JNK/AP-1	pathway	and	a	
failure	 to	 negatively	 regulate	 TGF-β/BMP	 signalling.	 It	 was	 shown	 during	 this	
chapter	that	removing	the	inhibition	on	TGF-β	leads	to	severe	synaptic	overgrowth	
and	 this	 may	 help	 to	 explain	 how	 oxidative	 stress	 is	 also	 causing	 overgrowth.	
Normally,	 a	 cell	 exhibiting	 high	 levels	 of	 oxidative	 stress	 and	 dysfunctional	




mediated	 JNK-dependent	 cell	 death	 pathway	 under	 conditions	 of	 high	 oxidative	
stress	 (Guadagno	 et	 al.,	 2013).	 HSP70	 and	HSP72	 however,	 exist	 to	 supress	 JNK-
mediated	 apoptosis,	 preserving	 critical	 neurons	 (Gabai	 et	 al.,	 1997,	 Gabai	 et	 al.,	
1998).	Neurons	also	require	low	levels	of	ROS	for	proper	development;	a	necessary	
process	aided	by	the	fact	that	Nrf2	signalling,	the	other	major	antioxidant	pathway,	
is	 repressed	 in	 young	 neurons	 to	 maintain	 ROS	 at	 a	 level	 adequate	 to	 induce	
JNK/AP-1	signalling	(Bell	et	al.,	2015).	In	mature	neurons,	short	bursts	of	increased	
ROS	 following	elevated	neuronal	activity	activates	 JNK	signalling,	which	 is	 rapidly	
switched	 off	 following	 the	 transcription	 of	 puckered.	 This	 mediates	 synaptic	
plasticity	 and	 increases	 synaptic	 strength	 (Sanyal	 et	 al.,	 2002).	 This	 fundamental	
process	 persists	 during	 ageing	 due	 to	 its	 importance	 for	 cognitive	 function.	
However,	the	accumulation	of	ROS	and	onset	of	oxidative	stress	with	age	may	lead	




which	may	 act	 through	 JNK/AP-1	 signalling,	 a	 pathway	 that	 has	 one	 of	 its	major	
roles,	apoptosis,	repressed	in	order	to	preserve	adult	neurons.	Apoptotic	repression	
means	that	ROS-induced	over	activation	of	JNK/AP-1	signalling	in	neurons	does	not	
result	 in	 cell	 death,	 and	 instead	 it	 leads	 to	 synaptic	 overgrowth,	 possibly	 through	
misregulation	of	TGF-β	signalling.	
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The	 reasons	 behind	 the	 context-dependent	 forms	 of	 AP-1	 are	 still	 unclear.	 We	
would	expect	the	transcriptional	output	from	AP-1	activated	via	mitochondrial	ROS	
to	 be	 different	 than	 cytosolic	 ROS	 in	 order	 for	 the	 pathway	 to	 respond	 to	 the	
contextual	ROS.	The	role	of	both	Fos	and	Jun	in	the	mitochondrial	oxidative	stress	
response	 may	 indicate	 this	 form	 has	 more	 prominent	 roles	 in	 responding	 to	
neuronal	activity	and	metabolism,	when	mediating	synaptic	plasticity.	How	binding	
partners	 of	 Fos	 and	 Jun	 change	when	mitochondrial	 oxidative	 stress	 occurs,	may	
help	us	clarify	the	role	of	AP-1	in	this	context.	
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Jun	 during	 normal	 conditions	 and	 under	 oxidative	 stress.	 To	 achieve	 this,	 N-
terminally	 Tandem	 Affinity	 Purification-tagged	 (NTAP)	 versions	 of	 Fos	 and	 Jun	
were	 created	 and	 expressed	 pan-neuronally	 in	 flies.	 We	 removed	 and	 collected	









Before	 we	 began	 tandem	 affinity	 purification,	 we	 ran	 an	 initial	 western	 blot	 to	
confirm	the	presence	of	the	NTAP-tag	in	our	Fos	and	Jun	constructs	when	expressed	
via	the	UAS-NTAP-Fos	and	UAS-NTAP-Jun	transgenes	respectively.	Each	of	the	TAP-




the	 TAP-tag	 and	 not	 Fos	 or	 Jun.	 The	 TAP-tag	 itself	 appears	 to	 be	 ~27kDa.	 Fos	
isoform	B	cDNA	which	is	~58kDa	was	cloned	into	the	NTAP-vector	(Veraksa	et	al.,	
2005).	With	the	addition	of	the	TAP-tag	we	would	expect	a	band	~85kDa,	which	we	







background.	 Expressing	 tagged-Fos	 in	 a	 null	 background	 (kay1/kay2)	 using	
actinGAL4	rescued	the	otherwise	lethal	null	mutant,	as	we	observed	flies	containing	
both	mutations	 (absence	 of	TM6b	 phenotype)	 surviving	 (see	 Figure	 2.3).	We	 also	
expressed	tagged-Jun	in	the	Jun	null	background	(jraIA109/jra76-19)	via	SpinGAL4	and	
observed	 flies	 carrying	 the	 compound	 heterozygote	 combination	 (absence	 of	CyO	
phenotype),	which	 is	not	observed	 in	 this	normally	 lethal	combination,	due	 to	 the	
expression	 of	 a	 TAP-tagged-Jun	 protein	 (see	 Figure	 2.4).	 Therefore,	 both	 NTAP-
tagged	Fos	and	Jun	retain	their	functionality	whilst	bound	to	a	TAP-tag.	With	this	in	
mind	we	proceeded	to	perform	tandem	affinity	purification	(see	section	2.6.3)	and	






using	 MASCOT	 using	 defined	 search	 parameters	 (see	 section	 2.6.4).	 The	
identifications	 were	 restricted	 to	 Drosophila	 proteins	 in	 the	 UniProt	 database.	
Unfortunately,	we	identified	relatively	few	peptides	(80	unique	across	4	samples);	
this	 was	 largely	 due	 to	 high	 levels	 of	 contamination	 in	 the	 samples.	 As	 a	
consequence,	 the	 number	 of	 peptide	 matches	 per	 protein	 was	 low,	 many	 only	
identified	by	a	single	peptide.	On	this	basis	we	decided	not	to	focus	on	aspects	such	
as	 relative	 abundance	 of	 each	 protein,	 which	 can	 be	 quantified	 using	 the	
exponentially	 modified	 Protein	 Abundance	 Index	 (emPAI)	 score,	 or	 the	 MASCOT	
protein	score	which	is	generated	using	the	number	and	quality	of	peptide	matches.	
Our	table	of	identified	proteins	focuses	purely	on	what	was	present	in	the	sample,	
showing	 only	 the	 number	 of	 significant	 peptide	 sequences	 that	 matched	 the	
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identified	 protein	 (see	 Table	 4.1).	 All	 proteins	 that	 were	 identified	 in	 the	 empty	
vector	 control	 groups	 were	 removed,	 as	 they	 are	 assumed	 to	 be	 binding	 non-
specifically	to	the	tag	rather	than	our	bait	proteins.	
Importantly	and	reassuringly,	we	identify	the	bait	proteins,	Fos	and	Jun	from	each	
condition.	We	 also	 identify	 Jun	 in	 the	NTAP-Fos	 control	 condition,	 and	Fos	 in	 the	
NTAP-Jun	control	and	DEM	treated	condition.	This	adds	confidence	to	our	data	as	
we	pull	down	the	proteins	known	to	dimerise	with	our	bait,	as	well	as	the	bait	itself.	
We	 identified	 80	 unique	 proteins	 across	 the	 4	 different	 tests	 and	 our	main	 focus	
was	to	identify	proteins	bound	to	both	Fos	and	Jun	in	either	control	or	DEM-treated	
































Kayak	 kay	 4	 3	 2	 2	
Jun-related	antigen	 Jra	 2	 0	 3	 5	
GTP	cyclohydrolase	1		 Pu	 2	 0	 2	 0	
Heterogeneous	nuclear	
ribonucleoprotein	at	27C	 Hrb27c	 2	 0	 0	 0	




Pcmt	 1	 1	 1	 0	
Jonah	74E	 Jon74E	 1	 1	 1	 0	
CG5805	 CG5805	 1	 1	 0	 0	
CG14016-PA	 tomb	 1	 1	 0	 0	
CG11876	 CG11876	 1	 0	 1	 1	




gamma	 1	 0	 1	 0	
Short	Spindle	5	 ssp5	 1	 0	 1	 0	
CG15825-PB	 fon	 1	 0	 1	 0	
Trehalose-6-phosphate	
synthase	1	 Tps1	 1	 0	 1	 0	
14-3-3zeta	 14-3-3zeta	 1	 0	 0	 0	
CG11180	 CG11180	 1	 0	 0	 0	
Ribosomal	protein	S15	 RpS15	 1	 0	 0	 0	
CG42619	 PRY	 1	 0	 0	 0	
CG2861	 CG2861-RA	 1	 0	 0	 0	
CG5720	 Nab2	 1	 0	 0	 0	
Cell	surface	receptor	
TOLLO	 Tollo	 1	 0	 0	 0	
UpSET	 upSET	 1	 0	 0	 0	
CG9634	 goe	 1	 0	 0	 0	
CG15611	 CG15611	 0	 1	 0	 1	
CG4341	 CG4341	 0	 1	 0	 1	
Spindle	D	 spn-D	 0	 1	 0	 1	
CG14692	 CG14692	 0	 1	 1	 0	
Phosphotidylinositol	3	
kinase	59F	 Pi3K59F	 0	 1	 1	 0	
Tropomyosin	1	 Tm1	 0	 1	 0	 0	
CG34355	 CG34355	 0	 1	 0	 0	
LDL	receptor	protein	1	 LRP1	 0	 1	 0	 0	
Dystrophin	 Dys	 0	 1	 0	 0	
Misfire	 mfr	 0	 1	 0	 0	
CG42814	 CG42814-
RA	 0	 1	 0	 0	
Four	way	stop	 fws	 0	 1	 0	 0	
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Histone	H2B	 His2B	 0	 1	 0	 0	
CG16739	 CG16739	 0	 1	 0	 0	
Ribosomal	protein	L40	 RpL40	 0	 1	 0	 0	
Transport	and	golgi	




CG32809	 0	 1	 0	 0	
Alpha-mannosidase	 LManII	 0	 1	 0	 0	
Protein	phosphatase	1c	
interacting	protein	1	 Ppi1	 0	 1	 0	 0	
CG12428	 CG12428	 0	 1	 0	 0	
Distracted	 dsd	 0	 1	 0	 0	
Nucleoporin	133kD	 Nup133	 0	 1	 0	 0	
Dipeptidase	B	 Dip-B	 0	 1	 0	 0	
CG3940	 CG3940	 0	 1	 0	 0	
CG9272	 CG9272	 0	 1	 0	 0	
CG9170	 CG9170	 0	 1	 0	 0	
Rudhira	 rudhira	 0	 1	 0	 0	
CG32813	 CG32813	 0	 1	 0	 0	
Phosphodiesterase	11	 Pde11	 0	 1	 0	 0	
Translocation	protein	1	 Trp1	 0	 1	 0	 0	
Phosphoenolpyruvate	
carboxykinase	[GTP]	 Pepck	 0	 0	 1	 1	
Rootletin	 Rootletin	 0	 0	 1	 1	
Stonewall	 stwl	 0	 0	 0	 1	
Tyrosine-protein	kinase	
hopscotch		 hop	 0	 0	 0	 1	
CG8468	 CG8468	 0	 0	 0	 1	
polyhomeotic	distal	 ph-d	 0	 0	 0	 1	
CG4393	 CG4393	 0	 0	 0	 1	
CG10211	 CG10211	 0	 0	 0	 1	
CG8668	 CG8668	 0	 0	 0	 1	
CG11449	 CG11449	 0	 0	 0	 1	
Ubiquinol-cytochrome	c	
reductase	core	protein	2	 UQCR-C2	 0	 0	 0	 1	
CG9861	 CG9861-RA	 0	 0	 0	 1	
CG3902	 CG3902-RA	 0	 0	 3	 0	
Scribbled	 scrib	 0	 0	 1	 0	
Isocitrate	
dehydrogenase	[NADP]		 Idh	 0	 0	 1	 0	
Phosphodiesterase	8	 Pde8	 0	 0	 1	 0	
V(2)k05816	 v(2)k05816	 0	 0	 1	 0	
Alcohol	dehydrogenase		 Adh	 0	 0	 1	 0	
40S	ribosomal	protein	
S25		 RpS25	 0	 0	 1	 0	
CG2051	 CG2051	 0	 0	 1	 0	
Hemomucin	 Hmu	 0	 0	 1	 0	
Probable	cytochrome	
P450	313a2		 Cyp313a2	 0	 0	 1	 0	
CG10137	 CG10137	 0	 0	 1	 0	





CG12262	 0	 0	 1	 0	
Protein	O-
mannosyltransferase	1	 rt	 0	 0	 1	 0	
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and	 cellular	 component.	 The	 protein	 results	 were	 split	 into	 the	 following	 before	
WebGestalt/GO	 slim	 analysis;	 NTAP-Fos	 control	 and	 DEM-treated	 (Figure	 4.2),	
NTAP-Jun	 control	 and	DEM-treated	 (Figure	 4.3),	NTAP-Fos	 and	NTAP	 Jun	 control	
only	 (Figure	 4.4)	 and	 finally	 NTAP-Fos	 and	 NTAP-Jun	 DEM-treated	 only	 (Figure	
4.5).	 When	 analysing	 proteins	 bound	 to	 Fos	 in	 both	 conditions,	 we	 observe	 that	
almost	 half	 of	 the	 proteins	 have	 an	 involvement	 in	metabolic	 processes,	 followed	
closely	 by	 roles	 in	 cellular	 component	 organisation,	 biological	 regulation	 and	
response	 to	 stimuli	 (Figure	 4.2A).	We	 identify	 the	majority	 of	 proteins	 as	 having	
molecular	 functions	 such	 as	 protein	 binding,	 hydrolase	 activity,	 ion	 binding	 and	
nucleic	acid	binding	(Figure	4.2B).	The	cellular	components	that	the	majority	of	our	
	127	
proteins	 were	 found	 in	 are	 macromolecular	 complexes	 followed	 by	 the	 nucleus,	
lipid	particles,	the	membrane	and	in	the	cytoskeleton	(Figure	4.2C).	
When	 analysing	 the	 proteins	 bound	 to	 Jun	 only	 in	 control	 and	 DEM-treated	
conditions,	 similar	 patterns	 are	 observed.	 We	 identify	 the	 majority	 of	 bound	
proteins	to	be	involved	in	metabolic	processes,	but	also	a	large	number	have	roles	
in	 biological	 regulation,	 cellular	 component	 organisation	 and	 response	 to	 stimuli	
(Figure	 4.3A).	 Similarly,	 the	 Jun-bound	 proteins	 are	 also	 largely	 involved	 in	 ion	
binding	as	well	as	nucleotide	binding	and	exhibit	transferase	activity	(Figure	4.3B).	







in	 metabolic	 processes,	 followed	 closely	 with	 involvement	 in	 cellular	 component	
organisation,	 biological	 regulation	 and	 response	 to	 stimuli	 (Figure	 4.4A).	 The	
molecular	 functions	 that	 the	majority	 of	 proteins	 exhibit	 are	 ion	 binding,	 protein	
binding,	 nucleotide	 binding	 and	 nucleic	 acid	 binding	 (Figure	 4.4B).	 The	 main	
cellular	 localisation	 of	 these	 proteins	 includes	 the	 macromolecular	 complex,	 the	
lipid	 particle,	 the	 nucleus	 and	 the	 mitochondria.	 Following	 recent	 work	 by	 the	




We	 again	 find	 that	 the	 majority	 of	 proteins	 are	 involved	 in	 the	 process	 of	
metabolism,	 but	 also	 biological	 regulation	 and	 response	 to	 stimuli	 (Figure	 4.5A).	
The	 difference	we	 see	 here	 is	 that	 upon	 DEM	 treatment,	 a	 large	 number	 (~35%	
compared	to	~23%	in	control	conditions)	of	the	proteins	identified	are	involved	in	
localisation.	This	may	indicate	that	DEM-treatment	is	initialising	a	cellular	response,	
and	may	 be	 up-regulating	 proteins	 involved	 in	 the	 localisation	 of	 activated	 AP-1.	
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Again,	 the	majority	of	bound	proteins	here	are	 involved	 in	 ion	binding,	 as	well	 as	
protein	 binding,	 hydrolase	 activity	 and	 nucleic	 acid	 binding	 (Figure	 4.5B).	 The	
majority	of	proteins	bound	to	Fos	and	Jun	in	DEM-treated	conditions	are	localised	
to	macromolecular	 complexes,	 not	 unlike	 the	 previous	 conditions.	 Many	 are	 also	
localised	in	the	cytoskeleton,	membrane-bound	lumen,	the	membrane,	nucleus	and	
mitochondria	(Figure	4.5C).	
To	 summarise,	 it	 appears	 we	 have	 pulled	 down	 proteins	 largely	 involved	 in	 the	
metabolic	 process,	 cellular	 organisation	 and	 regulation,	 as	 well	 as	 response	 to	
stimuli.	 Whilst	 this	 gives	 a	 good	 overview	 of	 what	 our	 bound	 proteins	 may	 be	
involved	in,	it	doesn’t	indicate	any	specific	roles	that	may	allude	to	how	Fos	and	Jun	
control	synaptic	plasticity.	Also	due	 to	 the	nature	of	our	results	and	 the	problems	
we	had	concerning	contamination,	we	put	a	very	limited	weight	on	any	analysis	we	
performed.	 However,	 due	 to	 the	 presence	 of	 our	 bait	 protein	 in	 each	 condition	









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































database	 derives	 its	 basis	 of	 interaction	 from	 various	 sources	 including	 genomic	
context	predictions,	which	uses	the	observations	that	2	or	more	proteins	with	the	
same	 expression	 pattern	 or	 absence	 in	 different	 genomes	 most	 likely	 have	 a	
functional	 link,	 high-throughput	 experiments,	 co-expression	data,	 automated	 text-
mining	 and	 from	previous	knowledge	gained	 from	other	databases	 (Szklarczyk	et	
al.,	2015).	Several	runs	of	analysis	were	performed	using	different	combinations	of	
our	results	looking	only	at	the	proteins	that	are	networked.	The	output	of	STRING	
analysis	 is	 shown	below	(Figure	4.6-Figure	4.9).	The	STRING	analysis	was	split	 to	
show	interaction	networks	of	proteins	identified	from	NTAP-Fos	control	and	DEM-
treated	(Figure	4.6),	NTAP-Jun	control	and	DEM-treated	(Figure	4.7),	NTAP-Fos	and	
NTAP	 Jun	 control	 only	 (Figure	 4.8)	 and	 finally	 NTAP-Fos	 and	 NTAP-Jun	 DEM-
treated	 only	 (Figure	 4.9).	 Identified	 proteins	 that	 showed	 no	 known	 interaction	




Without	 taking	 into	account	 the	change	 in	oxidative	 stress	 status,	when	analysing	
results	 from	 the	 NTAP-Fos	 control	 and	 DEM-treated	 condition	 we	 see	 Fos	 (kay)	
linked	 to	 Jun	 (Jra)	which	was	an	expected	 interaction.	Both	Fos	and	 Jun	are	 in	an	
interaction	 network	 including	 Dystrophin	 (Dys),	 Tropomyosin	 1	 (Tm1)	 and	
Transport	 and	 golgi	 organisation	 5	 (Tango	 5)	 (Figure	 4.6).	 Dys	 is	 required	 for	
appropriate	synaptic	 retrograde	communication	and	 forms	part	of	 the	Dystrophin	
Glycoprotein	 Complex	 (DGC).	 The	 DGC	 complex	 acts	 to	 maintain	 the	 integrity	 of	





itself.	 Mutations	 in	 this	 gene	 in	 humans	 cause	 Duchenne	 muscular	 dystrophy,	
characterised	by	muscle	wastage	and	also	occasionally	mental	retardation	(Pilgram	
et	 al.,	 2010).	 Tm1	 promotes	 cytoskeleton	 remodelling	 in	 response	 to	 oxidative	
stress	 via	 the	 ERK	 signalling	 pathway.	When	 unrestrained,	 Tm1	 causes	 axons	 to	
grow	longer	but	also	results	in	smaller	growth	cones	(Houle	et	al.,	2003).	Tango5	is	




treated	 conditions,	 we	 find	 several	 proteins	 in	 this	 interaction	 network	 that	 are	
known/predicted	 to	 interact	 with	 Jun/Fos	 (Figure	 4.7).	 However,	 these	 proteins	
differ	 from	 those	 bound	 to	 Fos.	 Importantly	we	 have	 identified	 Fos	 in	 these	 pull	
downs,	 known	 to	 bind	 Jun	 and	 form	AP-1.	Other	 proteins	 in	 the	more	 immediate	
interaction	 network	 include	 Hopscotch	 (Hop),	 Scribbled	 (Scrib)	 and	
Phosphoenolpyruvate	 carboxykinase	 (PEPCK).	 The	 Hop	 gene	 encodes	 Drosophila	
Janus	Kinase	(JAK),	which	plays	an	important	role	in	long-term	memory	formation	
within	 the	mushroom	 bodies	 (Copf	 et	 al.,	 2011).	 Scrib	 is	 required	 for	 short-term	
synaptic	plasticity.	At	 the	NMJ,	Scrib	colocalises	with	Discs-large	(Dlg),	 in	complex	
they	are	critical	for	the	development	of	normal	synapse	structure	and	function.	The	
phenotypes	 of	 scrib	 mutants	 are	 observed	 as	 increases	 in	 synaptic	 vesicles	 in	
synaptic	 boutons	 that	 act	 as	 the	 vesicle	 reserve	 pool,	 reduction	 in	 the	 number	 of	
active	zones,	a	 loss	of	 facilitation	and	faster	synaptic	depression.	 It	 is	 thought	that	
synaptic	 vesicle	 dynamics	 are	 also	 impaired	 in	 scrib	mutants,	 and	 taken	 together	
highlights	that	Scrib	is	essential	for	synaptic	plasticity	(Roche	et	al.,	2002).	PEPCK	is	










bound	 to	 metabolic	 proteins,	 as	 highlighted	 earlier	 (Figure	 4.2A).	 An	 important	
network	 identified	here	shows	Punch	bound	to	alcohol	dehydrogenase	(Adh),	 in	a	
network	 of	 metabolic	 proteins	 that	 connects	 Punch	 to	 Fos	 and	 Jun.	 Adh	 is	 the	
protein	 responsible	 for	 metabolising	 alcohol,	 isocitrate	 dehydrogenase	 (Idh)	 is	
responsible	 for	 metabolising	 isocitrate	 and	 CG11876	 exhibits	 pyruvate	






4.2.4.3 	Comparing	 STRING-generated	 networks	 of	 Fos	 and	 Jun-
bound	proteins	from	control	to	DEM-treated	conditions	
One	aim	of	 this	 investigation	was	 to	determine	how	Fos	and	 Jun	binding	partners	
change	when	oxidative	stress	ensues.	We	generated	a	STRING	interaction	network	
of	the	binding	partners	of	Fos	and	Jun	in	control	conditions	only,	to	reveal	that	no	
known	or	predicted	 interactions	occur	between	any	of	 the	 identified	proteins	and	
Fos	and	Jun	(Figure	4.8).	Interestingly,	in	control	conditions	we	still	identify	Punch	
being	bound	 into	 the	metabolic	protein	network	mentioned	previously,	bound	via	
Adh	 to	 Idh,	 CG11876	 etc.	 This	 network	 is	 not	 present	 when	 treating	 with	 DEM	
(Figure	4.9).	Firstly	we	do	not	 identify	Punch,	Adh,	 Idh	or	CG11876	when	treating	
with	DEM,	suggesting	 that	Fos	and	 Jun	may	have	a	more	metabolic	 role	when	 the	
cell	 is	 not	 oxidatively	 stressed.	 Upon	DEM	 treatment,	we	 identified	Dys,	 Hop	 and	
Tango5,	 which	 have	 roles	 in	 regulating	 neurotransmitter	 release/acting	 as	 a	
signalling	 scaffold,	 in	 long-term	 memory	 formation	 and	 in	 regulating	 autophagy.	
These	 represent	 physiological	 changes	 that	 may	 occur	 because	 oxidative	 stress	
ensued,	activating	AP-1	as	an	outcome	and	interacting	with	the	identified	proteins.		
These	 observations	 are	 purely	 hypothetical,	 as	 the	 STRING	 networks	 include	
predicted	 interactions	 and	 the	unlinked	 identified	proteins	 are	 removed	 from	 the	
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figures.	We	utilise	STRING	mainly	to	derive	insight	into	the	data	and	gain	some	idea	
of	 how	 Fos	 and	 Jun	 are	 functioning.	 Unfortunately,	 we	 identified	 relatively	 few	
proteins	 in	 this	 experiment,	 and	 the	proteins	we	do	 identify	 do	not	 appear	 often.	
Because	of	this	we	focused	our	attention	to	proteins	in	the	list	that	were	identified	
in	 either	 control	 or	 DEM-treated	 conditions	 only	 (Table	 4.2).	 Exploring	 the	
literature	we	found	GTP	cyclohydrolase	I,	or	Punch	to	be	of	interest,	and	it	is	one	of	
the	 few	 proteins	 identified	 that	 is	 only	 bound	 in	 control	 conditions,	 yet	 lost	 in	









Proteins	 identified	 in	 NTAP-Fos	 control	 and	 DEM-treated	 conditions	 were	 subject	 to	
STRING	analysis	to	generate	networks	of	known	interactions	within	our	results.	Fos	(kay)	
is	 shown	 to	 interact	 with	 Jun	 (Jra)	 in	 this	 network	 and	 is	 linked	 to	 Dystrophin	 (Dys),	








Proteins	 identified	 in	 NTAP-Jun	 control	 and	 DEM-treated	 conditions	 were	 subject	 to	
STRING	analysis	to	generate	networks	of	known	interactions	within	our	results.	Fos	(kay)	
is	 shown	 to	 interact	 with	 Jun	 (Jra)	 in	 this	 network.	 This	 network	 also	 links	 GTP	
cyclohydrolase	I	(Punch	(Pu))	to	Fos	and	Jun	via	Alcohol	Dehydrogenase	(Adh),	Isocitrate	




Figure	 4.8	 Interaction	 networks	 of	 proteins	 identified	 from	 NTAP-Jun	 and	
NTAP-Fos	control	conditions,	derived	in	STRING	









Figure	 4.9	 Interaction	 networks	 of	 proteins	 identified	 from	 NTAP-Jun	 and	
NTAP-Fos	DEM-treated	conditions,	derived	in	STRING	
Proteins	 identified	 in	 NTAP-Jun	 and	 NTAP-Fos	 DEM-treated	 conditions	 were	 subject	 to	
STRING	analysis	to	generate	networks	of	known	interactions	within	our	results.	Fos	(kay)	is	









limiting	 excessive	 BH4	 production	 (Yoneyama	 and	 Hatakeyama,	 2001).	 Upon	 the	
oxidation	of	BH4	or	its	expenditure	during	its	role	as	an	essential	cofactor,	GTPCH1	
is	released	into	its	stimulatory	state	which	initiates	the	first,	rate-limiting	step	in	the	
biosynthesis	 of	 BH4.	 The	 rise	 in	 BH4	 leads	 to	 negative	 feedback	 inhibition	 upon	
GTPCH1,	 returning	 it	 to	 its	 inhibited	 state	 (Thony	 et	 al.,	 2000).	 BH4	 is	 tightly	





site	 (Nar	 et	 al.,	 1995).	 It	 is	 localised	 in	 the	 cytosol,	 the	 nucleus	 and	 the	 cell	
membrane	 and	has	 important	 roles	 in	 neurotransmitter	 synthesis,	 specifically	 for	
serotonin	 and	 dopamine	 (DA)	 (Du	 et	 al.,	 2009).	When	mutated,	 levels	 of	 DA	 and	
serotonin	 are	 dramatically	 reduced,	 contributing	 to	 several	 human	 diseases	
including	 DOPA-responsive	 dystonia	 (DRD)	 and	 sepiapterin	 reductase	 (SR)	
(Nagatsu	 and	 Ichinose,	 1999).	Mutations	 in	GTPCH1	 have	 also	 been	 linked	 to	 the	
onset	of	PD	(Lewthwaite	et	al.,	2015).	This,	combined	with	its	role	in	the	synthesis	
of	the	potent	ROS	scavenger,	BH4,	makes	its	potential	interaction	with	Fos	and	Jun	
exciting.	 It	 could	 link	 the	 redox-sensitive	 JNK	 signalling	pathway	 to	GTPCH1/BH4,	
which	 exhibits	 clear	 roles	 in	 redox	 defence	 within	 the	 neuron	 and	 may	 have	







antibodies	 (see	 section	 2.5.3).	 Both	 anti-Punch182	 and	 anti-Punch183	 were	
characterised	 to	 confirm	 the	 working	 concentration	 for	 larval	 dissections	 and	
western	 blots	 and	 its	 localisation	 pattern	 in	 larval	 dissections.	 Their	 specificity	
toward	 Punch	 in	 both	 larval	 dissections	 and	western	 blots	 was	 also	 determined,	






(Punchr1/Df(2R)Exel6072)	 with	 both	 antibodies	 revealed	 a	 loss	 of	 the	 VNC	 nuclei	




To	 determine	whether	 Punch	 could	 possibly	 be	 interacting	with	 Fos	 and	 Jun,	we	
sought	 to	confirm	that	Punch	 is	expressed	 in	 the	motor	neuron	nuclei,	as	Fos	and	
Jun	are	found	to	be.	Again,	we	utilised	the	OK6-GFP	reporter	to	identify	the	motor	
neurons.	 Larvae	 expressing	 OK6-GFP	 were	 co-stained	 with	 Rabbit	 anti-Punch	
(courtesy	of	 the	O’Donnell	group)	(Alexa-Fluor®	405,	green)	and	anti-Jun59	(Cy3,	
magenta).	Not	only	do	we	show	 that	Punch	 is	expressed	 in	 the	motor	neuron,	we	
also	observe	possible	colocalisation	with	Jun	(Figure	4.11).	Unfortunately,	the	anti-
Punch	 antibody	 is	 raised	 in	 rabbit,	meaning	we	 cannot	 co-stain	with	 Rabbit-anti-






is	 localised	 to	 cells	 where	 Fos	 is	 also	 enriched	 (Figure	 4.12).	 We	 find	 Punch	 is	
expressed	in	the	larval	VNC	and	that	it	is	present	in	the	motorneuron	nuclei,	where	
Fos	and	Jun	are	enriched	(Figure	3.13).	Importantly,	we	find	possible	colocalisation	




Their	 specificity	was	 determined	 by	 comparing	 blots	 of	 protein	 sample	 extracted	
from	 the	 heads	 of	 WT’s,	 elavGAL4>UAS-Punch,	 Punch	 mutants	
(PunchEY02616A/Df(2R)Exel6072)	 and	 elavGAL4>UAS-Punch-RNAi.	 Both	 antibodies	
are	 specific	 to	Punch,	 as	we	 see	a	 complete	 loss	of	detectable	Punch	 in	 the	Punch	
mutant	sample,	a	substantial	loss	when	expressing	Punch-RNAi,	yet	present	in	both	












stained	 with	 anti-Punch	 (Alexa-Fluor®	 405	 (Green))	 (B)	 and	 anti-Jun59	 (Cy3	























































































































































































































































































































































































































control	 and/or	 oxidative	 stress	 conditions.	 Whilst	 the	 results	 of	 the	 mass	
spectrometry	were	not	 ideal	due	 to	high	 levels	of	 contamination,	we	were	able	 to	
gain	 insight	 into	the	types	of	proteins	AP-1	putatively	binds.	Many	of	 the	proteins	
were	involved	in	responding	to	cellular	stimuli	and	protein	regulation;	surprisingly	
a	 large	 proportion	 were	 also	 involved	 in	 metabolism.	 We	 identified	 more	
metabolically	associated	proteins	bound	to	Jun	than	Fos.	Using	STRING	analysis	we	
found	 a	 variety	 of	 closely	 associated	 proteins	 with	 neuronal	 roles	 that	 could	
indicate	how	AP-1	controls	synaptic	plasticity.	Importantly,	we	identify	the	protein	





stimuli	 and	 protein	 regulation.	 AP-1	 is	 activated	 in	 response	 to	 stress	 (heat,	 UV,	
ROS),	 cytokines	and	growth	 factors	 (Kyriakis,	1999,	Rahmani	et	al.,	1999,	Zhou	et	
al.,	2007,	Milton	et	al.,	2011,	Zhang	et	al.,	2015).	With	this	in	mind	it	was	surprising	
to	 see	 such	 a	 large	 involvement	 of	 metabolic	 proteins.	 This	 may	 indicate	 that	
Fos/Jun	have	a	role	in	metabolism,	possibly	acting	as	a	form	of	metabolic	defence	in	
response	 to	 increased	oxidative	 stress	 from	 the	mitochondria	or	 as	 a	 response	 to	
starvation,	 activating	 AP-1	 and	 subsequently	 autophagy	 to	 increase	 recycling	 of	
cellular	components	and	maintain	protein	 levels	 in	 the	cell	 (Heymann,	2006).	The	
ion	binding	function	of	the	majority	of	identified	proteins	may	indicate	roles	in	ROS	
binding	 or	 the	 electron	 transport	 chain.	 The	 majority	 of	 proteins	 were	 found	 to	
reside	 in	macromolecular	 complexes,	 followed	by	 the	nucleus,	mitochondria,	 lipid	
particle,	membrane	and	cytoskeleton.	This	is	a	relatively	vague	designation	but	does	
suggest	that	AP-1	may	directly	interact	with	macromolecular	complexes	involved	in	
stress	 responses.	 AP-1	 has	 a	 role	 in	 a	 variety	 of	 cellular	 processes	 and	may	 bind	
other	complexes	during	these	roles.	For	example,	 in	hepatoma	tissue	culture	cells,	




induce	 transcription	 of	 TGF-β-related	 growth	 genes	 via	 a	 binding	 of	 this	 complex	
with	DNA-binding	sites	(Liberati	et	al.,	1999).		
To	summarise,	AP-1	may	bind	a	variety	of	complexes	during	its	response	to	cellular	
stresses,	 and	 our	 identification	 of	 proteins	 involved	 in	 regulating	 proteins	 and	





receptor	 regulation	 and	 release,	 axonal	 growth/remodelling	 in	 response	 to	
oxidative	stress,	and	 finally	autophagy.	This	 fits	with	data	previously	presented	 in	
Chapter	3,	showing	that	increased	activation	of	Fos,	in	response	to	oxidative	stress	
leads	to	synaptic	overgrowth	which	may	occur	via	autophagy.	We	identified	Tm1,	a	
protein	 that	may	 regulate	 synaptic	 growth	 via	 ERK	 signalling.	 It	 has	 been	 shown	
that	increased	ERK	signalling	leads	to	AP-1	activation	(Karin,	1995).	ERK	signalling	
has	also	been	show	to	regulate	NMJ	growth	by	modulating	levels	of	FasII	(Koh	et	al.,	
2002).	 Reducing	 FasII	 levels	 causes	 NMJ	 growth,	 and	 ERK	 signalling	 is	 inversely	
correlated	to	FasII	levels	(Schuster	et	al.,	1996).	Therefore	increasing	ERK	signalling	
can	cause	NMJ	growth	via	a	reduction	 in	FasII	and	coincides	with	an	activation	of	











for	Fos	mediating	Tango5/Beclin	1	 in	autophagy	 induction	and	 that	 JNK	regulates	
many	aspects	of	autophagy	via	different	pathways.	Finally,	we	identified	Dys	bound	
to	 Fos	 during	 DEM-treated	 conditions,	 and	 STRING	 analysis	 reveals	 a	 predicted	
interaction	 with	 Jun.	 Dys	 is	 shown	 to	 be	 important	 for	 retrograde	 control	 of	
neurotransmitter	 release	 at	 the	 NMJ.	 In	 dys	 mutants,	 short-term	 facilitation	 is	
decreased,	whereas	 evoked	 neurotransmitter	 release	 is	 increased,	 suggesting	Dys	
may	have	a	role	in	synaptic	plasticity	(van	der	Plas	et	al.,	2006).	
During	STRING	analysis	of	Jun-bound	proteins,	we	identified	several	that	have	roles	
in	 mediating	 synaptic	 plasticity	 and	 morphology.	 Both	 Hop	 and	 Scrib	 have	
important	neuronal	roles,	and	whilst	no	current	data	suggest	 that	Scrib	binds	 Jun,	
we	 identified	 it	 in	 Jun	 control	 conditions.	 Hop	 was	 identified	 in	 DEM-treated	
conditions,	 and	 encodes	 the	 Drosophila	 Janus	 Kinase	 (JAK)	 protein.	 It	 is	 an	
important	 regulatory	 protein	 required	 for	 proper	 patterning	 of	 embryonic	
segments,	as	well	as	 in	 the	developing	eye	 (Binari	and	Perrimon,	1994,	Luo	et	al.,	
1999).	 Importantly,	 the	 JAK/STAT	 pathway	 is	 involved	 in	 mammalian	 synaptic	
plasticity,	specifically	 for	 the	 induction	of	 long-term	depression	(LTD)	 in	synapses	
(Nicolas	 Cé		 et	 al.,	 2012).	 LTD	 is	 an	 important	 regulatory	 process	 that	 reduces	
synaptic	strength	in	synapses.	LTD	has	been	linked	to	AD,	where	it	has	been	shown	
that	 soluble	amyloid	beta	protein	 facilitates	LTD	 in	 the	hippocampus,	and	may	be	
responsible	 for	 the	 onset	 of	 dementia	 and	 synaptic	 failure	 (Li	 et	 al.,	 2009b).	 The	
association	 of	 Hop	 with	 Jun	 during	 DEM-conditions	 could	 indicate	 an	 activity	
dependent	mechanism	where	 the	neuron	 responds	 to	ROS	by	 increasing	 synaptic	




and	 the	 onset	 of	 synaptic	 failure	 and	 neurodegenerative	 diseases.	 However,	 it	 is	
worth	noting	 that	 this	 theory	 is	 in	 contrast	 to	 already	published	data	 stating	 that	















GTP	 cyclohydrolase	 1.	 Punch	 was	 identified	 in	 Fos	 and	 Jun	 samples	 under	 non-
stressed	conditions.	Whilst	we	only	observed	two	significant	sequence	hits	per	Fos	
and	Jun,	it	was	still	one	of	our	strongest	results.	Punch	was	also	identified	in	a	small-
scale	pilot	run	of	our	pull	down	experiment,	where	 it	was	bound	to	 Jun	 in	control	
conditions	but	not	under	oxidative	stress	conditions.	Punch	also	 fit	our	criteria	of	
only	 binding	 in	 one	 condition,	 suggesting	 that	 a	 change	 in	 redox	 status	 alters	 its	
function.	During	STRING	analysis,	we	find	Punch	interacts	with	Adh,	and	is	linked	to	
AP-1	via	a	chain	of	metabolic	proteins.	Whilst	this	sheds	no	light	on	the	interaction	
of	 Punch	 and	 AP-1,	 it	 was	 of	 particular	 interest	 because	 of	 its	 role	 in	 the	










we	 haven’t	 looked	 further	 into	 investigating	 the	 majority	 of	 these	 proteins,	 they	
could	potentially	be	critical	future	experiments.	In	the	interest	of	time,	we	focused	
purely	on	Punch,	which	we	have	shown	is	localised	to	motor	neuron	nuclei,	where	
Fos	 and	 Jun	 are	 enriched;	 strengthening	 our	 theory	 that	 AP-1	 and	 Punch	may	 be	









of	 BH4,	 an	 essential	 cofactor	 involved	 in	 a	 variety	 of	 cellular	 processes.	 One	 such	
role	involves	the	hydrolysis	of	amino	acids,	where	BH4	is	required	by	hydroxylases	
for	 the	 conversion	 of	 phenylalanine,	 tyrosine	 and	 tryptophan	 into	 other	 useful	
molecules	 (Thony	 et	 al.,	 2000).	 These	 are	 classified	 as	 biopterin-dependent	
aromatic	amino	acid	hydroxylases.	Phenylalanine	hydroxylase	and	cofactor	BH4	act	
to	metabolise	excess	phenylalanine	 into	tyrosine,	an	 important	regulatory	process	
that	 prevents	 hyperphenylalaninemia	 (HPA).	 Severe	 HPA	 causes	 phenylketonuria	
(PKU),	 a	 disease	 in	 humans	 that	 causes	 postnatal	 brain	 damage	 and	 mental	
retardation	(Kaufman,	1999).	Tyrosine	hydroxylase	(TH)	and	BH4	convert	tyrosine	
to	 the	 catecholamine,	 dopamine	 (DA)	 (Daubner	 et	 al.,	 2011).	 DA	 is	 an	 important	
neurotransmitter	for	movement	control	in	humans,	and	also	plays	a	role	in	memory	
formation	 (Yamagata	 et	 al.,	 2015).	 Communication	 between	 neurons	 of	 the	
Substantia	nigra	and	the	basal	ganglia	occurs	via	DA	release.	Loss	of	DA	causes	PD,	
as	 well	 as	 DOPA-responsive	 dystonia,	 and	 can	 result	 from	 a	 mutation	 in	
GTPCH1/reduction	 in	 BH4	 (Dauer	 and	 Przedborski,	 2003,	 Ichinose	 et	 al.,	 1994).	
Tryptophan	hydroxylase	and	BH4	are	involved	in	the	initial	and	rate	limiting	step	in	
the	 synthesis	 in	 serotonin,	 as	 well	 as	 melatonin.	 Serotonin	 is	 an	 important	
regulatory	neurotransmitter	 for	 such	processes	 as	 sleep,	mood	 and	pain.	BH4	has	













as	 a	 self-protecting	 factor	 against	 NO	 toxicity,	 and	 these	 NO-producing	 neurons	




1995).	 Normally	 BH4	 acts	 to	 inhibit	 Punch	 activity,	 regulating	 its	 own	 synthesis.	
When	 BH4	 is	 oxidised	 following	 interactions	 with	 ROS,	 it	 is	 released	 as	 BH2	 and	
Punch	 is	 then	 free	 to	 synthesise	 more	 BH4,	 replenishing	 the	 levels	 in	 order	 to	
combat	oxidative	stress.	
The	 importance	 of	 Punch	 depends	 on	 its	 role	 in	 BH4	 biosynthesis.	 As	 previously	
mentioned,	 human	 diseases	 have	 implicated	 a	 loss	 of	 GTPCH1	 as	 the	 main	
contributor	to	the	pathology.	DOPA-responsive	dystonia	results	from	a	single	copy	
loss	 of	 GTPCH1,	 and	 PKU	 results	 from	 both	 copies	 of	 GTPCH1	 being	 mutated.	
Mutations	 in	 GTPCH1,	 specifically	 heterozygous	 single	 nucleotide	 polymorphisms	
(SNP’s)	 that	 result	 in	 nonsense	 mutations	 have	 recently	 been	 identified	 as	 risk	
factors	in	the	onset	and	progression	of	PD	(Nalls	et	al.,	2014).	
Our	identification	of	Punch	as	a	potential	binding	partner	of	both	Fos	and	Jun	may	
prove	 critical	 in	 the	 understanding	 of	 the	 oxidative	 stress	 response	 in	 motor	
neurons,	 linking	 the	 JNK	 signalling	 pathway,	 known	 to	 induce	 a	 transcriptional	
response	 to	 ROS,	 to	 a	 neuroprotective	 constitutive	 defence	 pathway	 known	 to	
reduce	 ROS.	 The	 following	 chapter	will	 attempt	 to	 elucidate	 the	 role	 of	 Punch	 in	
Drosophila	NMJ	 synapse	 growth	 and	 function,	 its	 relationship	 with	 Fos	 and	 Jun	





Heterozygous	 loss	 of	 GTPCH1	 in	 humans	 leads	 to	 a	 potent	 haploinsufficient	
pathological	 response.	We	 show	 here	 that	 the	 same	 is	 true	 for	Drosophila	 where	
heterozygous	 mutations	 in	 Punch	 lead	 to	 severe	 NMJ	 overgrowth.	 Two	 Punch	




crossing	 to	 either	Canton-S	 (CS)	 or	w1118.	 Punch	 is	 involved	 in	 the	biosynthesis	 of	
drosopterins,	a	red	pigment	which	gives	rise	to	the	red	eye	phenotype	of	Drosophila	





We	 found	 mean	 normalised	 bouton	 number	 was	 significantly	 increased	 in	 both	
heterozygous	 PunchEY02616A	 and	 Punchr1	 when	 crossed	 to	 either	 CS	 or	 w1118,	
compared	 to	 WT	 controls,	 suggesting	 that	 disruptions	 in	 the	 eye	 colour	
pigmentation	 pathway	 does	 not	 affect	 the	 severity	 of	 the	 synaptic	 overgrowth	 in	
terms	 of	 bouton	 number	 (Figure	 5.1;	 p<0.001,	 ANOVA).	 Combining	 both	 Punch	
mutants	 together	 did	 not	 produce	 any	 further	 increase	 in	 bouton	 number,	
suggesting	 each	 heterozygous	 mutant	 is	 exhibiting	 a	 sufficient	 and	 debilitating	
reduction	in	Punch	activity.	It	is	possible	that	mutations	in	Punch	lead	to	dominant	


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Analysis	 of	 branch	 number	 in	 these	 heterozygous	 Punch	 mutants	 revealed	





in	 NMJ	 length	 (µm)	 compared	 to	 WT	 controls	 (Figure	 5.2B;	 p<0.001,	 ANOVA).	
However,	 only	 PunchEY02616A/w1118	 showed	 significant	 difference	 to	 WT	 controls	
(p<0.05,	 ANOVA).	 Punchr1/w1118	 showed	 no	 significant	 difference	 to	WT	 controls	
(p>0.05,	 ANOVA),	 yet	 was	 found	 to	 be	 significantly	 different	 to	 both	
PunchEY02616A/CS	 (p<0.05,	ANOVA)	and	Punchr1/CS	 (p<0.01,	ANOVA).	No	significant	
difference	 was	 shown	 between	 PunchEY02616A/w1118	 and	 PunchEY02616A/CS	 or	
Punchr1/CS	(p>0.05,	ANOVA).	
NMJ	 length	 does	 not	 appear	 to	 increase	 as	 much	 when	 Punch	 mutants	 are	 in	 a	
white-eyed	 background.	 Whilst	 all	 subsequent	 heterozygous	 Punch	 mutant	
investigations	will	be	outcrossed	to	CS,	 it	 is	worth	noting	that	NMJ	length	may	not	
be	 as	 susceptible	 to	 morphological	 changes	 than	 bouton	 and	 branch	 number,	 an	
observation	that	was	made	previously	in	this	investigation	(see	section	3.2.1).	
	To	confirm	 that	a	 reduction	 in	Punch	activity	 causes	NMJ	overgrowth	we	utilised	
the	UAS/GAL4	system	to	express	Punch-RNAi	in	various	tissue	and	cell	types.	
UAS-Punch-RNAi	 (see	 Table	 2.1)	 was	 expressed	 pre-/post-synaptically	 using	
SpinGAL4,	 pan-neuronally	 using	 elavGAL4	 and	 in	 the	 muscle	 using	 MHCGAl4	 in	
order	 to	 interfere	 with	 Punch	 expression.	 In	 each,	 a	 reduction	 in	 Punch	 activity	
leads	 to	 the	 same	 severe	 synaptic	 overgrowth	 observed	 in	 the	 Punch	 mutants	
(Figure	5.3;	p<0.001,	ANOVA).	This	data	supports	the	idea	that	NMJ	overgrowth	is	
caused	by	a	reduction	in	Punch	activity.	
To	 remove	 any	 suspicion	 that	 the	 NMJ	 overgrowth	 is	 caused	 by	 second	 site	 or	
background	mutations	we	analysed	 the	NMJ’s	of	 flies	 that	are	deficient	 for	a	 large	
section	 of	 their	 genome,	 which	 spans	 the	 Punch	 gene.	 Two	 Punch	 deficiency	 fly	
stocks	were	 used,	 the	 first	 is	Df(2R)Exel6072	 which	 is	 deficient	 for	 chromosomal	
	159	
region	57B16-57D4.	The	second	 is	Df(2R)ED3791,	deficient	 in	 the	region	of	57B1-
57D4.	 Both	 regions	 are	 deficient	 for	 the	 entire	 Punch	 gene,	 and	 used	 as	
heterozygotes	 produce	 the	 same	 severe	NMJ	 overgrowth	 as	 the	PunchEY02616A	 and	
Punchr1	 mutants.	 Significant	 increases	 in	 bouton	 number	 are	 observed	 in	
Df(2R)Exel6072/+	and	Df(2R)ED3791/+	when	compared	to	WT	controls	(Figure	5.4;	
p<0.001,	ANOVA).	No	significant	difference	in	bouton	number	is	observed	between	
the	 2	 Punch-deficient	 lines	 and	 PunchEY02616A/+	 and	 Punchr1/+	 mutants	 (p>0.05,	
ANOVA).	This	supports	the	idea	that	reducing	Punch	causes	synaptic	overgrowth.		
We	previously	observed	that	combining	PunchEY02616A	and	Punchr1	mutants	did	not	
further	significantly	 increase	bouton	number	 (Figure	5.1).	This	 suggests	 that	both	
copies	of	the	Punch	gene	must	be	fully	functional	to	avoid	such	NMJ	overgrowth	in	
Drosophila,	 as	 such	 we	 can	 describe	 the	 Punch	 gene	 as	 haploinsufficient,	 able	 to	
generate	the	full	mutant	phenotype	as	heterozygotes.	To	confirm	that	the	severity	of	
the	Punch	 mutant	 phenotype	 does	 not	 increase	 upon	 both	 copies	 of	Punch	 being	
mutated,	the	deficiency	lines	were	combined	with	the	Punch	mutants.		
Both	 Punch	 deficiencies	 were	 combined	 with	 PunchEY02616A	 and	 Punchr1	 and	 the	
bouton	number	analysed.	No	significant	differences	were	found	between	any	of	the	
combinations	of	Punch	mutants	and	deficiencies	(Figure	5.5;	p>0.05,	ANOVA).	This	
supports	 the	 notion	 that	 loss	 of	 a	 single	 copy	 of	Punch	 is	 sufficient	 to	 produce	 a	




Figure	 5.3	 Neuronal	 and	 muscle	 expression	 of	 Punch-RNAi	 causes	 synaptic	
overgrowth	
A:	Analysis	of	NMJ’s	 from	larvae	expressing	Punch-RNAi	via	SpinGAL4	(137±7.9,	n=16),	elavGAL4	
(147±8.6,	 n=12)	 and	 MHCGAL4	 (130±8,	 n=15)	 reveal	 significantly	 increased	 mean	 normalised	
bouton	number	per	NMJ	compared	to	WT	controls	(78±2.6,	n=34)	(***p<0.001;	ANOVA	with	post	
hoc	 Bonferroni	 correction).	 No	 significant	 differences	 in	 mean	 normalised	 bouton	 number	 were	
observed	when	 comparing	 larvae	 expressing	Punch-RNAi	 via	 SpinGAL4,	 elavGAL4	and	MHCGAL4	
(NS	 p>0.05;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 Error	 bars	 display	 ±SEM.	 B:	









WT	 controls	 (83±3.8,	 n=16)	 (***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	
Heterozygous	Punch	mutants,	PunchEY02616A	and	Punchr1	crossed	to	CS	show	significantly	increased	
mean	 normalised	 bouton	 number	 per	 NMJ	 (158±8.3,	 n=16	 and	 142±7.7,	 n=16,	 respectively)	
compared	to	WT	controls	(***p<0.001;	ANOVA	with	post	hoc	Bonferroni	correction),	but	neither	
show	significant	differences	compared	to	Punch	deficient	lines,	Df(2R)Exel6072	and	Df(2R)ED3791	







A:	 NMJ	 analysis	 of	 Punch-deficient	 larvae	 (Df(2R)Exel6072	 and	 Df(2R)ED3791)	 combined	 with	




(139±5.7,	 n=14	 and	 149±9.3,	 n=13,	 respectively)	 compared	 to	WT	 controls	 (***p<0.001;	 ANOVA	
with	 post	 hoc	 Bonferroni	 correction).	 No	 significant	 difference	 is	 observed	 between	 any	 of	 the	





It	 is	 known	 that	 Punch	 is	 essential	 for	 the	 biosynthesis	 of	 BH4,	 which	 has	 been	
identified	as	a	neuroprotective	agent	and	potent	ROS	scavenger	(Thony	et	al.,	2000).	
In	the	absence	of	BH4,	increased	hydrogen	peroxide	production	occurs	via	the	NOS	
synthase	pathway	 (Scott-Burden,	 1995).	We	postulate	 that	Punch	mutants	 exhibit	
reduced	 levels	 of	 BH4,	 increasing	 the	 ROS	 production	 and	 reducing	 the	 ROS	
scavenging	 potential	 in	 the	 NMJ.	We	 have	 shown	 that	 increased	 levels	 of	 ROS	 in	
Drosophila	 lead	 to	 synaptic	 overgrowth	 (Figure	 3.1)	 (Milton	 et	 al.,	 2011)	 and	
hypothesise	that	the	Punch	mutants	may	be	reacting	similarly.	If	Punch	mutants	are	






We	 tested	 this	 by	 treating	Punch	mutants	 and	 larvae	 expressing	UAS-Punch-RNAi	
using	 various	 GAL4’s,	 with	 10mM	 DEM.	 No	 significant	 difference	 was	 observed	
when	 treating	 either,	 PunchEY02616A/+	 or	 Punchr1/+	 with	 DEM	 compared	 to	 their	
non-treated	control	(Figure	5.6A;	NS	p>0.05,	ANOVA).	Importantly,	PunchEY02616A/+	
controls	 (p<0.001,	ANOVA),	 as	well	 as	PunchEY02616A/+	and	Punchr1/+	 treated	with	
DEM	 (p<0.001	 and	 p<0.01	 respectively,	 ANOVA)	 showed	 significant	 increases	 in	
synaptic	 bouton	 number	 compared	 to	 WT	 treated	 with	 DEM.	 Similarly,	 treating	
UAS-Punch-RNAi	 larvae	 expressed	 either	 pre	 and	 post-synaptically	 (SpinGAL4),	
pan-neuronally	(elavGAL4)	and	in	the	muscle	(MHCGal4)	also	showed	no	significant	




To	 confirm	 this,	 we	 treated	 Punch	 mutants	 with	 10mM	 Trolox.	 Previously,	 we	
showed	 that	 treating	 flies	with	Trolox	does	not	 increase	 synaptic	 bouton	number	
and	that	it	can	reduce	DEM-induced	synaptic	overgrowth	(see	section	3.2.2).		
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Upon	 treatment	 with	 Trolox,	 the	 increased	 synaptic	 bouton	 number	 observed	 in	
both	PunchEY02616A/+	and	Punchr1/+	was	significantly	reduced	(Figure	5.7;	p<0.001,	
ANOVA).	Trolox-treated	PunchEY02616A/+	and	Punchr1/+	did	not	show	any	significant	
difference	 in	 bouton	 number	 compared	 to	WT	 controls	 (p>0.05,	 ANOVA).	 Branch	
number	was	also	reduced	when	treating	PunchEY02616A	(Figure	5.8A;	p<0.01,	ANOVA)	
and	 Punchr1	 (p<0.05,	 ANOVA)	 mutants	 with	 Trolox	 compared	 to	 their	 relative	
controls,	 which	 are	 significantly	 increased	 compared	 to	 WT	 controls	 (p<0.01,	
ANOVA).	 NMJ	 length	 (µm)	 was	 only	 significantly	 increased	 when	 comparing	
PunchEY02616A/+	 to	 WT	 controls	 (Figure	 5.8B;	 p<0.05,	 ANOVA).	 No	 significant	
difference	was	found	in	NMJ	length	when	treating	either	Punch	mutant	with	Trolox	
(p>0.05,	ANOVA).	
Whilst	 NMJ	 length	 remains	 unaffected,	 both	 bouton	 and	 branch	 number	 were	
significantly	rescued	in	Punch	mutants	when	treated	with	Trolox.	This	confirms	that	
Punch	 mutants	 are	 exhibiting	 an	 oxidative	 stress	 burden,	 however	 it	 does	 not	
explain	the	severity	of	this	overgrowth	compared	to	DEM-treated	larvae	which	also	
have	 an	 oxidative	 stress	 burden	 yet	 are	 significantly	 less	 overgrown	 than	 DEM-
treated	 Punch	 mutants.	 This	 may	 be	 indicative	 of	 other	 roles	 for	 Punch	 in	 the	




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3,4-dihydroxyphenylalanine,	 commonly	 know	 as	 Levodopa	 (L-DOPA),	 a	 precursor	
of	DA	would	also	rescue	NMJ	overgrowth.	








treatment	 can	 rescue	 oxidative	 stress-induced	 synaptic	 overgrowth.	 Ddc	 is	
responsible	 for	 the	 synthesis	 of	 DA	 and	 serotonin	 via	 decarboxylation	 of	 L-DOPA	
and	 L-5-hydroxytryptophan	 (Burkhard	 et	 al.,	 2001).	 Mutations	 in	 Ddc	 result	 in	
reduced	 levels	 of	 DA	 due	 to	 a	 reduced	 capacity	 to	 convert	 L-DOPA.	 We	 tested	
heterozygous	 Ddc	 mutants	 (DdcDE1/CS)	 and	 found	 they	 too	 exhibit	 significant	
synaptic	overgrowth	compared	to	WT	controls	(Figure	5.10;	p<0.001,	ANOVA).	This	
overgrowth	was	significantly	reduced	following	L-DOPA	treatment	compared	to	Ddc	
mutant	 controls	 (p<0.001,	 ANOVA),	 resulting	 in	 bouton	 numbers	 that	 were	 not	
significantly	 different	 to	 WT	 controls	 (p>0.05,	 ANOVA).	 The	 significant	 synaptic	
overgrowth	 observed	 in	 SOD1	 mutants	 (SOD1n1/SOD1n64)	 compared	 to	 WT	
(p<0.001,	 ANOVA)	 was	 not	 rescued	 when	 treating	 with	 L-DOPA	 and	 showed	 no	
significant	 difference	 to	 SOD1	 mutant	 controls	 (Figure	 5.10;	 p>0.05,	 ANOVA).	
Neither	WT	nor	SOD1	mutants	were	affected	by	L-DOPA	treatment	suggesting	that	
L-DOPA	is	not	reducing	bouton	number	and	that	it	cannot	rescue	oxidative	stress-




Currently,	 why	 a	 reduction	 in	 DA	 causes	 synaptic	 overgrowth	 remains	 unclear,	
however	 the	 link	 between	 Punch,	 DA	 synthesis	 and	 synaptic	 plasticity	 is	 very	




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.2.4 Punch-mutant	 induced	 NMJ	 overgrowth	 is	mediated	 by	 JNK	
signalling	
We	 have	 shown	 that	 reducing	 Punch	 activity	 causes	 NMJ	 overgrowth,	 and	 that	
relieving	 the	 oxidative	 stress	 burden/reduction	 in	 DA	 levels	 in	 these	 larvae	 can	




the	 dominant	 negative	 Jun	 via	 SpinGAL4	 (SpinGAL4>UAS-junDN)	 in	 a	 Punch/+	
background.	 We	 also	 repeated	 this	 to	 investigate	 the	 role	 of	 Fos,	 by	 crossing	
PunchEY02616A	 to	Fos	mutant	kay1,	and	 into	 larvae	expressing	FosDN	 (UAS-fosDN)	 via	
SpinGAL4	in	a	Punch/+	background.	
Significantly	 increased	 bouton	 number	 was	 observed	 in	 heterozygous	 Punch	
mutants	 (PunchEY02616A/+)	 (Figure	 5.11;	 p<0.001,	 ANOVA).	 Reducing	 Jun	 activity	
alone	(jraIA109/+)	showed	no	significant	difference	 in	bouton	number	compared	to	
WT	controls	(p>0.05,	ANOVA).	However,	crossing	the	jraIA109	mutant	or	expressing	
the	 dominant	 negative	 Jun	 via	 SpinGAL4	 in	 the	 heterozygous	 Punch	 mutant	
background	 significantly	 rescued	 this	 overgrowth	 (p<0.001,	 ANOVA)	 resulting	 in	
bouton	counts	not	significantly	different	to	WT	controls	(p>0.05,	ANOVA).	
The	same	was	true	when	repeated	with	the	Fos	mutant,	kay1	and	when	reducing	Fos	
activity	 via	 dominant	 negative	 Fos	 expression;	 when	 introduced	 into	 the	
heterozygous	Punch	mutant	background,	 synaptic	 overgrowth	no	 longer	occurred	
resulting	 in	 significantly	 reduced	 bouton	 numbers	 compared	 to	 PunchEY02616A/+	
alone	(Figure	5.12;	p<0.001,	ANOVA)	and	no	significant	difference	compared	to	WT	
controls	 (p>0.05,	 ANOVA).	 No	 significant	 difference	 was	 found	 between	 kay1/+	
alone	and	WT	controls	(p>0.05,	ANOVA).	
This	is	further	evidence	to	suggest	a	reduction	in	Punch	activity	causes	an	oxidative	
stress	burden,	as	 this	overgrowth	 is	mediated	by	and	 is	 completely	dependent	on	
functionally	active	 JNK	signalling,	which	we	have	shown	controls	oxidative	stress-
induced	 synaptic	 overgrowth	 in	 flies	 treated	 with	 DEM	 (see	 section	 3.3.2).	 We	
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believe	 the	 oxidative	 stress	 burden	 is	 caused	 by	 a	 reduction	 in	 BH4,	 which	 is	 a	
potent	 ROS	 scavenger	 acting	 to	 protect	 the	 neuron	 from	 oxidative	 stress.	 If	 so,	




Figure	 5.11	 Reducing	 Jun	 activity	 rescues	 the	 synaptic	 overgrowth	 observed	 in	
heterozygous	Punch	mutants	
A:	 Analysis	 of	 the	 NMJ	 at	 muscle	 6/7	 segment	 A3	 of	 PunchEY02616A/+	 3rd	 instar	 larvae	 revealed	
significantly	 increased	 mean	 normalised	 synaptic	 bouton	 number	 per	 NMJ	 (153±6.5,	 n=22)	
compared	to	WT	controls	(78±2.8,	n=18)(***p<0.001;	ANOVA	with	post	hoc	Bonferroni	correction).	
No	 significant	 difference	 in	 mean	 normalised	 bouton	 number	 per	 NMJ	 is	 found	 when	 comparing	
jraIA109/+	(83±5.6,	n=16)	to	WT	controls	(NS	p>0.05;	ANOVA	with	post	hoc	Bonferroni	correction).	
However,	 significant	 reduction	 in	 mean	 normalised	 bouton	 number	 per	 NMJ	 is	 found	 when	
comparing	 larvae	heterozygous	 for	 both	 the	 jraIA109	 and	PunchEY02616A	mutations	 (82±4.2,	 n=18)	 to	
PunchEY02616A/+	 alone	 (***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 Expressing	 the	
dominant	 negative	 version	 of	 Jun	 (UAS-junDN)	 pre-	 and	 post-synaptically	 (79±3.2,	 n=16)	 via	
SpinGAL4	 in	 the	PunchEY02616A/+	 larvae	also	significantly	reduces	mean	normalised	bouton	number	
per	 NMJ	 when	 compared	 to	 PunchEY02616A/+	 alone	 (***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	
correction).	 Neither	PunchEY02616A/jraIA109	 or	PunchEY02616A/+;	 SpinGAL4>UAS-junDN	 larvae	 displayed	
any	significant	difference	in	mean	normalised	bouton	number	per	NMJ	compared	to	WT	controls	(NS	





Figure	 5.12	 Reducing	 Fos	 activity	 rescues	 the	 synaptic	 overgrowth	 observed	 in	
heterozygous	Punch	mutants	
A:	 Analysis	 of	 the	 NMJ	 at	 muscle	 6/7	 segment	 A3	 of	 PunchEY02616A/+	 3rd	 instar	 larvae	 revealed	
significantly	 increased	 mean	 normalised	 synaptic	 bouton	 number	 per	 NMJ	 (153±6.5,	 n=22)	
compared	to	WT	controls	(78±2.8,	n=18)(***p<0.001;	ANOVA	with	post	hoc	Bonferroni	correction).	
No	 significant	 difference	 in	 mean	 normalised	 bouton	 number	 per	 NMJ	 is	 found	 when	 comparing	
kay1/+	 (74±3.4,	 n=16)	 to	WT	 controls	 (NS	 p>0.05;	 ANOVA	with	 post	 hoc	 Bonferroni	 correction).	
However,	 significant	 reduction	 in	 mean	 normalised	 bouton	 number	 per	 NMJ	 is	 found	 when	
comparing	 larvae	 heterozygous	 for	 both	 the	 kay1	 and	 PunchEY02616A	 mutations	 (97±5,	 n=16)	 to	
PunchEY02616A/+	 alone	 (***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 Expressing	 the	
dominant	negative	version	of	Fos	(UAS-fosDN)	pre-	and	post-synaptically	(75±4,	n=16)	via	SpinGAL4	
in	 the	 PunchEY02616A/+	 mutant	 background	 also	 significantly	 reduces	 mean	 normalised	 bouton	
number	 per	 NMJ	 when	 compared	 to	 PunchEY02616A/+	 alone	 (***p<0.001;	 ANOVA	 with	 post	 hoc	
Bonferroni	 correction).	 Neither	 PunchEY02616A/kay1	 or	 PunchEY02616A/+;	 SpinGAL4>UAS-fosDN	 larvae	
displayed	any	significant	difference	 in	mean	normalised	bouton	number	per	NMJ	compared	to	WT	
controls	 (NS	 p>0.05;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 Error	 bars	 display	 ±SEM.	 B:	




We	 aimed	 to	 determine	 whether	 increased	 expression	 of	 Punch	 could	 offer	
neuroprotection	against	oxidative	stress,	presumably	through	increases	in	BH4.	We	
used	 UAS-Punch	 fly	 lines	 to	 overexpress	 Punch	 pre-	 and	 post-synaptically	 via	
SpinGAL4.	 Two	 UAS-Punch	 lines	 were	 used,	 the	 first	 UAS-PunchA-WT,	 is	 purely	
Punch	 isoform	A;	 the	second	 is	UAS-PunchA-S37E,	a	variation	of	Punch	 isoform	A	
that	 exhibits	 increased	 enzymatic	 activity	 due	 to	 Serine	 37	 being	 modified	 to	
glutamic	 acid	 (Funderburk	 et	 al.,	 2006).	 To	 determine	 their	 functionality	 we	
expressed	both	UAS-Punch	versions	via	 SpinGAL4	 in	 a	heterozygous	PunchEY02616A	
mutant	background,	both	were	able	to	fully	rescue	the	increase	in	synaptic	bouton	
number	seen	in	PunchEY02616A/+	mutants	(Figure	5.13;	p<0.001,	ANOVA).	
Significantly	 increased	 branch	 number	 was	 observed	 in	 PunchEY02616A/+	 mutants	
compared	 to	 WT	 controls	 (Figure	 5.14A;	 p<0.001,	 ANOVA).	 Branch	 number	 was	
significantly	 lower	 when	 expressing	 UAS-PunchA-WT	 in	 the	 heterozygous	 Punch	
mutant	background	(p<0.01,	ANOVA),	however	NMJ	length	was	not	(Figure	5.14B;	
p>0.05,	 ANOVA)	 when	 comparing	 to	 heterozygous	 Punch	 mutants	 alone.	
PunchEY02616A/+	 mutant	 larvae	 in	 this	 experiment	 did	 not	 show	 any	 significant	
increases	 in	 NMJ	 length	 compare	 to	 WT	 controls	 (p>0.05,	 ANOVA),	 further	
suggesting	NMJ	length	is	less	amenable	to	change	than	bouton	and	branch	number.	
Expression	 of	 the	 high	 activity	 UAS-PunchA-S37E,	 in	 the	 heterozygous	 Punch	
mutant	background	rescued	the	increases	in	branch	number	(p<0.001,	ANOVA)	and	
was	 significantly	 lower	 than	 the	 NMJ	 length	 observed	 in	 heterozygous	 Punch	
mutants	alone	(p<0.01,	ANOVA).	
This	shows	that	expression	of	UAS-Punch	is	restoring	the	activity	levels	enough	to	
rescue	 the	 NMJ	 overgrowth	 of	 Punch	 mutants,	 at	 least	 in	 terms	 of	 bouton	 and	
branch	 numbers	 quantified	 from	 NMJ	 analysis,	 confirming	 UAS-PunchA-WT	 and	
UAS-PunchA-S37E	are	functioning	as	expected.		
Protection	 from	 oxidative	 stress	 was	 tested	 by	 treating	 larvae	 expressing	 either	




significant	 difference	 was	 found	 compared	 to	 their	 respective	 controls,	 or	 WT	
controls	(p>0.05,	ANOVA).	
Branch	number	was	also	significantly	increased	in	DEM	treated	larvae	compared	to	
WT	 controls	 (Figure	 5.16A;	 p<0.05,	 ANOVA).	 Treating	 either	 UAS-PunchA-WT	 or	
UAS-PunchA-S37E	 with	 DEM	 did	 not	 result	 in	 any	 significant	 increase	 in	 branch	
number	 compared	 to	 their	 respective	 controls	or	when	 compared	 to	WT	controls	
(p>0.05,	ANOVA).	
No	 significant	 difference	 in	NMJ	 length	 (µm)	was	 found	when	 treating	WT	 larvae	
with	 DEM	 compared	 to	 WT	 controls	 (Figure	 5.16B;	 p>0.05,	 ANOVA).	 Comparing	
DEM	 treated	UAS-PunchA-WT	 and	UAS-PunchA-S37E	 to	 their	 respective	 controls,	
and	 to	 WT	 controls	 revealed	 no	 significant	 difference	 in	 NMJ	 length	 (p>0.05,	
ANOVA).	
Expression	 of	 UAS-Punch	 acts	 to	 protect	 the	 NMJ	 from	 treatment	 with	 DEM,	
increasing	resistance	to	oxidative	stress-induced	synaptic	overgrowth.	
The	ability	 for	both	UAS-Punch	 lines	 to	 restore	Punch	activity	 as	well	 as	 increase	
resistance	 to	 oxidative	 stress-induced	 synaptic	 overgrowth	was	 also	 tested.	 UAS-
PunchA-WT	 and	 UAS-PunchA-S37E	 were	 expressed	 in	 larvae	 via	 SpinGAL4	 in	




WT	 or	 UAS-PunchA-S37E	 in	 the	 heterozygous	 Punch	 mutant	 background	 treated	
with	DEM	displayed	significantly	reduced	synaptic	bouton	number	when	compared	
to	 PunchEY02616A/+	 treated	 with	 DEM	 alone	 (p<0.001,	 ANOVA)	 and	 were	 not	
significantly	 different	 to	WT	 controls	 (p>0.05,	 ANOVA).	 Branch	 number	was	 also	
analysed,	both	WT	and	PunchEY02616A/+	larvae	treated	with	DEM	showed	significant	
increases	 in	 synaptic	 branch	 number	 compared	 to	 WT	 controls	 (Figure	 5.18A;	
p<0.05,	ANOVA).	However,	no	significant	difference	between	PunchEY02616A/+	larvae	
treated	 with	 DEM	 and	 either	 UAS-Punch	 expressed	 in	 the	 heterozygous	 Punch	
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mutant	 background	 treated	 with	 DEM	was	 found	 (p>0.05,	 ANOVA).	 WT	 controls	
also	 showed	 no	 significant	 difference	 to	 either	 UAS-Punch	 expressed	 in	 the	
heterozygous	Punch	mutant	background	treated	with	DEM	(p>0.05,	ANOVA).	
Neither	WT	 nor	 PunchEY02616A/+	 larvae	 treated	 with	 DEM	 showed	 any	 significant	
difference	 in	 NMJ	 length	 (µm)	 when	 compared	 to	 WT	 controls	 (Figure	 5.18B;	





in	 synaptic	 bouton	 number	 in	 Punch	 mutants,	 DEM	 treated	 wild-types	 and	 even	





Figure	 5.13	 Punch	 overexpression	 rescues	 the	 synaptic	 overgrowth	 observed	 in	
heterozygous	Punch	mutants	
A:	 Analysis	 of	 the	 NMJ	 at	 muscle	 6/7	 segment	 A3	 of	 PunchEY02616A/+	 3rd	 instar	 larvae	 revealed	
significantly	 increased	 mean	 normalised	 synaptic	 bouton	 number	 per	 NMJ	 (136±4.8,	 n=15)	
compared	to	WT	controls	(82±3.3,	n=14)(***p<0.001;	ANOVA	with	post	hoc	Bonferroni	correction).	
SpinGAL4	 driven	 expression	 of	 UAS-PunchA-WT	 and	 UAS-PunchA-S37E	 (high	 enzymatic	 activity)	
(81±4.6,	n=15	and	75±3.6,	n=16,	respectively)	 in	a	heterozygous	PunchEY02616A	mutant	background	
show	 no	 significant	 difference	 in	 mean	 normalised	 bouton	 number	 per	 NMJ	 compared	 to	 WT	
controls	 (NS	 p>0.05;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 They	 also	 show	 significant	
reduction	 in	 mean	 normalised	 bouton	 number	 per	 NMJ	 compared	 to	 PunchEY02616A/+	 alone	
(***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 Error	 bars	 display	 ±SEM.	 B:	














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure	 5.17	 Punch	 overexpression	 rescues	 the	 synaptic	 overgrowth	 observed	 in	
heterozygous	Punch	mutants	when	treated	with	DEM	
A:	Analysis	of	the	NMJ	at	muscle	6/7	segment	A3	of	WT	and	PunchEY02616A/+	3rd	instar	larvae	when	
treating	 with	 10mM	 DEM	 during	 development	 revealed	 significantly	 increased	 mean	 normalised	
synaptic	bouton	number	per	NMJ	(114±7,	n=14	and	135±9.4,	n=15,	respectively)	compared	to	WT	
controls	 (82±3.3,	 n=14)(**p<0.01	 and	 ***p<0.001	 respectively;	 ANOVA	with	 post	 hoc	 Bonferroni	
correction).	 SpinGAL4	 driven	 expression	 of	 UAS-PunchA-WT	 and	 UAS-PunchA-S37E	 (high	
enzymatic	activity)	(102±4.1,	n=18	and	90±3.9,	n=16,	respectively)	in	a	heterozygous	PunchEY02616A	
mutant	background	and	treated	with	10mM	DEM	show	no	significant	difference	in	mean	normalised	
bouton	number	 per	NMJ	 compared	 to	WT	 controls	 (NS	p>0.05;	ANOVA	with	 post	 hoc	Bonferroni	
correction).	However,	significant	reduction	in	mean	normalised	bouton	number	per	NMJ	is	observed	





































































































































































































































































































































































































































































































































































































































































































































































































































5.2.6 Punch	 overexpression	 rescues	 highwire-induced	 NMJ	
overgrowth	
The	highwire	 (hiw)	mutation	 causes	NMJ	 overgrowth	 via	 a	 failure	 to	 degrade	 the	
JNK	kinase	kinase,	Wallenda	 (Wnd),	 increasing	 JNK	activity.	As	 shown	previously,	
relieving	 the	 inhibition	 on	 JNK	by	mutating	 the	 negative	 regulator,	puckered,	 also	
causes	 NMJ	 overgrowth	 (see	 section	 3.2.4).	 Taken	 together	 it	 is	 clear	 that	 over	
activation	 of	 JNK	 signalling	 causes	 NMJ	 overgrowth.	 We	 aimed	 to	 determine	
whether	overexpressing	Punch	could	rescue	the	highwire-induced	NMJ	overgrowth.	
First	we	showed	that	expressing	the	newly	created	UAS-Punch,	a	fly	line	developed	
during	 this	 project,	 via	 nSybGAL4	 caused	 no	 significant	 difference	 in	 synaptic	
bouton	 number	 compared	 to	WT	 controls	 (Figure	 5.19;	 p>0.05,	 ANOVA).	 Driving	













Branch	number	 and	NMJ	 length	were	 also	 increased	 in	hiw	mutants	 compared	 to	
WT	(Figure	5.21;	p<0.01,	ANOVA).	Expression	of	UAS-Punch	in	the	hiw	background	
significantly	 reduced	 branch	 number	 (Figure	 5.21A;	 p<0.001,	 ANOVA)	 and	 NMJ	
length	 (Figure	 5.21B;	 p<0.01,	 ANOVA)	 compared	 to	 hiw	 mutants	 alone.	 Neither	
branch	number	nor	NMJ	length	were	significantly	different	to	WT	(p>0.05,	ANOVA).	
This	 may	 highlight	 a	 role	 for	 Punch	 in	 restraining	 JNK	 activity.	 Highwire	 acts	 to	
regulate	 Wallenda,	 and	 in	 its	 absence,	 JNK	 signalling	 becomes	 over	 activated	
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generating	synaptic	overgrowth	in	the	absence	of	oxidative	stress.	Overexpressing	





Figure	 5.19	 Pan-neuronal	 overexpression	 of	 Punch	 rescues	 the	 DEM-	 and	 Punch	
mutant-induced	synaptic	overgrowth	
A:	 Analysis	 of	 the	 NMJ	 at	muscle	 6/7	 segment	 A3	 of	 3rd	 instar	 larvae	 expressing	 UAS-Punch	 via	
nSybGAL4	revealed	no	significant	difference	 in	mean	normalised	synaptic	bouton	number	per	NMJ	
(79±4.5,	 n=16)	 compared	 to	 WT	 controls	 (76±3.7,	 n=16)(NS	 p>0.05;	 ANOVA	 with	 post	 hoc	
Bonferroni	 correction).	 Both	WT	 treated	with	DEM	 (132±9.9,	 n=16)	 and	PunchEY02616A/+	 (151±5.7,	
n=16)	 larvae	show	significant	 increases	 in	mean	normalised	bouton	number	per	NMJ	(***p<0.001;	
ANOVA	with	post	hoc	Bonferroni	correction).	Expressing	UAS-Punch	via	nSybGAL4	in	larvae	treated	
with	 DEM	 (83±5.4,	 n=15)	 or	 in	 a	 PunchEY02616A	 mutant	 background	 (94±7.4,	 n=15)	 showed	 no	
significant	 difference	 compared	 to	 WT	 controls.	 (NS	 p>0.05;	 ANOVA	 with	 post	 hoc	 Bonferroni	
correction).	 Expressing	 UAS-Punch	 via	 nSybGAL4	 in	 both	 larvae	 treated	 with	 DEM	 and	 in	 a	
PunchEY02616A	mutant	background	significantly	reduced	synaptic	bouton	numbers	compared	to	their	








increased	mean	 normalised	 synaptic	 bouton	 number	 per	 NMJ	 (138±5.9,	 n=16)	 compared	 to	WT	
controls	 (76±3.7,	 n=16)(***p<0.001;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 nSybGAL4	
driven	 expression	 of	 UAS-Punch	 in	 the	 highwire	 mutant	 background	 (93±3.7,	 n=15)	 show	 no	
significant	difference	 in	mean	normalised	bouton	number	per	NMJ	 compared	 to	WT	controls	 (NS	
p>0.05;	 ANOVA	 with	 post	 hoc	 Bonferroni	 correction).	 However,	 significant	 reduction	 in	 mean	




















































































































































































































































































































































































































































































































































































































































mechanisms	 that	 act	 to	 protect	 the	 cell.	 Here	 we	 describe	 Punch	 as	 a	
haploinsufficient	mutant	that	causes	severe	NMJ	overgrowth	when	a	single	copy	of	
the	 gene	 is	 mutated.	 We	 have	 shown	 that	 reducing	 Punch	 activity	 causes	 NMJ	
overgrowth	that	can	be	rescued	by	either	relieving	oxidative	stress	or	the	DA	deficit.	
Similar	to	DEM	treatment,	Punch-induced	NMJ	overgrowth	is	mediated	by	Fos	and	
Jun.	 This	 suggests	 the	 overgrowth	 is	 acting	 through	 JNK/AP-1	 signalling.	
Overexpression	of	Punch	offers	neuroprotection	 against	DEM	 treatment,	 reducing	
the	 associated	 overgrowth.	 The	 JNK	 mediated	 NMJ	 overgrowth	 observed	 in	 hiw	
mutants,	is	also	rescued	by	Punch	overexpression,	raising	the	idea	that	Punch	may	
normally	 act	 to	 inhibit	AP-1	during	non-stressed	 conditions.	This	 is	 supported	by	
our	 identification	 of	 Punch	 bound	 to	 Fos	 and	 Jun	 only	 in	 non-stressed	 conditions	





very	 exciting;	 we	 see	 severe	 neuronal	 dysfunction,	 which	 closely	 aligns	 to	
heterozygous	mutations	in	GTPCH1	documented	in	humans.	Both	DOPA-responsive	






2006).	 Our	 observations	 of	 NMJ	 overgrowth	may	 result	 from	 an	 oxidative	 stress	
burden	 in	Punch	mutants.	 BH4	 acts	 as	 a	 potent	ROS	 scavenger,	 and	 inhibiting	 the	
production	of	BH4	 leads	to	 increases	 in	superoxide	anions	(Nakamura	et	al.,	2001,	
Antoniades	et	al.,	2008).	Low	levels	of	BH4	also	lead	to	increased	ROS	production	via	
the	 nitric	 oxide	 synthase	 (NOS)	 pathway	 due	 to	 the	 uncoupling	 of	 electron	 flow	
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during	 nitric	 oxide	 production	 (Bevers	 et	 al.,	 2006).	 Not	 only	 may	 our	 Punch	
mutants	 have	 reduced	 ROS	 scavenging	 ability,	 they	may	 also	 be	 generating	more	
superoxide	 anions	 via	 the	 NOS	 pathway.	 We	 tested	 whether	 our	 Punch	 mutants	
were	 exhibiting	 an	 oxidative	 stress	 burden	 by	 treating	 them	 with	 antioxidant,	
Trolox.	 Trolox	 is	 a	 vitamin	 E	 analogue	 that	 acts	 to	 scavenge	 ROS	 and	 has	 been	
shown	 to	 rescue	 the	 effects	 of	 DEM,	 which	 we	 also	 recapitulate	 in	 this	 chapter,	
where	 Trolox	 treatment	 can	 rescue	DEM-induced	NMJ	 overgrowth	 (Hamad	 et	 al.,	






how	 increased	 Punch	 expression,	 relieves	 oxidative	 stress	 (Kojima	 et	 al.,	 1995,	
Nakamura	et	al.,	2001).	Upon	an	increase	in	hydrogen	peroxide,	BH4	is	synthesised	
via	 an	 increase	 in	 JAK2	 activation,	 suggesting	 this	 protective	mechanism	 directly	
responds	 to	 oxidative	 stress	 (Shimizu	 et	 al.,	 2003).	 Interestingly,	 we	 identify	 the	
protein	Hopscotch	(Hop)	bound	to	Jun	in	DEM-treated	conditions.	Hopscotch	is	the	
Drosophila	 homolog	 of	 JAK	 (Binari	 and	 Perrimon,	 1994).	 This	 may	 indicate	 that	
upon	 an	 increase	 in	 oxidative	 stress,	 Jun	 interacts	 with	 and	 activates	 Hopscotch,	
triggering	 events	 that	 lead	 to	BH4	biosynthesis.	 Combined	with	 the	Punch	mutant	
data,	this	suggests	Punch/BH4	is	critical	in	the	defence	against	oxidative	stress,	and	
that	AP-1	may	modulate	this.	
5.3.3 Punch-induced	 NMJ	 overgrowth	 is	 mediated	 by	 JNK/AP-1	
signalling	










We	 identified	 Fos	 and	 Jun	 bound	 to	 Punch	 during	 non-stressed	 conditions	 and	




Punch	 in	 a	 hiw	 mutant	 background.	 The	 mutant	 hiw	 fails	 to	 degrade	 the	 JNKKK	
wallenda,	 leading	 to	 over-activation	 of	 the	 JNK	pathway	 (Collins	 et	 al.,	 2006).	We	
find	 that	 Punch	 can	 rescue	 this	 hiw	 mutant	 overgrowth,	 suggesting	 Punch	 can	
restrain	the	JNK	signalling	pathway,	and	this	is	likely	to	be	occurring	at	Fos	and	Jun.	
We	showed	that	expressing	Punch	restricts	synaptic	overgrowth,	which	may	occur	
via	 either	 an	 increase	 in	 BH4	 and	 subsequent	 reduction	 in	 oxidative	 stress,	 or	
through	inhibition	of	AP-1;	and	may	be	a	combination	of	both.	
We	believe	 that	 during	 non-oxidatively	 stressed	 conditions,	 Punch	 is	 inhibited	 by	
high	BH4	levels	and	this	inhibitory	complex	restrains	AP-1	to	prevent	excessive	JNK	




object	 of	 a	 redox	 response	 pathway	 (Abate	 et	 al.,	 1990).	 Our	 proposed	 model	
(Figure	5.22)	 aims	 to	 explain	 the	 relationship	between	Punch	and	AP-1.	BH4	may	
scavenge,	or	preferentially	bind	ROS	in	the	vicinity	of	the	AP-1/Punch-BH4	complex.	
This	 releases	 AP-1	 from	 Punch	 as	 BH4	 is	 oxidised	 and	 allows	 AP-1	 to	 transcribe	
genes	 involved	 in	 synapse	 growth	 and	 cellular	 protection.	 Released	 Punch	 then	
induces	the	synthesis	of	BH4,	which	scavenges	ROS,	reducing	the	level	of	oxidative	
stress.	When	 the	 redox	balance	 is	 restored,	we	believe	BH4	 then	 reinhibits	Punch	
into	 the	 inhibitory	 complex	 that	 is	 then	 able	 to	 continue	 restraining	 AP-1.	 This	
mechanism	serves	 to	elegantly	regulate	 JNK	signalling,	a	process	 that	 is	 critical	 to	
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synaptic	plasticity	and	 function.	 It	 is	already	apparent	 that	 the	cell	 acts	 to	 rapidly	
regulate	JNK	signalling,	as	a	transcriptional	target	of	AP-1	is	puckered,	the	negative	
feedback	 regulator	 of	 JNK	which	 inhibits	 JNK	 signalling	 upon	 expression	 (Martín-
Blanco	et	al.,	1998).		
In	Punch	mutants,	we	believe	that	not	only	are	these	larvae	experiencing	oxidative	
stress,	 they	 also	 fail	 to	 restrain	 AP-1.	 This	 explains	 the	 severe	 NMJ	 overgrowth	
compared	to	oxidative	stress	alone	in	DEM	treated	larvae.	
This	could	be	a	critical	finding	in	developing	our	understanding	of	oxidative	stress,	
ageing	 and	 neurodegenerative	 diseases.	 Reductions	 in	 Punch	 activity	 as	 we	 age	
could	lead	to	an	oxidative	stress	burden	and	increases	in	JNK/AP-1	signalling,	both	
of	which	have	been	 implicated	 in	AD	and	PD	 (Peng	and	Andersen,	2003,	Borsello	
and	 Forloni,	 2007,	 Yarza	 et	 al.,	 2015).	 Increased	 JNK	 signalling	 could	 occur	 from	
increases	 in	 oxidative	 stress	 with	 age,	 or	 potentially	 mutations	 in	 Punch	 if	 our	
theory	is	correct.	Recently,	SNP’s	have	been	identified	in	Punch	that	contributes	to	





Figure	 5.22	 Proposed	 mechanism	 for	 the	 interaction	 between	 JNK/AP-1	 and	
Punch/BH4	
Increases	 in	neuronal	ROS	activate	 JNK	signalling	and	AP-1.	 Inhibitory	Punch	restrains	AP-1	until	
BH4	 is	 oxidised	 and	 released.	 Simultaneous	 release	 of	 Punch	 from	 AP-1	 allows	 transcriptional	
activation	 by	 AP-1	 and	 the	 synthesis	 of	 BH4	 by	 stimulatory	 Punch.	 Increased	 BH4	 scavenges	 the	




During	 this	 chapter,	 it	was	 shown	 that	DOPA	decarboxylase	 (Ddc)	mutants	 exhibit	
NMJ	overgrowth,	and	treating	both	these	mutants	and	Punch	mutants	with	L-DOPA	
significantly	 rescues	 this.	 Punch	 and	 Ddc	 are	 involved	 in	 cuticle	 pigmentation	 in	






has	 also	 been	 shown	 that	 mutations	 in	 parkin	 lead	 to	 an	 upregulation	 of	 JNK	
signalling,	which	we	know	is	heavily	involved	in	synaptic	plasticity,	is	required	for	
oxidative	stress-induced	synaptic	overgrowth	and	directly	causes	synaptic	growth	





releasing	 it	 from	 its	 inhibitory	 complex	 that	 acts	 to	 restrain	 JNK.	 This	 allows	 the	
biosynthesis	 of	 BH4	 to	 attempt	 to	 fulfil	 its	 role	 in	 the	 generation	 of	 DA.	 The	 side	




this	 experiment	 using	 a	 different	 DA-deficient	 fly	 line	 to	 ensure	 synaptic	
overgrowth	 occurs	 when	 DA	 is	 low.	 To	 summarise,	 these	 data	 may	 represent	 a	
novel	 role	 for	 DA	 in	 the	 regulation	 of	 JNK	 signalling,	 which	 occurs	 via	 a	 Punch-




We	 have	 identified	 Punch	 as	 a	 haploinsufficient	 mutant,	 of	 which	 exhibit	 severe	
synaptic	overgrowth	due	to	reduced	Punch/BH4.	This	overgrowth	can	be	rescued	by	
treatment	with	Trolox,	L-DOPA,	reducing	oxidative	stress	and	DA	deficit.	Increasing	




























Glutathione	 acts	 as	 a	 cofactor	 for	 the	 neutralisation	 of	 hydrogen	 peroxide	 via	
glutathione	 peroxidase	 and	 peroxiredoxin,	 as	 well	 as	 exhibiting	 its	 own	 ROS	
scavenging	 activity	 (Marí	 et	 al.,	 2009,	 Bhabak	 and	 Mugesh,	 2010).	 Glutathione	
therefore	is	a	key	survival	antioxidant	in	the	mitochondria,	and	DEM	acts	to	deplete	
its	 functional	 form.	This	 is	made	 apparent	 by	 the	 significant	 synaptic	 overgrowth	




which	 concentration	 we	 believe	 is	 the	 point	 where	 glutathione	 is	 reduced	
significantly,	 causing	 a	 deficit	 in	 the	 antioxidant	 defence	 of	 the	mitochondria	 and	
synaptic	 overgrowth.	 DEM	 does	 not	 act	 to	 increase	 ROS	 generation;	 it	 merely	
depletes	 the	 cells	 capacity	 to	 remove	 the	 ROS	 it	 generates	 naturally.	 This	 initial	
study	 shows	 that	 oxidative	 stress	 causes	 synaptic	 overgrowth	 in	 the	 larval	 NMJ.	
Oxidative	 stress-induced	 synaptic	 overgrowth	 has	 been	 shown	 previously	 in	
spinster	 loss	 of	 function	 mutants	 and	 larvae	 raised	 on	 the	 mitochondrial	 poison,	
paraquat	 (Milton	 et	 al.,	 2011).	 Furthermore,	 mutations	 in	 parkin,	 which	 induce	
mitochondrial	dysfunction	and	resultant	oxidative	stress,	have	been	shown	to	cause	
synaptic	 overgrowth	 (Vincent	 et	 al.,	 2012).	 This	 highlights	 the	 importance	 of	 the	
cellular	 antioxidant	 system	 and	 also	 shows	 that	 redox	 balance	 is	 essential	 for	
maintaining	 a	 healthy	 cellular	 environment.	 The	 use	 of	 DEM	 to	 induce	 oxidative	





likely	 to	 be	 occurring	 through	 increased	 hydrogen	 peroxide	 scavenging	 by	 this	
vitamin	E	analogue	and	antioxidant	(Hamad	et	al.,	2010).	Expressing	UAS-Catalase	
via	SpinGAL4	in	DEM-treated	larvae	and	analysing	bouton	number	may	support	this	







6.3 DEM-induced	 synaptic	 overgrowth	 is	 mediated	 by	 JNK/AP-1	
signalling	
Previous	work	published	from	the	Sweeney	lab	demonstrated	that	oxidative	stress-
induced	 synaptic	 overgrowth	 is	 mediated	 by	 JNK/AP-1	 signalling	 (Milton	 et	 al.,	
2011).	 They	 described	 a	 context	 dependent	 activation	 of	 AP-1,	 where	 putative	
cytosolic	 oxidative	 stress	 activates	 a	 Fos:Fos	 homodimer	 of	 AP-1	 and	 Jun	 is	 not	
required.	However,	in	the	synaptic	overgrowth	caused	by	treatment	with	paraquat,	
Jun	 inhibition	 was	 able	 to	 rescue	 this	 overgrowth.	 We	 show	 during	 this	
investigation	that	mitochondrial	oxidative	stress	via	DEM	treatment	causes	synaptic	
overgrowth	that	requires	Fos	and	Jun,	as	well	as	ASK1.	By	reducing	the	activity	of	
Fos,	 Jun	 and	 ASK1	 we	 can	 ameliorate	 the	 synaptic	 overgrowth	 following	 DEM	
treatment.	 This	 suggests	 that	 Jun	 plays	 a	 role	 in	 responding	 to	 mitochondrial	
oxidative	 stress,	 but	 has	 a	 lesser	 role	 in	 cytosolic	 oxidative	 stress;	 an	 exciting	
development	in	uncovering	the	role	of	Fos	and	Jun.	This	falls	in	line	with	previous	







redox	 status	 suggests	 that	 they	 serve	 different	 functions	 and	 would	 likely	 have	
different	transcriptional	outputs	following	activation.	It	 is	already	well	established	
that	various	signalling	pathways	can	activate	JNK	signalling,	specifically	Fos	which	
can	be	phosphorylated	 at	 distinct	 sites	 by	overlapping	 JNK	or	ERK	 signalling	 in	 a	
context	 dependent	 manner	 (Ciapponi	 et	 al.,	 2001).	 This	 produces	 different	
signalling	 outcomes	 where	 ERK	 activation	 of	 Fos	 enables	 its	 role	 in	 wing	 vein	
formation	and	eye	development,	the	latter	of	which	is	also	regulated	in	part	by	JNK	





The	phosphorylation	 code	of	 Fos	 and	 Jun	may	hold	 critical	 information	 into	 their	
function,	 and	 identifying	 this	 is	 imperative	 if	 we	 are	 to	 fully	 characterise	 the	
neuronal	 role	 of	 Fos	 and	 Jun	 in	 the	 oxidative	 stress	 response.	We	would	wish	 to	
bolster	 this	 finding	 in	 future	 by	 the	 use	 of	 ROS	 sensitive	 fluorescent	 proteins	 to	
image	 and	 localise	 more	 precisely	 the	 source	 of	 ROS	 in	 neurons	 undergoing	
oxidative	stress.		




Other	 such	 upstream	 JNK	 kinases	 that	 have	 been	 shown	 to	 mediate	 overgrowth	
include	wallenda	(Wnd)	and	TGF-β-activated	kinase	1	(TAK1).	Previous	research	in	
the	Sweeney	lab	has	identified	a	role	for	the	JNKKK	TAK1	in	mediating	the	synaptic	
overgrowth	 observed	 in	 Rab8	 mutants,	 which	 are	 thought	 to	 occur	 due	 to	
accumulations	 of	 plenty-of-SH3s	 (POSH)	which	 induce	 ectopic	 activation	 of	 TAK1	
and	 elevated	 JNK	 signalling	 (West	 et	 al.,	 2015).	 Furthermore	 they	 show	
overexpression	 of	 TAK1	 also	 produces	 a	 synaptic	 overgrowth	 and	 that	 inhibiting	
Fos	 can	 reduce	 the	 Rab8-induced	 synaptic	 overgrowth.	 Similar	 observations	 for	
elevated	 JNK	 signalling	 in	 synaptic	 overgrowth	 are	 observed	 in	 highwire	 (hiw)	
mutants.	The	MAPKKK,	Wnd	is	known	to	activate	JNK	signalling	and	is	degraded	by	
the	actions	of	hiw.	Synaptic	overgrowth	occurs	in	hiw	mutants	that	fail	to	degrade	
Wnd,	 leading	 to	 over	 activation	 of	 upstream	 JNK	 kinases,	 which	 can	 be	 rescued	
through	 inhibition	 of	 Fos	 but	 not	 Jun	 (Collins	 et	 al.,	 2006).	 These	 investigations	
describe	a	clear	role	for	upstream	JNK	kinases	in	synaptic	overgrowth	and	our	work	
with	ASK1	is	in	keeping	with	this,	appearing	to	regulate	downstream	JNK	signalling	
when	 activated	 by	 mitochondrial	 oxidative	 stress.	 Also	 shown	 in	 these	
investigations	 are	 clear	 context	 dependencies	 for	 Fos,	 which	 appears	 to	 regulate	
synaptic	 growth	downstream	of	both	TAK1	and	Wnd	without	 the	action	of	 Jun.	 It	
would	 be	 interesting	 to	 determine	 whether	 neuronal	 overexpression	 of	 ASK1	
causes	 synaptic	 overgrowth	 and	 whether	 neuronal	 Jun	 is	 required	 for	 such	





or	 when	 the	 mitochondria	 are	 disrupted	 (Milton	 et	 al.,	 2011,	 Vincent,	 2013).	
However,	Jun	does	not	have	a	role	when	synaptic	overgrowth	occurs	due	to	putative	
cytosolic	oxidative	stress	as	seen	in	spinster	mutants,	or	when	various	upstream	JNK	
activators	 are	 misregulated	 (Collins	 et	 al.,	 2006,	 Milton	 et	 al.,	 2011,	 West	 et	 al.,	
2015).	
6.4 Identifying	 the	 binding	 partners	 of	 Fos	 and	 Jun	 during	
mitochondrial	oxidative	stress	
Our	 investigation	 into	 the	 context-dependent	 forms	 of	 AP-1	 activated	 under	
conditions	of	oxidative	stress	started	with	 identifying	binding	partners	of	Fos	and	
Jun;	and	how	these	might	change	when	we	induce	an	oxidative	stress	burden.	It	was	
shown	 that	 NTAP-tagging	 Fos	 and	 Jun	 did	 not	 alter	 function,	 as	 the	 transgenes	








activating	 Fos	 and	 Jun	 during	 the	 processes	 of	 learning	 and	 memory.	 Given	 the	
energetic	 requirement	 for	 learning	 and	 memory	 formation	 via	 energy	 producing	
mitochondrial	function,	the	proteins	we	identified	may	highlight	how	neuronal	Fos	
and	 Jun	mediate	 learning	 and	memory	 responses.	We	 suggest	 that	 the	 identified	
proteins	are	 likely	 to,	at	 least	 in	part,	 facilitate	 the	 formation	of	memories	 in	both	
mammals	and	Drosophila.	
It	 would	 be	 very	 interesting	 to	 repeat	 this	 experiment	 but	 generate	 cytosolic	
oxidative	stress	and	determine	how	the	binding	partners	change	and	whether	this	
helps	 explain	 the	 context	 dependant	 forms	 of	 AP-1.	 The	 protocol	 may	 have	 to	





from	 the	 larvae	 or	 fly	 before	 homogenising.	 This	 would	 be	 an	 extremely	 time	
consuming	task	however,	so	the	number	of	required	brains	would	likely	be	reduced,	






sample,	 as	 phosphorylated	 segments	 of	 digested	 proteins	 are	 identified	 far	 less	
frequently	 following	 LC-MS.	 This	 may	 help	 uncover	 how	 context	 and	 code	 is	
conferred	on	Fos/Fos	homodimers	and	Fos/Jun	heterodimers.		
6.5 Reducing	Punch	activity	causes	synaptic	overgrowth	
We	 have	 shown	 that	 haploinsufficient	 Punch	 mutants	 exhibit	 severe	 synaptic	
overgrowth	 and	 that	 reducing	 the	 activity	 of	 Punch	 in	 the	 muscle	 or	 synapse	
produces	the	same	results.	This	is	an	exciting	discovery	as	heterozygous	mutations	
in	 the	 GTPCH1	 gene,	 the	 human	 orthologue	 of	 Punch,	 causes	 DOPA-responsive	
dystonia,	a	severe	movement	disorder	which	can	predispose	the	patient	to	PD	later	
in	 life	 (Mencacci	 et	 al.,	 2014).	 Single	 nucleotide	 polymorphisms	 have	 also	 been	
identified	in	Punch,	which	contributes	to	the	onset	of	PD	(Nalls	et	al.,	2014).	Punch	
is	 responsible	 for	 the	 production	 of	 BH4,	 an	 essential	 cofactor	 in	 a	 variety	 of	






oxidative	 stress-induced	 synaptic	 overgrowth,	 as	 following	 Trolox	 treatment;	 we	
were	able	to	rescue	the	overgrowth.	We	also	demonstrated	that	overexpression	of	
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Punch	 can	 protect	 against	 DEM-induced	 synaptic	 overgrowth.	 This	 indicates	 that	
BH4	may	be	a	critical	regulator	of	ROS	within	the	neuron,	offering	neuroprotection	
to	 oxidative	 stress,	 though	 a	 direct	 determination	 of	 BH4	 concentrations	 in	 these	
experiments	would	solidify	this	finding.	However,	it	has	been	found	that	high	levels	
of	BH4	may	in	fact	be	toxic	to	dopaminergic	neurons,	which	may	be	mediated	by	DA.	
It	 is	 believed	 that	 BH4	 during	 the	 hydrolysis	 of	 phenylalanine,	 forms	 several	
intermediates	that	may	generate	hydrogen	peroxide	and	the	auto-oxidation	of	BH4	




peroxide	production,	 thereby	 linking	 the	 role	of	BH4	 in	DA	 synthesis	 to	 increased	
ROS	 following	 the	 DA	 production	 and	 catabolism	 (Maker	 et	 al.,	 1981).	Whilst	we	
have	shown	BH4	to	protect	against	oxidative	stress	in	the	motor	neurons,	it	may	be	
possible	 that	 in	 dopaminergic	 neurons,	 elevated	 levels	 of	 BH4	 are	 toxic.	 This	
suggests	 that	overexpression	of	Punch	 in	dopaminergic	neurons	would	also	cause	
toxicity	or	 lethality	due	 to	 the	 increased	 synthesis	 of	BH4,	which	may	be	 a	 critical	
future	 experiment	 in	 determining	 the	 context	 dependency	 of	 Punch.	 We	 treated	
Punch	mutants	with	 L-DOPA,	which	 alleviated	 the	 observed	 synaptic	 overgrowth.	
Intriguingly,	 increasing	 DA	 has	 been	 shown	 to	 increase	 ROS	 generation	 and	 in	
Punch	 mutants	 that	 are	 already	 experiencing	 oxidative	 stress,	 we	 reduce	 the	
overgrowth.	 This	 further	 indicates	 that	 DA	 and	 BH4	 toxicity	 may	 be	 context	
dependent.	
Treating	 SOD1	 mutants	 with	 L-DOPA	 did	 not	 rescue	 synaptic	 overgrowth,	
suggesting	 that	 to	 some	 degree,	 a	 lack	 of	 DA	 is	 contributing	 to	 the	 severe	
overgrowth	 observed	 in	 Punch	 mutants.	 We	 tested	 this	 further	 using	 the	 DA	
deficient	 DOPA	 decarboxylase	 (Ddc)	mutants.	 A	 reduction	 in	Ddc	 causes	 synaptic	
overgrowth,	 though	not	as	severe	as	Punch	mutants.	Whilst	 this	 is	 interesting,	we	
have	 not	 ruled	 out	 the	 possibility	 that	 Ddc	 mutants	 are	 experiencing	 oxidative	
stress,	 and	 it	will	 be	 critical	 to	 assess	 this,	 simply	by	 treating	 these	mutants	with	
Trolox	 and	 observing	 subsequent	 changes	 in	 synaptic	 growth.	 It	 has	 previously	
been	shown	that	mutations	in	parkin	and	subsequent	disruption	of	DA	production	
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causes	 increases	 in	 JNK/AP-1	 signalling	 which	 may	 contribute	 to	 the	 synaptic	




and	 generating	 oxidative	 stress,	 which	 may	 increase	 JNK	 signalling	 further	 in	
addition	 to	relieving	 the	suppression	of	 JNK	 (Vincent	et	al.,	2012).	Further	 testing	
requires	 a	 DA	 deficient	 fly	 line	 to	 be	 investigated	 that	 does	 not	 result	 in	
mitochondrial	 dysfunction	 and	 oxidative	 stress.	 Several	 fly	 lines	 would	 fit	 these	
criteria,	and	they	involve	the	manipulation	of	Tyrosine	Hydroxylase	(TH),	which	is	
one	 of	 the	 primary	 enzymes	 involved	 in	 DA	 synthesis	 that	 requires	 BH4	 as	 a	
cofactor.	 By	 using	 either	 a	 UAS-TH-RNAi	 line	 or	 the	 TH	 mutant,	 ple4,	 we	 could	
disrupt	 DA	 synthesis	without	 directly	 affecting	 the	mitochondria	 in	 a	mechanism	




mutations,	 are	 indeed	 subject	 to	 the	 combinatorial	 effects	 of	 oxidative	 stress	 and	
reductions	in	DA	levels.	However,	a	potential	confounding	factor	may	arise	in	these	
experiments.	 If	 DA	 reduces	 or	 restrains	 neuronal	 activity	within	 networks	 of	 the	
CNS,	 then	 the	 increased	 metabolism	 of	 the	 CNS	 in	 the	 absence	 of	 DA	 due	 to	




cause	 synaptic	 overgrowth.	 Specifically,	 it	 would	 be	 useful	 to	 express	 Punch	 in	 a	
Dad	 mutant	 background.	 We	 demonstrated	 that	 reducing	 the	 activity	 of	 Dad,	 an	









background.	Whilst	we	demonstrated	 that	Punch	could	 rescue	 the	effects	of	DEM,	
this	was	in	a	system	where	the	antioxidant	defence	was	fully	functional.	It	would	be	
useful	 to	 show	that	 increased	Punch/BH4	could	bolster	 the	defence	of	 flies	with	a	
debilitated	 antioxidant	 system.	 This	 would	 indicate	 whether	 Punch	 could	
compensate	 for	 this	 loss	 of	 antioxidants	 as	 well	 as	 increase	 resistance	 to	 ROS.	
Limitations	 in	 our	 studies	 showing	 the	 overexpression	 of	 Punch	 can	 reduce	
oxidative	stress-induced	synaptic	overgrowth	are	that	we	are	yet	to	show	whether	
this	rescue	 is	a	result	of	reducing	ROS	via	 increased	BH4	production	or	 increasing	




To	 further	 characterise	 the	 Punch	 mutations,	 it	 would	 be	 ideal	 to	 determine	
whether	the	synapses	are	experiencing	physiological	defects.	Because	BH4	is	vital	in	
the	production	of	DA	and	serotonin,	it	is	plausible	that	in	Punch	mutants	there	may	
be	 issues	 with	 neuronal	 signalling.	 Increased	 neuronal	 signalling	 is	 thought	 to	
promote	synaptic	growth,	and	dopamine	has	been	shown	to	reduce	neuronal	firing	
(Cooper	 and	 Neckameyer,	 1999,	 Berke	 et	 al.,	 2013).	 A	 reduction	 in	 Punch	 may	
reduce	 levels	 of	 DA	 and	 its	 dampening	 effects	 on	 neuronal	 networks	 in	 the	 fly,	
leading	 to	 increased	 neuronal	 activity	 and	 growth	 promotion	 leading	 to	 larger	
numbers	of	synaptic	boutons.	In	this	context,	synaptic	growth	may	also	be	mediated	
by	 increased	 ROS	 generated	 by	 the	 energetic	 demand	 made	 on	 neuronal	
mitochondria	 with	 increased	 neuronal	 activity.	 It	 may	 be	 useful	 to	 measure	 the	
excitation	 junction	 potentials	 of	 Punch	 mutant	 NMJ’s	 as	 measures	 of	 neuronal	
activity;	this	may	help	explain	the	severity	of	the	phenotype.	
Our	studies	have	mainly	 focused	on	 the	role	of	Punch/BH4	 in	maintaining	cellular	
redox	 balance	 and	 the	 synthesis	 of	 neurotransmitters;	 however,	 we	 have	 not	
currently	 looked	 at	 how	 it	 relates	 to	NOS	 signalling.	 It	 is	 known	 that	 nitric	 oxide	
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(NO)	 has	 a	 role	 in	 synaptic	 plasticity,	 neuronal	 transmission	 and	 the	 immune	
response	 (Murphy,	2000,	Esplugues,	2002).	BH4	 is	an	 important	 cofactor	 for	NOS.	
With	 the	 roles	 of	 NO	 in	mind	 it	 would	 be	 essential	 to	 investigate	 how	 JNK/AP-1	
signalling	 is	 affected	 by	 NOS	 signalling.	 Important	 data	 could	 be	 obtained	 by	
inhibiting	NOS	signalling	 in	 the	Drosophila	 larvae,	 and	 then	analysing	 the	NMJ	 for	
AP-1	dependent	growth.	This	could	be	achieved	by	treating	larvae	with	L-NAME,	a	
potent	 NOS	 inhibitor.	 This	 may	 help	 us	 determine	 whether	 disruption	 in	 NO	
production	is	contributing	to	the	synaptic	overgrowth	observed	in	Punch	mutants.	It	
is	proposed	that	a	reduction	of	BH4	leads	to	the	uncoupling	of	NOS	during	its	redox	





We	 identified	Punch	 in	 our	 purification	 of	 proteins	 bound	 to	 both	 Fos	 and	 Jun	 in	
control	 conditions,	 but	 not	when	 inducing	 oxidative	 stress	 by	 treating	with	DEM.	
This	 suggests	 that	 Punch	may	 have	 a	 role	 in	 regulating	 neuronal	 AP-1	 activity	 in	
response	 to	 oxidative	 stress.	 We	 first	 determined	 that	 the	 Punch-mediated	
overgrowth	requires	Fos	and	Jun,	which	adds	weight	to	our	previous	findings,	that	
Punch	 mutants	 are	 subject	 to	 oxidative	 stress	 and	 that	 their	 severe	 synaptic	
overgrowth	 is	a	result	of	highly	over	activated	 JNK/AP-1	signalling.	 It	 is	proposed	
that	Punch/BH4	are	acting	to	restrain	AP-1	 in	a	redox-regulated	manner.	Previous	
studies	 have	 shown	 that	 both	 JNK	 and	 ASK1	 are	 regulated	 by	 redox	 sensitive	
mechanisms.	 JNK	 is	 restrained	 by	 the	 binding	 of	 GSTp	 during	 non-oxidising	




mitochondria,	 redox	 sensitive	 cysteines	 of	 reduced	 Trx	 are	 oxidised,	 displacing	
ASK1	allowing	 for	 its	activation	 (Saitoh	et	al.,	1998,	Zhang	et	al.,	2004).	What	our	
data	 may	 represent	 is	 the	 uncovering	 of	 additional	 redox-sensitive	 regulatory	
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mechanisms	 that	 serve	 to	 finely	 tune	 the	 activity	 of	 JNK	 signalling	 in	 response	 to	
oxidative	 stress,	 specifically	 by	 the	 restraining	 action	 of	 Punch/BH4	 upon	 AP-1	
during	non-oxidising	conditions.	
It	is	critical	that	future	work	defines	whether	Punch	binds	directly	to	Fos	or	Jun	and	
that	 this	 interaction	 is	 fully	 characterised.	 An	 initial	 proposed	 experiment	 is	 to	
repeat	the	pull	down	and	purification	of	bound	proteins,	but	this	time	to	use	Punch	






of	 Punch	 to	 Jun.	 However,	 Punch	 also	 seems	 to	 bind	 non-specifically	 to	 our	 GST	
control	 in	a	non-dose	responsive	manner.	We	are	currently	working	 to	refine	 this	
experiment,	though	initial	results	prove	promising.	
6.7 Punch	may	restrain	AP-1	signalling	
We	 theorised	 that	 Punch,	 in	 an	 inhibitory	 complex	 with	 BH4	may	 actually	 act	 to	
restrain	 Fos	 and	 Jun	 activity	 during	 non-stressed	 conditions.	Upon	 an	 increase	 in	
ROS,	BH4	is	oxidised,	releasing	Punch	from	the	inhibitory	complex	that	is	restraining	
AP-1.	 Punch	 is	 then	 able	 to	 synthesise	 BH4	 to	 combat	 the	 increase	 in	 oxidative	
stress,	and	AP-1	 is	 free	 to	activate	 JNK	signalling	until	 the	ROS	 levels	are	reduced	
and	inhibitory	Punch/BH4	can	restrain	AP-1	again.	We	believe	Punch	is	restraining	
AP-1	 activity,	 because	 overexpression	 of	 Punch	 rescues	 synaptic	 overgrowth	
observed	 in	 Highwire	 mutants,	 which	 arises	 as	 a	 result	 of	 increased	 JNK/AP-1	
signalling	 and	 not	 oxidative	 stress.	 Further	 work	 here	 is	 needed	 to	 measure	 the	
levels	 of	 Fos/Jun	 in	 the	 motor	 neuron	 of	 hiw	 mutants	 before	 and	 after	 Punch	
overexpression.	 However,	 our	 current	 work	 does	 suggests	 the	 role	 of	 Punch	 in	
synaptic	 plasticity	 extends	 beyond	maintaining	 the	 cellular	 redox	 balance,	 and	 is	







This	 model	 may	 also	 incorporate	 responses	 to	 low	 levels	 of	 DA.	 Though	 further	
work	 is	needed,	we	have	shown	that	DA	deficient	Ddc	mutants	display	overgrown	
synapses.	 It	 is	 possible	 that	 a	 feedback	 mechanism	 exists	 that	 increases	 JNK	
signalling	and	AP-1	activation,	when	DA	levels	are	low.	In	the	Ddc	mutants,	chronic	
low	 DA	 may	 cause	 over	 activation	 of	 JNK/AP-1	 and	 subsequent	 synaptic	




It	 has	 been	 shown	 that	 increased	 JNK	 activity	 contributes	 to	 cell	 death	 in	 PD	 via	
activation	 of	 proapoptotic	 pathways	 (Peng	 and	 Andersen,	 2003).	 Therefore,	 a	
mechanism	 that	 appears	 neuroprotective	 in	 our	 model	 could	 rapidly	 shift	 to	 be	
detrimental	if	misregulation	occurs.	Reductions	in	Punch	activity,	increases	in	ROS	
and	 possibly	 decreases	 in	 DA	 synthesis	 may	 relieve	 the	 restraint	 between	
Punch/BH4	and	AP-1,	acting	to	increase	JNK	signalling,	which	may	cause	apoptosis	
and	cell	death	in	dopaminergic	neurons	(Wang	et	al.,	2004).	Our	Punch	mutant	data	
would	 support	 this,	 as	 we	 observe	 severe	 synaptic	 overgrowth,	 which	 is	 often	
associated	 with	 dysfunction	 and	 disease.	 Disrupting	 Fos	 and	 Jun	 activity	 rescues	
this	 dysfunction,	 which	 has	 also	 been	 shown	 by	 a	 study	 using	 the	 JNK	 inhibitor	
SP600125,	 which	 reduces	 Jun	 phosphorylation	 and	 activity	 and	 increases	 the	
protection	 against	 dopaminergic	 cell	 death	 (Wang	 et	 al.,	 2004).	 Our	 work	 may	
eventually	contribute	to	the	understanding	and	development	of	novel	strategies	for	
halting	 the	 progression	 of	 PD,	 and	 possibly	 other	 neurodegenerative	 diseases	
through	manipulations	of	JNK/AP-1	activity.		
Much	work	 is	 required	 to	 fully	 elucidate	 this	 system.	 It	 is	 still	 unclear	 how	AP-1	
mediates	synaptic	plasticity	in	response	to	oxidative	stress	and	where	Punch/BH4	
plays	 a	 role.	 However,	 we	 believe	 that	 our	 findings	 are	 of	 great	 importance,	
demonstrating	 what	 appears	 to	 be	 a	 critical	 redox-sensitive	 regulatory	 node	
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2. Oxidative	 stress-induced	 synaptic	 overgrowth	 is	 mediated	 by	 JNK/AP-1	
signalling	
	
























WT	0mM	DEM	 78.389	±	2.776	 74892	±	1956	 NA	 18	
WT	1mM	DEM	 84.125	±	4.309	 81306	±	3085	 78.924	±	4.831	 16	
WT	3mM	DEM	 90.533	±	4.552	 84375	±	3014	 80.360	±	2.607	 15	
WT	10mM	DEM	 114.055	±	3.812	 70958	±	2744	 123.923	±	6.898	 18	
WT	30mM	DEM	 119.188	±	5.666	 74900	±	3597	 122.724	±	7.566	 16	
	
Figure	3.3.	Trolox	treatment	rescues	DEM-induced	increases	in	bouton	number	
WT	Control	 79.5	±	2.387	 79675	±	2596	 NA	 17	
WT	10mM	Trolox	 79.875	±	3.927	 86712	±	2381	 73.684	±	3.551	 16	
WT	10mM	DEM	 128.063	±	6.242	 84310	±	3997	 125.779	±	9.456	 16	
WT	10mM	DEM	+	




WT	Control	 78.438	±	3.679	 76008	±	3109	 NA	 16	
WT	10mM	DEM	 117.769	±	4.756	 76005	±	2316	 118.741	±	5.462	 13	
SOD1n1/SOD1n64	Control	 123.313	±	5.5	 79215	±	2052	 120.225	±	7.162	 16	
SOD1n1/SOD1n64	10mM	
DEM	 119.688	±	4.25	 73664	±	1625	 124.761	±	6.027	 16	
	
Figure	3.6.	Loss	of	puckered	causes	synaptic	overgrowth	by	relieving	JNK	inhibition	
WT	control	 76.936	±	2.254	 85425	±	1982	 NA	 16	
WT	10mM	DEM	 114.933	±	3.985	 73719	±	2316	 120.945	±	6.771	 15	
pucE69/+	Control	 119.625	±	5.570	 83700	±	3788	 126.559	±	9.060	 16	
pucE69/+	10mM	DEM	 134.375	±	7.253	 82956	±	2345	 138.746	±	6.854	 16	
	
Figure	3.7.	Loss	of	Dad	causes	synaptic	overgrowth	by	relieving	TGF-β	inhibition	
WT	control	 76.936	±	2.254	 85425	±	1982	 NA	 16	
WT	10mM	DEM	 114.933	±	3.985	 73719	±	2316	 120.945	±	6.771	 15	
Dadlacz/+	Control	 151.625	±	5.694	 80936	±	1574	 160.506	±	6.074	 16	




WT	control	 79.75	±	2.387	 79675	±	2596	 NA	 16	
WT	10mM	Trolox	 79.875	±	3.927	 86712	±	2381	 73.684	±	3.55	 16	
SOD1n1/SOD1n64	control	 107.857	±	6.181	 78697	±	5381	 111.738	±	4.945	 14	
SOD1n1/SOD1n64	10mM	
Trolox	 82.125	±	2.908	 79917	±	2625	 83.206	±	4.003	 16	
pucE69/+	control	 119.625	±	5.569	 83700	±	3787	 118.041	±	8.45	 16	






WT	Control	 66.848	±	2.222	 60432	±	1739	 NA	 46	
WT	10mM	DEM	 91.8	±	3.110	 54800	±	1579	 104.094	±	4.682	 35	
SpinGAL4>UAS-fosDN	
Control	 77.481	±	2.752	 81059	±	2439	 59.719	±	3.356	 27	
SpinGAL4>UAS-fosDN	
10mM	DEM	 73.8	±	2.686	 84807	±	2078	 53.553	±	2.425	 30	
SpinGAL4>UAS-junDN	
Control	 90.192	±	3.710	 89441	±	2979	 62.303	±	3.003	 26	
SpinGAL4>UAS-junDN	
10mM	DEM	 97.267	±	3.946	 85150	±	2337	 70.707	±	3.829	 30	
SpinGAL4>UAS-ask1DN	
Control	 88.2	±	5.238	 79963	±	2859	 69.277	±	5.249	 25	
SpinGAL4>UAS-ask1DN	
10mM	DEM	 91.714	±	4.420	 79967	±	2236	 70.731	±3.818	 28	
	
Figure	5.1.	Heterozygous	Punch	mutants	exhibit	synaptic	overgrowth	
WT	 78.176	±	2.606	 82162	±	3434	 NA	 34	
PunchEY02616A/CS	 144.136	±	6.812	 77676	±	2415	 152.790	±	6.516	 22	
PunchEY02616A/w1118	 136.182	±	6.319	 77692	±	2098	 144.853	±	6.744	 22	
Punchr1/CS	 139.684	±	5.554	 81548	±	1669	 141.867	±	6.343	 19	
Punchr1/w1118	 123	±	4.975	 70168	±	1852	 144.501	±	5.331	 14	




WT	 78.176	±	2.606	 82162	±	3434	 NA	 34	
SpinGAL4>UAS-Punch-
RNAI	 135.938	±	6.3	 82332	±	2158	 137.283	±	7.922	 16	
elavGAL4>UAS-Punch-
RNAI	 131.75	±	6.281	 75077	±	3423	 146.683	±	8.570	 12	
MHCGAL4>UAS-Punch-




WT	 83.125	±	3.784	 88647	±	3263	 NA	 16	
PunchEY02616A/+	 140.813	±	6.280	 80153	±	3158	 158.173	±	8.277	 16	
Punchr1/+	 121.875	±	6.150	 76677	±	2561	 142.211	±	7.730	 16	
Df(2R)Exel6072/+	 129.25	±	4.850	 81024	±	2562	 143.163	±	6.240	 16	




WT	 83.125	±	3.784	 88647	±	3263	 NA	 16	
Df(2R)Exel6072/PunchEY
02616A	 101.714	±	5.885	 74172	±	3676	 123.094	±	7.008	 14	
Df(2R)Exel6072/Punchr1	 131	±	4.6	 84275	±	2386	 138.954	±	5.707	 14	
Df(2R)ED3791/PunchEY0
2616A	 114.286	±	4.511	 67920	±	1757	 149.806	±	6.263	 14	






WT	Control	 78.176	±	2.606	 82162	±	3434	 NA	 34	
WT	10mM	DEM	 119.539	±	4.245	 85479	±	1623	 116.170	±	4.781	 26	
PunchEY02616A/+	Control		 144.136	±	6.812	 77676	±	2415	 152.790	±	6.516	 22	
PunchEY02616A/+	10mM	
DEM	 177.926	±	5.071	 91595	±	2505	 162.198	±	6.108	 27	
Punchr1/+	Control	 139.684	±	5.554	 81548	±	1669	 141.867	±	6.343	 19	
Punchr1/+	10mM	DEM	 133.067	±	7.397	 72574	±	2499	 152.053	±	8.616	 15	
SpinGAL4>UAS-Punch-
RNAi	 135.938	±	6.3	 82332	±	2158	 137.283	±	7.922	 16	
SpinGAL4>UAS-Punch-
RNAi	10mM	DEM	 136.15	±	4.725	 82316	±	2428	 137.744	±	5.801	 20	
elavGAL4>UAS-Punch-
RNAi	 131.75	±	6.281	 75077	±	3423	 146.683	±	8.570	 12	
elavGAL4>UAS-Punch-
RNAi	10mM	DEM	 141.875	±	6.381	 78649	±	1981	 147.866	±	6.030	 16	
MHCGAL4>UAS-Punch-
RNAi		 106	±	5.834	 68126	±	2681	 129.974	±	8.042	 15	
MHCGAL4>UAS-Punch-




WT	Control	 79.5	±	2.387	 79675	±	2596	 NA	 17	
WT	10mM	Trolox	 79.875	±	3.927	 86712	±	2381	 73.684	±	3.551	 16	
PunchEY02616A/+	Control	 135.938	±	5.568	 76008	±	2424	 143.438	±	5.379	 16	
PunchEY02616A/+	10mM	
Trolox	 99.563	±	5.675	 85354	±	2020	 93.335	±	5.301	 16	
Punchr1/+	Control	 121.875	±	6.149	 76677	±	2561	 127.819	±	6.948	 16	




WT	Control	 79.5	±	2.387	 79675	±	2596	 NA	 17	
WT	L-DOPA	 99.25	±	4.823	 92434	±	2845	 85.684	±	3.614	 16	
PunchEY02616A/+	Control	 135.938	±	5.568	 76008	±	2424	 143.438	±	5.379	 16	
PunchEY02616A/+	L-DOPA	 103.75	±	7.183	 80486	±	2260	 103.174	±	7.273	 16	
Punchr1/+	Control	 121.875	±	6.149	 76677	±	2561	 127.819	±	6.948	 16	




WT	Control	 79.5	±	2.387	 79675	±	2596	 NA	 17	
WT	L-DOPA	 99.25	±	4.823	 92434	±	2845	 85.684	±	3.614	 16	
DdcDE1/+	Control	 122.4	±	6.037	 85837	±	3604	 117.457	±	8.588	 15	
DdcDE1/+	L-DOPA	 95.25	±	4.915	 93066	±	2374	 81.524	±	3.485	 16	
SOD1n1/SOD1n64	Control	 107.857	±	6.181	 78697	±	5381	 111.738	±	4.945	 14	







WT	 78.389	±	2.776	 74892	±	1956	 NA	 19	
PunchEY02616A/+	 144.136	±	6.812	 77676	±	2415	 152.790	±	6.516	 22	
jraIA109/+	 81	±	4.05	 74095	±	1970	 83.115	±	5.585	 16	
PunchEY02616A/jraIA109	 84.778	±	1.909	 80369	±	3430	 82.124	±	4.188	 18	
PunchEY02616A/+;SpinGAL




WT	 78.389	±	2.776	 74892	±	1956	 NA	 19	
PunchEY02616A/+	 144.136	±	6.812	 77676	±	2415	 152.790	±	6.516	 22	
kay1/+	 89.938	±	3.219	 91915	±	1847	 73.726	±	3.352	 16	
PunchEY02616A/kay1	 88.625	±	4.0793	 70634	±	2762	 96.753	±	5.069	 16	
PunchEY02616A/+;	




WT	 82.143	±	3.28	 76363	±	3251	 NA	 14	
PunchEY02616A/+	 136.6	±	3.433	 77163	±	1584	 136.22	±	4.771	 15	
SpinGAL4>UAS-
PunchA-WT;	
PunchEY02616A	 76.733	±	3.947	 73460	±	2766	 80.7	±	4.616	 15	
SpinGAL4>UAS-
PunchA-S37E;	
PunchEY02616A	 83	±	3.559	 86030	±	3040	 74.589	±	3.569	 16	
	
Figure	5.15.	Punch	overexpression	rescues	DEM-induced	synaptic	overgrowth	
WT	 82.143	±	3.28	 76363	±	3251	 NA	 14	
WT	10mM	DEM	 117.429	±	4.704	 80280	±	2873	 113.887	±	6.966	 14	
SpinGAL4>UAS-
PunchA-WT	Control	 68.786	±	4.897	 76497	±	2781	 69.225	±	4.973	 14	
SpinGAL4>UAS-
PunchA-WT	10mM	DEM	 84.067	±	3.445	 79483	±	2265	 80.857	±	2.632	 15	
SpinGAL4>UAS-
PunchA-S37E	Control	 78.4	±	3.810	 80751	±	4035	 76.495	±	4.886	 16	
SpinGAL4>UAS-
PunchA-S37E	10mM	




WT	 82.143	±	3.28	 76363	±	3251	 NA	 14	
WT	10mM	DEM	 117.429	±	4.704	 80280	±	2873	 113.887	±	6.966	 14	
PunchEY02616A/+	10mM	




DEM	 100.944	±	4.123	 75477	±	3453	 102.181	±	4.100	 18	
SpinGAL4>UAS-








WT	 76.375	±	3.696	 83660	±	2394	 NA	 16	
nSybGAL4>UAS-Punch	 77.187	±	3.312	 83489	±	3462	 79.252	±	4.540	 16	
WT	10mM	DEM	 128.063±6.242	 84310±3997	 132.07±9.929	 16	
nSybGAL4>UAS-Punch	
10mM	DEM	 78.4	±	4.769	 80648	±	3475	 82.559	±	5.429	 15	
PunchEY02616A/+	 135.938±5.568	 76008±2424	 150.612±5.648	 16	
nSybGAL4>UAS-Punch;	




WT	 76.375	±	3.696	 83660	±	2394	 NA	 16	
hiwND9/Y	 138.25	±	5.379	 85062	±	3107	 137.712	±	5.862	 16	
nSybGAL4>UAS-Punch;	









Figure	 3.2.	 DEM	 increases	 NMJ	 branch	 number	 and	 length,	 causing	 synaptic	
overgrowth	
WT	0mM	DEM	 9.25	±	1.082	 74892	±	1956	 NA	 8	
WT	1mM	DEM	 12	±	0.866	 81306	±	3085	 10.99	±	0.776	 9	
WT	3mM	DEM	 12.1	±	1.197	 84375	±	3014	 11.369	±	1.148	 10	
WT	10mM	DEM	 15	±	1.011	 70958	±	2744	 17.13	±	1.320	 10	




WT	Control	 8.7	±	0.512	 79675	±	2596	 NA	 10	
WT	10mM	Trolox	 9.3	±	0.857	 86712	±	2381	 8.311	±	0.691	 10	
WT	10mM	DEM	 12	±	0.897	 84310	±	3997	 11.910	±	1.026	 9	
WT	10mM	DEM	+	10mM	
Trolox	
7.2	±	0.463	 81954	±	3798	 7.177	±	0.559	 9	
	
Figure	 5.2.	 Heterozygous	 Punch	 mutants	 exhibit	 increased	 NMJ	 length	 and	
branching		
WT	 9	±	0.942	 82162	±	3434	 NA	 10	
PunchEY02616A/CS	 16.455	±	1.575	 77676	±	2415	 18.285	±	1.848	 11	
PunchEY02616A/w1118	 15.4	±	1.147	 77692	±	2098	 16.867	±	1.310	 10	
Punchr1/CS	 19.2	±	1.162	 81548	±	1669	 19.216	±	1.017	 10	
Punchr1/w1118	 14.444	±	1.237	 70168	±	1852	 17.013	±	1.248	 9	
		
Figure	 5.8.	 Trolox	 treatment	 rescues	 increased	 branch	 number	 observed	 in	
heterozygous	Punch	mutants		
WT	Control	 8.7	±	0.512	 79675	±	2596	 NA	 10	
WT	10mM	Trolox	 9.3	±	0.857	 86712	±	2381	 8.311	±	0.691	 10	
PunchEY02616A/+	Control	 12.8	±	1.052	 76008	±	2424	 13.315	±	0.878	 10	
PunchEY02616A/+	10mM	Trolox	 9	±	1.047	 85354	±	2020	 8.441	±	0.831	 10	
Punchr1/+	Control	 12.4	±	1.035	 76677	±	2561	 13.195	±	1.156	 10	




WT	 9	±	0.719	 76363	±	3251	 NA	 14	
PunchEY02616A/+	 14	±	0.730	 77163	±	1584	 14.210	±	0.795	 10	
SpinGAL4>UAS-PunchA-WT;	
PunchEY02616A	
9.1	±	0.526	 73460	±	2766	 9.638	±	0.624	 10	
SpinGAL4>UAS-PunchA-S37E;	
PunchEY02616A	







WT	 9	±	0.719	 76363	±	3251	 NA	 14	
WT	10mM	DEM	 13.7	±	0.955	 80280	±	2873	 13.111	±	1.116	 10	
SpinGAL4>UAS-PunchA-WT	
Control	
7.5	±	0.671	 76497	±	2781	 7.532	±	0.571	 10	
SpinGAL4>UAS-PunchA-WT	
10mM	DEM	
8.6	±	0.777	 79483	±	2265	 8.379	±	0.649	 10	
SpinGAL4>UAS-PunchA-S37E	
Control	
9	±	0.696	 80751	±	4035	 8.623	±	0.638	 10	
SpinGAL4>UAS-PunchA-S37E	
10mM	DEM	




WT	 9	±	0.719	 76363	±	3251	 NA	 14	
WT	10mM	DEM	 13.7	±	0.955	 80280	±	2873	 13.111	±	1.116	 10	
PunchEY02616A/+	10mM	DEM	 12.9	±	1.233	 78262	±	3324	 12.897	±	1.436	 10	
SpinGAL4>UAS-PunchA-WT;	
PunchEY02616A	10mM	DEM	
9.3	±	0.873	 75477	±	3453	 9.003	±	0.693	 10	
SpinGAL4>UAS-PunchA-S37E;	
PunchEY02616A	10mM	DEM	




WT	 8.8	±	0.784	 83660	±	2394	 8.849	±	0.899	 10	
hiwND9/Y	 13.9	±	0.924	 85062	±	3107	 13.283	±	0.803	 10	
nSybGAL4>UAS-Punch;	
hiwND9/Y	
















WT	0mM	DEM	 373	±	37.829	 74892	±	1956	 NA	 8	
WT	1mM	DEM	 442	±	25.018	 81306	±	3085	 402.63	±	21.205	 9	
WT	3mM	DEM	 431	±	25.399	 84375	±	3014	 402.60	±	21.536	 10	
WT	10mM	DEM	 432.7	±	17.305	 70958	±	2744	 496.07	±	33.068	 10	




WT	Control	 399.9	±	25.531	 79675	±	2596	 NA	 10	
WT	10mM	Trolox	 454.4	±	32.243	 86712	±	2381	 406.142	±	24.812	 10	
WT	10mM	DEM	 527.111	±	42.941	 84310	±	3997	 515.416	±	32.634	 9	
WT	10mM	DEM	+	10mM	
Trolox	
383.888	±	36.798	 81954	±	3798	 372.527	±26.226	 9	
		
Figure	5.2.	Heterozygous	Punch	mutants	exhibit	increased	NMJ	length	and	branching		
WT	 378.92	±	28.768	 82162	±	3434	 NA	 10	
PunchEY02616A/CS	 542.636	±	26.457	 77676	±	2415	 598.294	±	33.944	 11	
PunchEY02616A/w1118	 465.2	±	26.937	 77692	±	2098	 505.374	±	20.262	 10	
Punchr1/CS	 617.8	±	35.058	 81548	±	1669	 615.729	±	24.836	 10	




WT	Control	 399.9	±	25.531	 79675	±	2596	 NA	 10	
WT	10mM	Trolox	 454.4	±	32.243	 86712	±	2381	 406.142	±	24.812	 10	
PunchEY02616A/+	Control	 494.9	±	32.897	 76008	±	2424	 516.193	±	26.493	 10	
PunchEY02616A/+	10mM	
Trolox	
449.7	±	38.664	 85354	±	2020	 424.765	±	36.029	 10	
Punchr1/+	Control	 460.8	±	24.848	 76677	±	2561	 491.651	±	30.263	 10	




WT	 404.429	±	25.817	 76363	±	3251	 NA	 14	
PunchEY02616A/+	 516	±	16.508	 77163	±	1584	 524.760	±	23.068	 10	
SpinGAL4>UAS-PunchA-
WT;	PunchEY02616A	
407.5	±	31.442	 73460	±	2766	 424.793	±	23.150	 10	
SpinGAL4>UAS-PunchA-
S37E;	PunchEY02616A	




WT	 404.429	±	25.817	 76363	±	3251	 NA	 14	
	219	
WT	10mM	DEM	 537.9	±	17.944	 80280	±	2873	 514.870	±	34.625	 10	
SpinGAL4>UAS-PunchA-
WT	Control	
317.5	±	23.615	 76497	±	2781	 319.224	±	21.701	 10	
SpinGAL4>UAS-PunchA-
WT	10mM	DEM	
416.7	±	30.880	 79483	±	2265	 407.197	±	29.012	 10	
SpinGAL4>UAS-PunchA-
S37E	Control	
401.2	±	30.152	 80751	±	4035	 383.989	±	32.088	 10	
SpinGAL4>UAS-PunchA-
S37E	10mM	DEM	




WT	 404.429	±	25.817	 76363	±	3251	 NA	 14	
WT	10mM	DEM	 537.9	±	17.944	 80280	±	2873	 514.870	±	34.625	 10	
PunchEY02616A/+	10mM	
DEM	












WT	 375.8	±	20.024	 83660	±	2394	 376.350	±	26.426	 10	
hiwND9/Y	 558.4	±	39.417	 85062	±	3107	 528.959	±	28.665	 10	
nSybGAL4>UAS-Punch;	
hiwND9/Y	
















Q7KRU0	 40	 42913	 3	 1	 0.08	 7.55	 CG2246,	isoform	C	
OS=Drosophila	melanogaster	
GN=CG2246	PE=4	SV=1	
A4V3Q6	 40	 51030	 1	 1	 0.06	 5.66	 Elongation	factor	1-alpha	
OS=Drosophila	melanogaster	
GN=Ef1alpha100E	PE=3	SV=1	









Q24185	 27	 77187	 1	 1	 0.04	 3.77	 Protein	hook	OS=Drosophila	
melanogaster	GN=hk	PE=1	
SV=2	
E1JGX3	 24	 236244	 1	 1	 0.01	 0.94	 Nipped-B,	isoform	G	
OS=Drosophila	melanogaster	
GN=Nipped-B	PE=4	SV=1	
Q1W9P9	 23	 194724	 1	 1	 0.02	 1.89	 Echinus	splice	form	3	
OS=Drosophila	melanogaster	
GN=ec	PE=2	SV=1	
H9XVM5	 18	 152135	 1	 1	 0.02	 1.89	 CG31998,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG31998	PE=4	SV=1	





Q7KMG7	 17	 28736	 2	 1	 0.12	 11.32	 Ercc1	OS=Drosophila	
melanogaster	GN=Ercc1	PE=4	
SV=1	
A8DYZ4	 17	 62630	 1	 1	 0.05	 4.72	 CG34162	OS=Drosophila	
melanogaster	GN=CG34162	
PE=4	SV=2	
































Q0KHZ6	 43	 27258	 1	 1	 0.12	 9.23	 CG7834,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG7834	PE=4	SV=1	
Q7KRU0	 33	 42913	 2	 1	 0.08	 6.15	 CG2246,	isoform	C	
OS=Drosophila	melanogaster	
GN=CG2246	PE=4	SV=1	
Q1W9P9	 28	 194724	 3	 1	 0.02	 1.54	 Echinus	splice	form	3	
OS=Drosophila	melanogaster	
GN=ec	PE=2	SV=1	
Q7KMG7	 25	 28736	 1	 1	 0.12	 9.23	 Ercc1	OS=Drosophila	
melanogaster	GN=Ercc1	PE=4	
SV=1	
M9ND86	 23	 104102	 1	 1	 0.03	 2.31	 Spellchecker1,	isoform	D	
OS=Drosophila	melanogaster	
GN=spel1	PE=3	SV=1	
A8JNP1	 20	 40126	 1	 1	 0.08	 6.15	 Arginine	kinase,	isoform	G	
OS=Drosophila	melanogaster	
GN=Argk	PE=3	SV=2	
Q9VUC2	 17	 196543	 1	 1	 0.02	 1.54	 Bluestreak	OS=Drosophila	
melanogaster	GN=blue	PE=4	
SV=1	
Q7YU67	 17	 124911	 1	 1	 0.03	 2.31	 RE68041p	OS=Drosophila	
melanogaster	GN=Sema-5c	
PE=2	SV=1	




A1ZBB1	 14	 37132	 1	 1	 0.09	 6.92	 Galectin	OS=Drosophila	
melanogaster	GN=CG5335-RA	
PE=2	SV=1	









E1JGP0	 74	 40574	 3	 3	 0.26	 15.20	 Actin	57B,	isoform	C	
OS=Drosophila	melanogaster	
GN=Act57B	PE=2	SV=1	









Q9V3P0	 30	 21952	 1	 1	 0.15	 8.77	 Peroxiredoxin	1	
OS=Drosophila	melanogaster	
GN=Jafrac1	PE=1	SV=1	
A1ZA58	 24	 64366	 1	 1	 0.05	 2.92	 CG33464	OS=Drosophila	
melanogaster	GN=sli	PE=4	
SV=2	
Q9W0D3	 23	 221067	 1	 1	 0.01	 0.58	 CG13917,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG13917	PE=2	SV=1	
E2QD61	 21	 195649	 1	 1	 0.02	 1.17	 CG34384,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG14462	PE=4	SV=1	
Q8I8V0-2	 20	 48856	 1	 1	 0.07	 4.09	 Isoform	A	of	Transcriptional	
adapter	2B	OS=Drosophila	
melanogaster	GN=Ada2b	
Q9VFE0	 20	 24433	 2	 1	 0.14	 8.19	 AT11516p	OS=Drosophila	
melanogaster	GN=RpL10Aa	
PE=2	SV=1	




Q7K540	 19	 29422	 1	 1	 0.11	 6.43	 GH14032p	OS=Drosophila	
melanogaster	GN=yuri	PE=2	
SV=1	
Q9W309	 18	 17778	 1	 1	 0.19	 11.11	 CG9686	OS=Drosophila	
melanogaster	GN=CG9686	
PE=2	SV=1	




Q7KUW4	 17	 45872	 2	 1	 0.07	 4.09	 CG7206,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG7206-RB	PE=2	SV=1	
Q8MLW8	 16	 55163	 1	 1	 0.06	 3.51	 Cht12	OS=Drosophila	
melanogaster	GN=Cht12	
PE=3	SV=1	
Q9VXQ7	 16	 21383	 1	 1	 0.16	 9.36	 CG8206	OS=Drosophila	
melanogaster	GN=CG8206	
PE=2	SV=1	










P19107	 49	 45342	 3	 3	 0.24	 20.51	 Phosrestin-1	OS=Drosophila	
melanogaster	GN=Arr2	PE=1	
SV=2	








B7Z098	 39	 70654	 1	 1	 0.05	 4.27	 CG7414,	isoform	D	
OS=Drosophila	melanogaster	
GN=CG7414	PE=4	SV=2	
O62619	 34	 57917	 1	 1	 0.06	 5.13	 Pyruvate	kinase	
OS=Drosophila	melanogaster	
GN=PyK	PE=2	SV=2	
Q9VJB0	 25	 25461	 2	 1	 0.13	 11.11	 Elfless,	isoform	B	
OS=Drosophila	melanogaster	
GN=elfless	PE=2	SV=2	
E1JJN9	 24	 258571	 1	 1	 0.01	 0.85	 Set2,	isoform	B	
OS=Drosophila	melanogaster	
GN=Set2	PE=4	SV=1	
Q9VGR0	 20	 34863	 1	 1	 0.1	 8.55	 CG17187	OS=Drosophila	
melanogaster	GN=CG17187	
PE=2	SV=2	
Q8T3Z0	 17	 49975	 1	 1	 0.07	 5.98	 AT25102p	OS=Drosophila	
melanogaster	GN=Tektin-C	
PE=2	SV=1	
M9NES0	 15	 41315	 1	 1	 0.08	 6.84	 Arrestin	1,	isoform	B	
OS=Drosophila	melanogaster	
GN=Arr1	PE=4	SV=1	








Q8IMA2	 14	 52240	 1	 1	 0.06	 5.13	 CG32006	OS=Drosophila	
melanogaster	GN=CG32006-
RA	PE=2	SV=1	















L0MQ04	 71	 54649	 4	 3	 0.19	 6.71	 ATP	synthase	subunit	beta	
OS=Drosophila	melanogaster	
GN=ATPsyn-beta	PE=3	SV=1	
Q9VT23	 63	 28337	 3	 2	 0.25	 8.83	 CG8329	OS=Drosophila	
melanogaster	GN=CG8329	
PE=3	SV=1	
Q9W3M7	 52	 100698	 1	 1	 0.03	 1.06	 CG10777	OS=Drosophila	
melanogaster	GN=CG10777	
PE=2	SV=1	
P19107	 41	 45342	 1	 1	 0.07	 2.47	 Phosrestin-1	OS=Drosophila	
melanogaster	GN=Arr2	PE=1	
SV=2	




Q9VRL0	 36	 33857	 1	 1	 0.1	 3.53	 CG4769,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG4769	PE=2	SV=1	




















O62619	 24	 57917	 1	 1	 0.06	 2.12	 Pyruvate	kinase	
OS=Drosophila	melanogaster	
GN=PyK	PE=2	SV=2	




Q9VXP3	 22	 65238	 1	 1	 0.05	 1.77	 GH05406p	OS=Drosophila	
melanogaster	GN=mRpS30	
PE=2	SV=1	
Q1RL12	 22	 37343	 1	 1	 0.09	 3.18	 IP16413p	OS=Drosophila	
melanogaster	GN=nrv2	PE=2	
SV=1	




P48596	 20	 35804	 1	 1	 0.09	 3.18	 GTP	cyclohydrolase	1	
OS=Drosophila	melanogaster	
GN=Pu	PE=2	SV=3	
Q9VJ21	 18	 148749	 1	 1	 0.02	 0.71	 CG31792,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG31792	PE=3	SV=4	
E1JJM7	 18	 138872	 1	 1	 0.02	 0.71	 LIM-kinase1,	isoform	E	
OS=Drosophila	melanogaster	
GN=LIMK1	PE=4	SV=1	








E2QD61	 17	 195649	 1	 1	 0.02	 0.71	 CG34384,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG14462	PE=4	SV=1	
P40797	 16	 60448	 1	 1	 0.05	 1.77	 Protein	peanut	
OS=Drosophila	melanogaster	
GN=pnut	PE=1	SV=2	
Q9V4E6	 16	 82046	 1	 1	 0.04	 1.41	 Maverick	OS=Drosophila	
melanogaster	GN=mav	PE=2	
SV=1	




Q9VHT2	 15	 36839	 1	 1	 0.09	 3.18	 FI07663p	OS=Drosophila	
melanogaster	GN=tex	PE=2	
SV=1	
B5RIM9	 14	 39931	 1	 1	 0.08	 2.83	 FI03663p	OS=Drosophila	
melanogaster	GN=Gpdh	
PE=2	SV=1	
Q8INE6	 14	 13510	 1	 1	 0.25	 8.83	 AT25705p	OS=Drosophila	
melanogaster	GN=Oscp	PE=2	
SV=1	
















Q9VT23	 84	 28337	 3	 3	 0.4	 21.16	 CG8329	OS=Drosophila	
melanogaster	GN=CG8329	
PE=3	SV=1	
Q8INE6	 67	 13510	 1	 1	 0.25	 13.23	 AT25705p	OS=Drosophila	
melanogaster	GN=Oscp	PE=2	
SV=1	
P19107	 40	 45342	 1	 1	 0.07	 3.70	 Phosrestin-1	OS=Drosophila	
melanogaster	GN=Arr2	PE=1	
SV=2	








Q9V429	 28	 12859	 1	 1	 0.27	 14.29	 Thioredoxin-2	
OS=Drosophila	melanogaster	
GN=Trx-2	PE=1	SV=2	
Q9VB18	 28	 155635	 1	 1	 0.02	 1.06	 Tusp	OS=Drosophila	
melanogaster	GN=Tusp	
PE=4	SV=3	
E1JJM7	 27	 138872	 1	 1	 0.02	 1.06	 LIM-kinase1,	isoform	E	
OS=Drosophila	melanogaster	
GN=LIMK1	PE=4	SV=1	




Q8IMI5	 20	 64115	 1	 1	 0.05	 2.65	 FI04474p	OS=Drosophila	
melanogaster	GN=spdo	PE=2	
SV=1	
M9PF59	 18	 95157	 1	 1	 0.03	 1.59	 CG43759,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG42506	PE=4	SV=1	
E1JIV0	 18	 28503	 1	 1	 0.12	 6.35	 CG5902,	isoform	C	
OS=Drosophila	melanogaster	
GN=CG5902	PE=4	SV=1	
Q9W444	 18	 231343	 1	 1	 0.01	 0.53	 CG5937,	isoform	C	
OS=Drosophila	melanogaster	
GN=CG5937	PE=4	SV=3	




E2QD61	 17	 195649	 1	 1	 0.02	 1.06	 CG34384,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG14462	PE=4	SV=1	
Q9VA18	 16	 24397	 1	 1	 0.14	 7.41	 Lethal	(3)	03670	
OS=Drosophila	melanogaster	
GN=l(3)03670	PE=2	SV=1	
M9PDT5	 15	 103120	 1	 1	 0.03	 1.59	 Bric	a	brac	1,	isoform	D	
OS=Drosophila	melanogaster	
GN=bab1	PE=4	SV=1	













Q0E9E2	 225	 133332	16	 16	 0.44	 9.64	 CG1516,	isoform	I	
OS=Drosophila	melanogaster	
GN=PCB	PE=4	SV=1	



























Q9VD58	 38	 40698	 2	 2	 0.16	 3.51	 CG6439,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG6439	PE=2	SV=1	





32	 42174	 2	 2	 0.15	 3.29	 Actin	87E,	isoform	C	
OS=Drosophila	melanogaster	
GN=Act87E	PE=4	SV=1	
L0MQ04	 59	 54649	 1	 1	 0.06	 1.31	 ATP	synthase	subunit	beta	
OS=Drosophila	melanogaster	
GN=ATPsynbeta	PE=3	SV=1	
Q7KY08	 58	 107348	4	 1	 0.001	 0.02	 Argonaute	protein	
OS=Drosophila	melanogaster	
GN=AGO1	PE=2	SV=1	
A8DYH1	 55	 197410	3	 1	 0.02	 0.44	 Muscle	wasted,	isoform	C	
OS=Drosophila	melanogaster	
GN=mute	PE=4	SV=1	





M9NDP0	 45	 212195	3	 1	 0.001	 0.02	 CG9932,	isoform	C	
OS=Drosophila	melanogaster	
GN=CG9932	PE=4	SV=1	
A8JRB8	 39	 43402	 1	 1	 0.07	 1.53	 CG5028,	isoform	C	
OS=Drosophila	melanogaster	
GN=CG5028-RC	PE=2	SV=1	
Q7KMG7	 36	 28736	 5	 1	 0.11	 2.41	 Ercc1	OS=Drosophila	
melanogaster	GN=Ercc1	
PE=4	SV=1	





29	 159101	2	 1	 0.02	 0.44	 Tusp,	isoform	G	
OS=Drosophila	melanogaster	
GN=Tusp	PE=4	SV=1	
X2JAP0	 28	 36952	 2	 1	 0.08	 1.75	 CG4623,	isoform	C	
OS=Drosophila	melanogaster	
GN=Gdap1	PE=4	SV=1	








Q9VA48	 24	 72871	 5	 1	 0.04	 0.88	 Serpin	100A	OS=Drosophila	
melanogaster	GN=Spn100A	
PE=3	SV=1	
Q8MZG9	 24	 36730	 4	 1	 0.08	 1.75	 CG2070,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG2070	PE=2	SV=1	
Q8IQH4	 23	 89778	 1	 1	 0.03	 0.66	 CG10948,	isoform	D	
OS=Drosophila	melanogaster	
GN=CG10948	PE=4	SV=2	













22	 246680	1	 1	 0.01	 0.22	 Slit,	isoform	F	OS=Drosophila	
melanogaster	GN=sli	PE=4	
SV=1	




Q9VAJ9	 22	 34825	 1	 1	 0.09	 1.97	 CG1907	OS=Drosophila	
melanogaster	GN=CG1907	
PE=2	SV=1	




Q7KT60	 20	 273958	1	 1	 0.01	 0.22	 CG31817	OS=Drosophila	
melanogaster	GN=CG31817	
PE=4	SV=2	





Q95U34	 20	 54777	 1	 1	 0.06	 1.31	 GH11113p	OS=Drosophila	
melanogaster	GN=Galk	PE=2	
SV=1	




E1JJM7	 19	 138872	1	 1	 0.02	 0.44	 LIM-kinase1,	isoform	E	
OS=Drosophila	melanogaster	
GN=LIMK1	PE=4	SV=1	




P18167	 19	 61415	 1	 1	 0.05	 1.10	 Esterase	P	OS=Drosophila	
melanogaster	GN=Est-P	
PE=2	SV=2	
Q9VEV2	 19	 52111	 1	 1	 0.06	 1.31	 CG14882,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG14882	PE=4	SV=1	
















17	 123367	1	 1	 0.02	 0.44	 Slamdance,	isoform	C	
OS=Drosophila	melanogaster	
GN=sda	PE=4	SV=1	




P55830	 17	 30549	 1	 1	 0.1	 2.19	 40S	ribosomal	protein	S3a	
OS=Drosophila	melanogaster	
GN=RpS3A	PE=1	SV=4	
Q9VZ81	 16	 141219	1	 1	 0.02	 0.44	 CG13708,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG13708	PE=4	SV=1	








Q9VB05	 16	 92938	 1	 1	 0.03	 0.66	 ALG-2	interacting	protein	X	
OS=Drosophila	melanogaster	
GN=ALiX	PE=1	SV=1	
Q9VVH0	 16	 66606	 1	 1	 0.05	 1.10	 AT14039p	OS=Drosophila	
melanogaster	GN=CG12229	
PE=2	SV=1	
Q9I7V0	 15	 137381	1	 1	 0.02	 0.44	 Mid1	ortholog,	isoform	A	
OS=Drosophila	melanogaster	
GN=Mid1	PE=2	SV=3	
Q9W2U2	 15	 41763	 1	 1	 0.07	 1.53	 CG32687,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG32687	PE=2	SV=2	





15	 43075	 1	 1	 0.07	 1.53	 CG2246,	isoform	J	
OS=Drosophila	melanogaster	
GN=CG2246	PE=4	SV=1	
Q9W3W6	 15	 375647	1	 1	 0.01	 0.22	 CG14438,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG14438	PE=4	SV=2	
Q9VXQ7	 14	 21383	 1	 1	 0.15	 3.29	 CG8206,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG8206	PE=2	SV=1	














Q0E9E2	 158	 133332	 9	 7	 0.15	 2.87	 CG1516,	isoform	I	
OS=Drosophila	melanogaster	
GN=PCB	PE=4	SV=1	
X2JCP8	 103	 42194	 7	 7	 0.64	 12.26	 Actin	5C,	isoform	E	
OS=Drosophila	melanogaster	
GN=Act5C	PE=3	SV=1	








P06603	 103	 50561	 5	 4	 0.27	 5.17	 Tubulin	alpha-1	chain	
OS=Drosophila	melanogaster	
GN=alphaTub84B	PE=2	SV=1	















39	 79811	 3	 3	 0.12	 2.30	 Glycogen	synthase,	isoform	D	
OS=Drosophila	melanogaster	
GN=GlyS	PE=4	SV=1	
Q9VNW6	 67	 84610	 2	 2	 0.04	 0.77	 CG7470,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG7470	PE=2	SV=1	













L0MQ04	 17	 54649	 2	 2	 0.12	 2.30	 ATP	synthase	subunit	beta	
OS=Drosophila	melanogaster	
GN=ATPsynbeta	PE=3	SV=1	
Q7KY08	 85	 107348	 6	 1	 0.03	 0.57	 Argonaute	protein	
OS=Drosophila	melanogaster	
GN=AGO1	PE=2	SV=1	
M9NDP0	 66	 212195	 4	 1	 0.001	 0.02	 CG9932,	isoform	C	
OS=Drosophila	melanogaster	
GN=CG9932	PE=4	SV=1	




Q7KMG7	 55	 28736	 14	 1	 0.11	 2.11	 Ercc1	OS=Drosophila	
melanogaster	GN=Ercc1	
PE=4	SV=1	
A8DYH1	 50	 197410	 3	 1	 0.02	 0.38	 Muscle	wasted,	isoform	C	
OS=Drosophila	melanogaster	
GN=mute	PE=4	SV=1	















Q9VTP0	 30	 411349	 7	 1	 0.01	 0.19	 CG42255	OS=Drosophila	
melanogaster	GN=CG32092	
PE=4	SV=4	
X2JAP0	 29	 36952	 3	 1	 0.08	 1.53	 CG4623,	isoform	C	
OS=Drosophila	melanogaster	
GN=Gdap1	PE=4	SV=1	




E1JJM7	 27	 138872	 1	 1	 0.02	 0.38	 LIM-kinase1,	isoform	E	
OS=Drosophila	melanogaster	
GN=LIMK1	PE=4	SV=1	










26	 246680	 1	 1	 0.01	 0.19	 Slit,	isoform	F	OS=Drosophila	
melanogaster	GN=sli	PE=4	
SV=1	
X2J7M7	 26	 54884	 1	 1	 0.06	 1.15	 CG4658,	isoform	E	
OS=Drosophila	melanogaster	
GN=CG4658	PE=4	SV=1	
Q9VD58	 25	 40698	 1	 1	 0.08	 1.53	 CG6439,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG6439	PE=2	SV=1	






24	 159101	 2	 1	 0.02	 0.38	 Tusp,	isoform	G	
OS=Drosophila	melanogaster	
GN=Tusp	PE=4	SV=1	





22	 43075	 5	 1	 0.07	 1.34	 CG2246,	isoform	J	
OS=Drosophila	melanogaster	
GN=CG2246	PE=4	SV=1	
Q8SYU5	 22	 52762	 1	 1	 0.06	 1.15	 CG10086	OS=Drosophila	
melanogaster	GN=CG10086	
PE=2	SV=1	
Q9V4I0	 22	 59268	 1	 1	 0.05	 0.96	 Cytochrome	P450	9b1	
OS=Drosophila	melanogaster	
GN=Cyp9b1	PE=2	SV=1	




















A1ZBM3	 20	 155575	 1	 1	 0.02	 0.38	 Outer	segment	6	
OS=Drosophila	melanogaster	
GN=Oseg6	PE=4	SV=1	
Q7KT60	 20	 273958	 4	 1	 0.01	 0.19	 CG31817	OS=Drosophila	
melanogaster	GN=CG31817	
PE=4	SV=2	









A8JQX3	 20	 72804	 1	 1	 0.04	 0.77	 Curled,	isoform	D	
OS=Drosophila	melanogaster	
GN=cu	PE=4	SV=1	
Q9VA48	 20	 72871	 4	 1	 0.04	 0.77	 Serpin	100A	OS=Drosophila	
melanogaster	GN=Spn100A	
PE=3	SV=1	




Q0E8E2	 19	 128674	 1	 1	 0.02	 0.38	 CG4998,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG4998	PE=3	SV=1	















17	 91996	 1	 1	 0.03	 0.57	 Flyers-cup,	isoform	F	
OS=Drosophila	melanogaster	
GN=f-cup	PE=4	SV=1	















16	 98526	 1	 1	 0.03	 0.57	 CG2698,	isoform	D	
OS=Drosophila	melanogaster	
GN=CG2698	PE=4	SV=1	
Q86P48	 16	 43142	 1	 1	 0.07	 1.34	 AT-rich	binding	protein	
OS=Drosophila	melanogaster	
GN=ATbp	PE=2	SV=2	
M9PD43	 16	 28020	 1	 1	 0.11	 2.11	 CG16865,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG16865	PE=4	SV=1	
































P48596	 40	 35804	 2	 2	 0.18	 9.36	 GTP	cyclohydrolase	1	
OS=Drosophila	melanogaster	
GN=Pu	PE=2	SV=3	





Q7K5K3	 49	 39611	 1	 1	 0.08	 4.16	 CG11876,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG11876	PE=2	SV=1	











35	 28324	 1	 1	 0.11	 5.72	 14-3-3zeta,	isoform	K	
OS=Drosophila	melanogaster	
GN=14-3-3zeta	PE=4	SV=1	










Q9Y119	 26	 92046	 1	 1	 0.03	 1.56	 BcDNA.GH08860	
OS=Drosophila	melanogaster	
GN=Tps1	PE=2	SV=1	
X2JFT2	 26	 100239	1	 1	 0.001	 0.05	 CG9634,	isoform	B	
OS=Drosophila	melanogaster	
GN=goe	PE=4	SV=1	
Q9VMQ3	 25	 26904	 1	 1	 0.12	 6.24	 CG14016-PA	OS=Drosophila	
melanogaster	GN=tomb	
PE=2	SV=1	





19	 68668	 1	 1	 0.04	 2.08	 CG11180,	isoform	B	
OS=Drosophila	melanogaster	
GN=CG11180	PE=4	SV=1	




Q9V3H9	 17	 113870	1	 1	 0.03	 1.56	 BcDNA.LD27873	
OS=Drosophila	melanogaster	
GN=Nab2	PE=2	SV=1	
Q9VC40	 16	 38348	 1	 1	 0.001	 0.05	 CG5805,	isoform	A	
OS=Drosophila	melanogaster	
GN=CG5805	PE=2	SV=1	
Q9V477	 16	 154976	1	 1	 0.02	 1.04	 Cell	surface	receptor	TOLLO	
OS=Drosophila	melanogaster	
GN=Tollo	PE=2	SV=1	
D2CFV7	 16	 32763	 1	 1	 0.001	 0.05	 CG42619	(Fragment)	
OS=Drosophila	melanogaster	
GN=PRY	PE=4	SV=1	
A1ZAY9	 16	 67827	 1	 1	 0.05	 2.60	 Ionotropic	receptor	54a	
OS=Drosophila	melanogaster	
GN=Ir54a	PE=4	SV=2	
Q8IRS2	 14	 88069	 1	 1	 0.001	 0.05	 CG2861,	isoform	C	
OS=Drosophila	melanogaster	
GN=CG2861-RA	PE=2	SV=2	
































Q9VMQ3	 29	 26904	 1	 1	 0.12	 5.28	 CG14016-PA	OS=Drosophila	
melanogaster	GN=tomb	
PE=2	SV=1	













































Q9W1M7	 20	 108504	 2	 1	 0.03	 1.32	 GH13170p	OS=Drosophila	
melanogaster	GN=Pi3K59F	
PE=1	SV=2	










Q9VGW4	 19	 318080	 1	 1	 0.01	 0.44	 CG14692	OS=Drosophila	
melanogaster	GN=CG14692	
PE=4	SV=4	




Q7JYK1	 18	 15005	 1	 1	 0.21	 9.24	 RE10554p	OS=Drosophila	
melanogaster	GN=RpL40	
PE=2	SV=1	






























Q8MRN4	 16	 115660	 2	 1	 0.03	 1.32	 GH12664p	OS=Drosophila	
melanogaster	GN=Ppi1	
PE=2	SV=1	
Q9VIH0	 16	 43940	 1	 1	 0.07	 3.08	 CG9272	OS=Drosophila	
melanogaster	GN=CG9272	
PE=4	SV=2	
Q9VCW3	 16	 136088	 1	 1	 0.02	 0.88	 LP09464p	OS=Drosophila	
melanogaster	GN=Nup133	
PE=2	SV=2	




















Q4V671	 14	 19494	 1	 1	 0.001	 0.04	 CG16739	OS=Drosophila	
melanogaster	GN=CG16739	
PE=2	SV=1	



















Q9VVU1	 43	 45565	 4	 3	 0.22	 10.37	 CG3902-PA	OS=Drosophila	
melanogaster	GN=CG3902-
RA	PE=2	SV=1	









Q9VGD8	 28	 82275	 2	 1	 0.04	 1.89	 GH27720p	OS=Drosophila	
melanogaster	GN=ssp5	
PE=2	SV=1	
Q9VGW4	 28	 318080	 2	 1	 0.01	 0.47	 CG14692	OS=Drosophila	
melanogaster	GN=CG14692	
PE=4	SV=4	
Q9VN14	 17	 159110	 2	 1	 0.001	 0.05	 Contactin	OS=Drosophila	
melanogaster	GN=Cont	
PE=1	SV=2	





















































Q9W1M7	 22	 108504	 1	 1	 0.03	 1.41	 GH13170p	OS=Drosophila	
melanogaster	GN=Pi3K59F	
PE=1	SV=2	












Q9VIU5	 16	 105611	 1	 1	 0.03	 1.41	 CG10137	OS=Drosophila	
melanogaster	GN=CG10137	
PE=2	SV=2	



















Q9VB46	 14	 63547	 1	 1	 0.001	 0.05	 FI18644p1	OS=Drosophila	
melanogaster	GN=Hmu	
PE=2	SV=1	













































Q8SZ30	 22	 31474	 1	 1	 0.1	 7.69	 RE19845p	OS=Drosophila	
melanogaster	GN=spn-D	
PE=2	SV=1	




Q9W1S3	 21	 103179	 1	 1	 0.03	 2.31	 CG9861	OS=Drosophila	
melanogaster	GN=CG9861-
RA	PE=2	SV=1	































Q9VV75	 14	 45559	 1	 1	 0.07	 5.38	 AT02348p	OS=Drosophila	
melanogaster	GN=UQCR-C2	
PE=2	SV=1	
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